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Terpenes are secondary natural products consisting of carbon five units produced by 
terpene synthase. They have been found to have functional importance ranging from 
medical uses (taxadiene), biofuel potential and taste and smell for cinnamon and mint. One 
terpene precursor substrate can produce up to 400 different products through various 
terpene synthase with some single enzymes producing over 50 different compounds. This 
broad chemical diversity is a critical focus for the engineering effort to produce novel 
terpenes.  
 
Terpene synthase reactions are all initiated by the removal of a pyrophosphate to create a 
cation that is shaped in a hydrophobic section of the active site controlling the product 
structure. Little is known about how this hydrophobic region controls production, so this site 
is the focus of engineering work.  
 
The aim of this project was to engineer Streptomyces pristinaespiralis selina-4(15),7(11)-
diene synthase to produce novel compounds. Through this engineering, we could gain 
mechanistic insight into Streptomyces pristinaespiralis selina-4(15),7(11)-diene synthase 
and terpene synthases. Streptomyces pristinaespiralis selina-4(15),7(11)-diene synthase is a 
specific terpene synthase with selina-4(15),7(11)-diene comprising over 90% of the product 
profile and the second by-product germacrene B.  
 
Using ligand binding software, a series of site directed mutants was produced with the aim of 
altering product binding and product distribution. An “in culture” GC/MS screen was 
developed to screen these targeted mutagenesis variants. Initially alanine scanning was 
performed at specific points in the active sites to identify potential hotspots for further 
targeted mutagenesis. While no novel products were found in the current screening, variant 
V187F showed a switch in specificity between the products and a Y152F showed a 50:50 
ratio of wild-type products. The kinetic parameters of V187F and Y152F were determined 
and showed an increased Km  suggesting the variant reduces the substrate affinity favouring 
specificity of germacrene B. It was concluded that, V187 and Y152 have a key roles in the 
conversion of germacrene B to selina-4(15),7(11)-diene and the formation of the two rings. 
This mechanistic insight may be used to engineer futher terpene synthase to produce novel 
ring terpenes.   
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Chapter 1 – Introduction 
 
1.1 Natural Products 
Natural products are defined as compounds of limited molecular weight (less than 3000 Da) 
produced by living organisms and can be classified into primary and secondary metabolites. 
Primary metabolites are directly involved in normal growth and development of the organism 
whereas secondary metabolites are not necessarily produced under all conditions (Dewick, 
2011). Therefore, secondary metabolites can be described as non-essential molecules, not 
required for the organism’s normal metabolism (Figure 1-1) (Dar et al., 2017). A wide variety 
of organisms including animal, bacteria and fungi produce a wide variety of natural products 
with a range of functions. These functions range from defensive responses to toxic products. 
The chemical diversity of natural products comes from the diversity of the organisms and 
their biological activities (Bernardini et al., 2018). There is a large potential number of 
uncharacterised natural products in unexplored species and organisms’ silent biosynthetic 
gene clusters (Boufridi and Quinn, 2018).  
 
Figure 1-1 The four main structural classes of natural products. Structural examples for 
each of the four main classes of natural products or secondary metabolites.  
 
Natural products have been a large source for pharmaceuticals with approximately half of all 
drugs in current use being natural products or natural product derivatives (Dar et al., 2017). 
Of the 175 anticancer drugs that were FDA approved between 1940 and 2014, 63% were 
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natural products or natural product derivatives (Boufridi and Quinn, 2018). On average 
natural products have higher oxygen content and a lower nitrogen content when compared 
to the potential chemical space, while favouring aliphatic over aromatic structures with 38% 
of characterised natural products containing arenes (Rodrigues et al., 2016).  
 
Natural products have been used as medicinal sources throughout history, with a significant 
shift towards natural products following the isolation of penicillin in 1928 by Alexander 
Fleming and its subsequent development for clinical use in the 1940s. Following this the 
focus was on the isolation of products from microbial sources and the discovery of antibiotics 
including; tetracycline and streptomycin (Bernardini et al., 2018) (Carlson, 2010). Preceding 
the discovery of penicillin, Friedrich Sertürner discovered alkaloids by isolating morphine 
from the poppy plant in 1817 and the consequent isolation of other alkaloids, caffeine and 
nicotine from plant sources (Bernardini et al., 2018). In addition, the first natural compound 
produced by chemical synthesis was salicylic acid in 1853 by Charles Gerhardt leading to 
the development of the drug aspirin (Jeffreys, 2004). Following these advances a large focus 
was put on the isolation of natural products until the second half of the 20th century when 
pharmaceutical efforts shifted towards the use of combinatorial chemistry and the production 
of libraries by chemical synthesis (Carlson, 2010). However, these libraries did not have the 
hoped-for impact when compared to previous natural product libraries results with a several 
fold higher hit rate (Newman and Cragg, 2016). Recent efforts show 43% of published clinal 
candidates in 2016 and 2017 were derived from previously known compounds compared to 
29% identified from random high throughput screening (Brown and Boström, 2018). So, in 
recent years the focus has shifted back towards natural products and their derivatives with 
the advancement of emerging genetic technologies.  
 
1.2 Terpenes    
Terpenes are a range of chemically diverse compounds consisting of isoprene units with 
over 80,000 chemically distinct characterised products (Figure 1-2) (Byres et al., 2007) 
(Harms, Kirschning and Dickschat, 2020) (Leferink et al., 2019). The number of 
characterised terpenes is increasing due to emerging genome analysis, genome mapping 
and biosynthetic tools (Citron et al., 2012). Terpene diversity is derived from cation 
quenching and the range of hydrocarbon backbones (Zhou and Peters, 2011). This 
assembly mechanism leads to a diverse range of linear and chiral skeletons from a limited 
number of substrates, with one substrate producing over 400 characterised products 
(Ajikumar et al., 2008).  
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Terpene substrates are produced from sequential isomerisation of isoprene units. As 
terpenes are produced from carbon five isoprene units, they can be categorised by 
constituent number. A single isoprene unit is found in the hemiterpenes and two isoprene 
units are monoterpenes (Figure 1-2). Three isoprene units are sesquiterpenes and four 
isoprene units are diterpenes (Figure 1-2). Both five and seven isoprene units, sesterpenes 
and sesquaterpenes respectively, are rare in nature, however both six and eight isoprene 
units, triterpenes and tetraterpenes respectively, are common in nature (Figure 1-2). Larger 
terpenes are produced in nature for example natural rubber consists of cis polyisoprene 
units (Gao, Honzatko and Peters, 2012).    
 
Figure 1-2 Schematic of terpene nomenclature. Schematic of increasing numbers of C5 
isoprene units and the associated nomenclature.   
 
Terpenes are produced by a variety of organisms including bacteria, plants, yeast and fungi. 
In addition, recently terpenes have been found in Dictyostelium discoideum, a social amoeba 
with various terpenes dependent on their developmental stage (Rabe et al., 2016).   
 
Terpenoids are functionally and chemically modified terpene skeletons, modified by tailoring 
enzymes including; P450 and acyl transferases (Ajikumar et al., 2008) (Rinkel et al., 2016). 
Terpenes are volatile compounds and have a high vapour pressure at room temperature 
(Ajikumar et al., 2008).    
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1.2.1 Functional importance of terpene’s 
Characterised terpenes have a wide variety of functional roles within the producing organism 
and to the benefit humans. These roles include; antimicrobial, antifungal, antiviral, 
antiparasitic and potential biofuels (Ajikumar et al., 2008). One of the most notable 
terpenoid’s is paclitaxel, an anticancer agent that acts by binding tubulin heterodimers 
stopping cell division (Figure 1-3a). Paclitaxel is a diterpenoid extracted from bark of yew 
trees Taxus chinenis that can be used to treat breast and ovarian cancers (Edgar et al., 
2017) (Ajikumar et al., 2008). Other terpenes with anticancer activity include D-limonene and 
perillyl alcohol that inhibit post-translational isoprenylation of proteins regulating cell growth 
and can be used to treat a range of cancers (Figure 1-3b and c) (Ajikumar et al., 2008). 
 
Another medically important terpenoid’s is artemisinin extracted from Artemisia annua to 
treat malaria using the epoxide ring in Figure 1-1 (Withers and Keasling, 2007) (Tu, 2017). 
Various antibacterial diterpenes have been extracted from Salvia species acting against 
bacterial species which include; S. aureus, S. epidermis, B. subtilis, E. coli. In addition to  
antibacterial activity, terpenoids can have antifungal activity for example carvone is 
antifungal agent which is active against Candida albicans, a human pathogenic fungi (Figure 
1-3d). Terpenes and terpenoids have natural advantages as drugs with low toxicity and low 
skin irritation along with good penetration (Gao, Honzatko and Peters, 2012). In addition 
there are a variety of terpene functions that are not medically relevant such as a 
hydrogenated bisabolene, bisabolane is a potential biofuel with similar properties to diesel 
fuel D2 (Figure 1-3e) (McAndrew et al., 2011). Terpenoids are also the molecules 
responsible for the taste and scents in cinnamon and mint (Fujisawa et al., 2010).   
 
Terpenes also have vital roles within the organism that produce them including; defence, 
attraction, ecological communication between organism and cell regulation (Miller and 
Allemann, 2012). For example (E)-"-bisabolene from Abies grandis is produced following 
wound inducing signals as shown from stem wounding experiments (Bohlmann et al., 1998). 
Terpenoids constitute a large range of plant hormones with a variety of key functions. 
Stringolactones are essential plant terpenoid hormones that regulate roots structures and 
branching (Figure 1-3f) (Chen, Zhang and Lindley, 2019). Carotenoids are the light 
harvesting terpenoids, involved in regulation of photosynthesis and protect plants from the 
effect of UV radiation (Figure 1-3g) (Chen, Zhang and Lindley, 2019). Volatile terpenes can 
be released to attract pollinators for example (E)-β-ocimene and myrcene are released from 
snapdragon flowers in floral development (Figure 1-3h and i) (Tholl, 2006). Other plant 
hormones are used for defence and therefore can be used as environmentally friendly 
insectides (Ajikumar et al., 2008).      
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Figure 1-3 Schematic of functionally important terpenes. (a) Structure of paclitaxel. (b) 
Structure of d-limonene. (c) Structure of perilly alcohol. (d) Structure of carvone. (e) 
Structure of bisabolene. (f) Structure of (+)-strigol a stringolactone. (g) Structure of !-
carotene a carotenoid. (h) Structure of (E)- !-ocimene. (i) Structure of myrcene.    
 
1.3 Isoprene unit production  
Isoprenes are five carbon units with the molecular formula C5H8 and are produced by 
combinations of isopentyl pyrophosphate and dimethylallyl pyrophosphate (Tholl, 2006). The 
isoprene precursor compounds are produced by two separate pathways; the mevalonic acid 
(MVA) pathway (Figure 1-4) and the methylerythritol phosphate (MEP) pathway (Figure 1-5). 
The MVA pathway is active in the cytosol of bacteria, plants, fungi and other eukaryotes 
mainly for the production of triterpenes and sesquiterpenes. The MVA pathway consist of 7 
enzymatic reactions. Whereas the MEP pathway is active in plants and bacteria to supply 
precursors mainly for monoterpene and diterpene production (Roberts, 2007) (Ajikumar et 
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al., 2010). This second pathway consists of 8 reaction steps. Mechanisms for both pathways 
were determined using isotopic labelling experiments and are described below (Figure 1-4 





Figure 1-4 Schematic of the mevalonate pathway producing isopentyl pyrophosphate 
(IPP) and dimethylallyl pyrophosphate (DMAPP). The pathway begins with a thioester 
Claisen condensation reaction joining two molecules of acetyl-CoA forming acetoacetyl-CoA. 
Next is a thioester Claisen condensation reaction by 3-hydroxy-3-methylglutaryl-CoA 
synthase (HMG-CoA synthase) joining acetoacetyl-CoA to an acetyl-CoA forming 3-hydroxy-
3-methylglutaryl-CoA (HMG-CoA) (Ajikumar et al., 2008). HMG-CoA synthase contains a 
nucleophilic cysteine residue used to acetylate the enzyme releasing the reduced co-
enzyme A followed by a nucleophilic attack of acetyl-CoA (Theisen et al., 2004). Next HMG-
CoA is reduced and the co-enzyme A is released forming mevalonate using HMG-CoA 
reductase and NADPH (Haines, Wiest and Stauffacher, 2013) (Ajikumar et al., 2008). 
Mevalonate and phosphomevalonate kinases perform sequential phosphorylation of 
mevalonate using two molecules of ATP forming mevalonate-5-phosphate and then 
mevalonate-5-diphosphate. Mevalonate-5-diphosphate is converted to IPP through an ATP 
dependent decarboxylation in a two-step reaction. The first step of reaction is 
phosphorylation to produce a reactive intermediate which undergoes dephosphorylation and 
decarboxylation as the second step (Byres et al., 2007). To convert IPP to DMAPP isopentyl 
pyrophosphate isomerase utilises a protonation / deprotonation mechanism to isomerise the 
double bond. OPP is used on drawing IPP and DMAPP to signify pyrophosphate.   
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Figure 1-5 Schematic of the methylerythritol phosphate pathway producing isopentyl 
pyrophosphate and dimethylallyl pyrophosphate. Pyruvate and glyceraldehyde-3-
phosphate (G3P) undergo acyloin condensation to produce 1-deoxy-D-xylulose-5-phosphate 
(DXP) by DXP synthase and a thiamine pyrophosphate cofactor (UniProt, 2017) (Ajikumar et 
al., 2008). DXP undergoes and NADP dependent reduction and rearrangement under the 
control of DXP reductoisomerase (IspC) forming 2-C-methyl-D-erythritol-4-phosphate 
(Ajikumar et al., 2008). After 4-diphosphocytidyl-2-C-methyl-d-erythritol synthase utilises a 
nucleophilic attack mechanism to join cytidine diphosphate to 2-C-methyl-D-erythritol-4-
phosphate forming 4-diphosphocytidyl-2-C-methyl-d-erythritol (Jin et al., 2016). 4-
diphosphocytidyl-2-C-methyl-D-erythritol kinase utilises ATP to phosphorylate 4-
diphosphocytidyl-2-C-methyl-d-erythritol forming 4-diphosphocytidyl-2-C-methyl-d-erythritol-
2-phosphate. Following this 2-C-methyl-D-erythritol-2,4-cyclodiphsophate synthase 
catalyses the removal of the CMP forming 2-C-methyl-D-erythritol-2,4-cyclodiphsophate 
(Richard et al., 2002) (Kemp, Bond and Hunter, 2002). 2-C-methyl-D-erythritol-2,4-
cyclodiphsophate was then oxidised 4-hydroxy-3-methylbut-2-enyl diphosphate by 4-
hydroxy-3-methylbut-2-enyl-diphosphate synthase (IspG). 4-hydroxy-3-methylbut-2-enyl 
diphosphate reductase (IspH) then produces IPP and DMAPP which are used further in 
terpene production.     
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Both pathways utilise common cell metabolism products to produce the isomers IPP and 
DMAPP. Isopentyl-diphosphate isomerase (or isopentyl pyrophosphate isomerase) (IDI) 
stereospecificially converts IPP to DMAPP by isomerising the carbon-carbon double bond 
(Ajikumar et al., 2008). There are two types of IDI enzymes; IDI-I found in eukaryotes and 
some bacteria (including E. coli)  and IDI-II found in some Streptomyces strains, archaea 
and bacteria. Both types are monomeric, divalent cation-dependent enzymes with alternating 
α-helices and β-sheets creating a buried active site (Zheng et al., 2007). Metal ion 
coordination and key glutamate residues stabilise the carbocation formed by the initial 
protonation in the reaction mechanism (Zheng et al., 2007). 
 
1.3.1 Prenyltransferases  
Prenyltransferases catalyse the synthesis of linear prenyl pyrophosphates by the head to tail 
condensation of DMAPP and IPP in a sequential manner to produce products of various 
terpene precursors lengths (Tholl, 2015). The general mechanism of action is the elimination 
of a pyrophosphate ion to form an allylic cation which is subsequently attacked by an IPP 
molecule and the stereospecific removal of a proton from the newly formed carbon-carbon 
bond (Figure 1-6) (Tholl, 2015) (Ajikumar et al., 2008). Cis- or trans- stereochemistry of the 
double bonds in the prenyl pyrophosphate product determines whether the enzyme operates 
as a cis or trans prenyltransferase. The majority of work has focused on trans-short chain 
prenyltransferases producing monoterpene, sesquiterpene and diterpenes but there is 





Figure 1- 6 Schematic shows the sequential addition of IPP units in a head-to-tail 
condensation. The schematic shows head-to-tail condensation of IPP and DMAPP. The 
DMAPP is ionised as the pyrophosphate leaves creating an electrophile. This electrophile is 
then attacked by the double bond in IPP creating a new carbon bond. Consequently a proton 
is abstracted to remove the positive charge on the cation using a base provided in the 
enzyme creating a double bond (Kennepohl, 2016).       
Short-chain prenyltransferases share a common 13 "-helices protein fold with 10 "-helices 
forming the active site. Substrates are bound within the active site that contains 2 highly 
conserved aspartate-rich regions; DDx2-4D (FARM or first aspartate-rich-motif) and DDxxD 
(SARM or second aspartate-rich-motif) binding divalent metal ions. The product chain length 
is in part regulated by the amino acids upstream of the FARM in the hydrophobic substrate 
binding region: the bulkier the residues the shorter the chain. This is shown when comparing 
farnesyl pyrophosphate synthase’s bulkier aromatic residues and geranylgeranyl 
pyrophosphate synthase’s smaller residues in the same locations. In addition, the second 
layer of active site residues can provide additional active site flexibility and can influence the 
chain lengths (Tholl, 2015) (Christianson, 2017).  
 
1.4 Terpene synthase 
Terpene synthases catalyse the cyclisation reactions of isoprene-based substrates. The 
ionisation of a pyrophosphate ester generates an allylic carbocation. Once the highly 
reactive cation is formed it can undergo a reaction cascade and structural rearrangement 
before final reaction termination by proton elimination or solvent addition (Christianson, 


































rearrangements (Christianson, 2017). Folding of the substrate carbocation within the active 
site may act as a template for the product (Zhou and Peters, 2011). This folding brings the 
carbocation and the C-C cyclisation bond in close proximity for initiating ionisation and 
cyclisation due to anchimeric assistance or interaction of an electron pair and its adjacent 
reaction centre (Zhou and Peters, 2011).  Terpene synthases catalyse reactions with high 
regio- and stereospecificity and produce enantiomerically pure products (Rinkel et al., 2016). 
Some terpene synthases are highly specific producing one specific product and some 
produce product mixtures (Tholl, 2006). Due to their reaction mechanism and the 
stereospecificity of products terpene synthases are mechanistically and chemically 
interesting enzymes (Dickschat, 2017). 
 
All terpene synthases have tertiary homology containing catalytically critical aspartate 
residues and a hydrophobic pocket but have low primary sequence homology (Wendt and 
Schulz, 1998) (Shishova et al., 2007). The primary sequence homology is conserved to the 
aspartate rich motifs that coordinate divalent cations to stabilise the pyrophosphate moiety, 
predominantly magnesium ions (Rynkiewicz, Cane and Christianson, 2001) (Little and 
Croteau, 2002) (McAndrew et al., 2011) (Gao, Honzatko and Peters, 2012). The binding of 
divalent cations is postulated to induce the conformational changes needed to close and 
sequester the active site (Vedula et al., 2005). The hydrophobic pocket is the lower region of 
the active site and is predominantly lined with hydrophobic and aromatic residues that create 
a template for shaping and orienting the substrate. The aromatic residues create an 
electrostatic effect to stabilise the cation through cation-pi interactions. (Dougherty, 1996). 
However the secondary layer of residues for the active site can generate further diversity 
with an effect on the active site contour (Lodeiro et al., 2004). All terpene synthases have 
these key features but otherwise can be classified in two classes; I and II (see section 1.4.1 
and 1.4.2). Terpene synthases can also be classed as specific or promiscuous enzymes 
depending on the number of products produced.   
 
1.4.1 Class I terpene synthases 
Class I terpene synthases have a classic "-helical terpene synthase fold called the "-
domain. The active site contains two conserved aspartate rich motifs that bind divalent 
cations; DDxxD motif and NSE or DTE motif (Figure 1-7). The DDxxD motif is typically found 
on helix D. The NSE or DTE motif is found on helix H with the sequence 
(N,D)D(L,I,V)X(S,T)XXXE (Christianson, 2017). These motifs resemble the motif in 
prenylelongases, leading to a similar catalytic mechanism with ionisation of the allylic 
diphosphate ester bond and pyrophosphate removal forming a cation (Figure 1-7) (Gao, 
 27 
Honzatko and Peters, 2012). The quenching of the cation, enzyme activity and active site 
contour produces the diversity in the products (Tholl, 2015). Class I terpene synthases are 
traditionally monoterpene synthase, sesquiterpene synthase, sesterterpene synthase and 
some diterpene synthase (Christianson, 2017) (Tholl, 2006).   
 
 
Figure 1-7 Alignment of class I active sites with farnesyl pyrophosphate synthase. (a) 
Alignment of class I active sites of Selina-4(15),7(11)-diene synthase in grey (PDB 4OKM), 
pentalene synthase in gold  (PDB 1PS1), Aspergillus terreus aristolochene synthase in blue 
(PDB 2OA6), Penicillium roqueforti aristolochene synthase in green (PDB 1DI1), 5-epi-
arisotolchene synthase in pink (PDB 51K9) and farnesyl pyrophosphate synthase in orange 
(PDB 1UBX) using SALIGN. (b) Active site alignment in pymol of farnesyl pyrophosphate 
synthase (PDB 1UBX) with magnesium ions and farnesyl pyrophosphate and Nicotiana 
tabacum 5-epi-aristolochene synthase (PDB 5IK9) with farnesyl monophosphate. Overall the 
active sites helices align well in shape and the magnesium ions can coordinate both bound 
substrates.  
 
Monoterpene synthases catalyse the cyclisation of the C10 isoprenoid substrate geranyl 
pyrophosphate. All cyclisation reactions proceed through the formation of the "-terpinyl 
carbocation resulting from the C1-C6 bond formation (Christianson, 2017). The diverse 
products are then controlled by the enzyme active site contour acting as a product template, 
with the more product-like the template the more high-fidelity the terpene synthase 
(Christianson, 2017). Previously a number of monoterpene synthases have been structurally 
and functionally characterised producing various crystal structures. These crystal structures 
suggest some monoterpene synthases have a coordinated solvent molecule for further 
diversity in the termination products (Christianson, 2017). One example of a monoterpene 
synthase is bornyl diphosphate synthase, a homodimer with multiple crystal structures 
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containing an active site water. However this active site water is not directly involved in the 
termination of the product but in the coordination of the cation (Christianson, 2017).  
 
Specific sesquiterpene synthases cyclise the C15 farnesyl pyrophosphate into over 400 
products through six initial cyclisation routes compared to monoterpenes one (Yamada et al., 
2015). These cyclisation events will either form; 1,10-(E,E)-germacradienyl cation, 1,11-
(E,E)-humulyl cation or nerolidyl cation leading to a 1,6-bisabolyl cation, 1,7-cycloheptenyl 
cation and (E,Z)- germacradienyl and humulyl cations (Figure 1-8) (Harms, Kirschning and 
Dickschat, 2020). Many sesquiterpene synthases have been structurally and functionally 
characterised and show a diverse range of products and features all with the core class I 
components. For example, pentalene synthase is a monomeric sesquiterpene synthase 
whereas trichodiene synthase is an antiparallel homodimer (Lesburg et al., 1997) 
(Rynkiewicz, Cane and Christianson, 2001). These differences are even seen between the 
same enzyme but from different species as aristolochene synthase from Penicillium 
roqueforti is a monomer and produces side products germacrene A and valencene whereas 
that from Aspergillus terreus is a tetramer with tight specificity (Caruthers et al., 2000) 
(Shishova et al., 2008) (Yu, Miller and Allemann, 2007). When comparing the active site of 
each enzyme the active site contour shape is similar suggesting a similar level of control on 
their final product with differences seen at the secondary layer of the active site contour 




Figure 1-8 Schematic of the sesquiterpene cyclisation cations. Schematics of the six 
cyclisation mechanisms from farnesyl pyrophosphate and the six distinct cations which are 
the basis of the over 400 sesquiterpene products.  
 
1.4.2 Class II terpene synthases  
Class II terpene synthases all contain a hydrophobic pocket and an aspartate motif within 
their enzyme active sites similar to class I. However only one aspartate motif, DXDD, is 
found in class II active sites, unrelated to the class I aspartate motif (Christianson, 2017). 
Structurally, class II enzymes have a minimum of two domains, ! and #. Both domains are 
made up of " helices and the class II active site is at the interface of the two domains 
(Christianson, 2017). Class II terpene synthases initiate reactions differently from class I by 
protonating to C-C or $ bond in the epoxide moiety forming a carbocation that moves 
towards the hydrophobic pocket of the active site (Christianson, 2017). Class II terpene 
synthases include triterpene synthase and some diterpene synthases.  
 
Triterpene synthases act on C30 isoprenoid substrates and due to the substrate size the 
enzyme active site contour is critical to the product (Christianson, 2017). Triterpene 
synthases initiate reactions by protonating the terminal $ bond of squalene or the terminal 
epoxide moiety of squalene oxide creating a cation for the cascade of carbon-carbon bond 
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forming and rearranging reactions (Christianson, 2017). One example of a triterpene 
synthase is squalene-hopene cyclase which has been extensively studied and crystallised in 
a variety of mechanistic conformations. In addition, squalene-hopene cyclase can also be 
active (Bronsted acid activation) with C15, C20, C30 and C35 substrates. An additional example 
is oxidosqualene cyclase with the expected !# domain structure homologous to squalene-
hopene cyclase. Through computational and crystallographic studies, a mechanism has 
been postulated for oxidosqualene cyclase initiated by protonation (Christianson, 2017).  
 
Diterpene synthases act on geranylgeranyl pyrophosphate and initiate reactions by 
protonating the terminal $ bond of geranylgeranyl pyrophosphate. Generally this initiation 
goes along with the formation of both the C10-C15 and C6-C11 bonds forming the bicyclic 
intermediate before the cascade of further reactions (Christianson, 2017). One diterpene 
synthase has been extensively studied in two organisms ent-Copalyl diphosphate synthase 
from Arabidopis thaliana and Streptomyces platensis CB00739 (Sun Tai ping and Kamiya, 
1994) (Rudolf et al., 2016). The bacterial enzyme has a !# domain architecture whereas, the 
plant enzyme has a "!# domain with a non-functional "	domain. However using crystal 
structures with a variety of substrates and sequence comparison the same mechanism of 
action has been postulated for both enzymes (Christianson, 2017). 
 
1.4.3 Bifunctional terpene synthases                      
Bifunctional terpene synthases catalyse tandem or coupled cyclisation reactions in two 
distinct active sites on the same protein. Previously it was thought these reactions are only 
tandem diterpene cyclisation reactions but other examples have been found more recently 
(Christianson, 2017). In these bifunctional enzymes there is not always a channel to direct 
the product of one reaction to the second active site. One example geosmin synthase, is an 
"" domain bifunctional enzyme that first catalyses the cyclisation of farnesyl pyrophosphate 
to germacradienol and minor amounts of germacrene D. Following this a protonation 
dependent cyclisation-fragmentation produces C12 geosmin and acetone (Cane et al., 2006). 
Geosmin synthase has two class I terpene synthase " domains both with bound magnesium 
ions with the N-terminal domain catalysing the first reaction and C-terminal the second 
reaction (Christianson, 2017). Another example is abietadiene synthase which contains a 
class I and a class II active site cyclising geranylgeranyl pyrophosphate (Christianson, 
2017). The first reaction is the initial cyclisation of geranylgeranyl pyrophosphate copalyl 
pyrophosphate in a class II active site by protonation. The second reaction occurs in the 
class I active site with bound magnesium ions to form a tricyclic carbocation and 
consequently abietadiene (Christianson, 2017).  
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1.5 Terpene synthase structures 
As discussed terpene synthases have low primary sequence homology but all have 
catalytically critical aspartate residues and a hydrophobic active site (Degenhardt, Köllner 
and Gershenzon, 2009). The catalytic importance of aspartate rich motifs was established 
due to the loss of activity and loss of efficiency through the decrease in kcat and increase in 
Km (Yoshikuni, Ferrin and Keasling, 2006) (Felicetti and Cane, 2004). The hydrophobic active 
sites are electron rich and unreactive but have a key role in shaping and orientating the 
cation into productive conformations (Lodeiro et al., 2004) (Li et al., 2014) (Vedula et al., 
2008). Generally terpene synthase reactions are successful as a more product like 
isoprenoid analogue is more thermodynamically favourable (Christianson, 2008). 
 
1.5.1 Class I terpene synthase structures  
Class I terpene synthases have a characteristic "-helical domain called the classic terpene 
synthase fold by Oldfield (Harris et al., 2015). Generally the key DDxx(D,E) motif is located 
on helix D and coordinates magnesium ions A and C whereas the DTE/NSE motif is on helix 
H and binds magnesium ion B (Figure 1-9) (Miller and Allemann, 2012) (Degenhardt, Köllner 
and Gershenzon, 2009). From structural analysis it is postulated that the closing of the active 
site cap is dependent on metal ion binding and not substrate binding (Rynkiewicz, Cane and 
Christianson, 2002). In addition even though terpene synthases have low primary sequence 
homology there is a conserved arginine residue 46 residue upstream of the NSE motif which 





Figure 1-9 Class I active site with key aspartate motif residues highlighted. Active site 
of Nicotiana tabacum 5-epi-aristolochene synthase (PDB 5IK9) with farnesyl 
monophosphate and three magnesium ions bound. Highlighted are the key aspartate 
residues D301, D304, D305, D444 and E452 in the critical aspartate motifs. These residues 
are shown to be involved in the binding and control of three magnesium ions and 
consequently the phosphate moiety on farnesyl monophosphate. D301, D304 and D305 are 
within the DDxxD and D444 and E452 are part of the NSE motif.       
 
Limonene synthases are monoterpene synthase and have been found and studied in 
various organisms. Despite all isotypes having a sequence identity below 50%, they all have 
similar tertiary structural features (Figure 1-10). Two structural examples are (+)-limonene 
synthase from Citrus sinensis and (4S)(-)-limonene synthase from Mentha spicata 
(Christianson, 2017). Both limonene synthases have a 2 "-helical domain architecture with 
both domains adopting similar overall folds (Figure 1-10). The C-terminal domain contains 
the monoterpene synthase active site and has all the characteristic features of a class I 
terpene synthase. (+)-Limonene synthase C-terminal domain terpene fold consists of 12 
helices with the enzyme active site consisting of mostly nonpolar, hydrophobic and aromatic 
amino acids but is flanked on either side with aspartate motifs (Figure 1-10b) (Morehouse et 
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al., 2017). The enzyme contour of both enzymes is similar to orient the carbocation in the 
same manner. Both N-terminal domains have no known function except being involved in 
the closing of the C-terminal active site. The (+)-limonene synthase has a pair of arginine 
residues involved in sensing the closure of the active site (Morehouse et al., 2017). Whereas 
in (4S)(-)-limonene synthase the N-terminal domain folds back to form a component of the 
active site cap with the J and K helices (Figure 1-10c) (Hyatt et al., 2007). Both limonene 
synthases have been crystallised with a variety of substrate and intermediate analogues 
including; 2-flurogeranyl pyrophosphate and 2-fluorolinalyl pyrophosphate in which the 
electron withdrawing fluorine atoms make the analogues unreactive (Hyatt et al., 2007).  
 
 
Figure 1-10 Comparison of limonene synthase structures. (a) SALIGN alignment of + 
limonene synthase from Citrus sinensis in red (PDB 5UV1) and chain A of – limonene 
synthase from Mentha spicata in blue (PDB 2ONG). The alignment has a score of 96.5% 
showing how similar the two structures and active site are. (b) Structure of +limonene 
synthase from Citrus sinensis (PDB 5UV1) with the manganese ions used for crystallisation 
displayed in green and 2-flurogeranyl pyrophosphate bound in the active site displayed in 
yellow. (c) Structure of (4S)(–)-limonene synthase from Mentha spicata (PDB 2ONG) with 
the magnesium ions used for crystallisation displayed in green and 2-flurogeranyl 
pyrophosphate bound in the active site displayed in yellow. 
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Sesquiterpene synthases have been extensively studied. They have a large structural 
variation especially at a quaternary level, but all contain the key class I terpene synthase 
features. Pentalene synthase is the smallest sesquiterpene synthase as an "-terpene 
domain monomer with 11 "-helices (Figure 1-11d). Five of these 11 "-helices with longer 
loops surround the active site with a cavity 15 Å deep and 9 Å wide (Lesburg et al., 1997). 
As with other terpene synthases the bottom of the active site cavity is predominantly 
hydrophobic with aromatic residues to shape the cation, with F77 and N219 said to direct the 
cation into a U shaped conformation (Lesburg et al., 1997). The most closely related terpene 
synthase to pentalene synthase is epi-isozizianene from Streptomyces coelicolor, with 10 " 
helices forming the "-helical terpene fold (Figure 1-11c) (Aaron et al., 2010). One significant 
difference is the epi-isozizianene synthase active site is deeper and defined by 5 helices 
(Aaron et al., 2010). There are a number of structures of epi-isozizanene with a variety of 
substrate analogues and a number of mutagenesis studies including in the aspartate motifs 
and aromatic residues in the hydrophobic cavity of the active site (Blank, Barrow and 
Christianson, 2019). These mutations create changes in the active site contour and the 
product profile of the enzyme. Hedycaryol synthase from Kitasatospora setae KM-6054, is 
another monomeric sesquiterpene synthase with 11 antiparallel "-helices all connected 
through short loops and contains all the key class I terpene synthase structural features 
(Figure 1-11b) (Baer, Rabe, Citron, et al., 2014). Despite producing chemically distinct 
terpenes and despite having low sequence homology these three single domain terpene 
synthases align with a score of 91 % (Braberg et al., 2012). Therefore, diversity is based on 
the specific protein sequence and the active site contour the sequence forms (Figure 1-11a) 
(Braberg et al., 2012).      
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Figure 1-11 Structures and structural alignment of single domain sesquiterpene 
synthases. (a) SALIGN alignment of epi-isozizaene synthase from Streptomyces coelicolor 
in green (PBD 4LTV), hedycaryol synthase from Kitasatospora setae KM-6054 in pink (PDB 
4MC0) and pentalene synthase from Streptomyces exfolitaus in gold (PDB 1PS1). Overall, 
the structures align well with a score of 91.0 % with the main differences seen in the loops 
and ends of helices with the majority of the helices giving the overall terpene fold. (b) 
Structure of epi-isozizaene synthase from Streptomyces coelicolor in the apo form (PDB 
4LTV) showing the classical terpene synthase fold. (c) Structure of hedycaryol synthase 
from Kitasatospora setae KM-6054 in apo from (PDB 4MC0) showing the classical terpene 
synthase fold. (d) Structure of pentalene synthase from Streptomyces exfolitaus in apo from 
(PDB 1PS1) showing the classical terpene synthase fold. Comparison of the structures 
shows the key differences are on the left-hand side of the structures.         
 
Other sesquiterpene synthases are dimeric or heteromeric and have additional domains with 
unknown functions like limonene synthase. Trichodiene synthase is an antiparallel 
homodimeric terpene synthase from Fusarium sporotrichiodes (Rynkiewicz, Cane and 
Christianson, 2001). A monomer of trichodiene synthase has 17 "-helices with 6 helices 
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creating the active site and containing the DDxx(D,E) and NSE motifs for binding 3 
magnesium ions. As with other sesquiterpene synthases, trichodiene synthase has multiple 
structures with various ligands as well as having undergone mutagenesis studies, 
specifically of the critical aspartate residues. This includes D100E which was crystallised in 
apo conformation and with pyrophosphate. These structures show the active site is over 10 
% larger by attenuating the closure of the active site. As a result, only two magnesium ions 
bind to the active site, weakening the electrostatic environment around the pyrophosphate 
moiety. This mutation produces 4 premature products and a 20 fold decrease in kcat/Km 
compared to wild type (Rynkiewicz, Cane and Christianson, 2002). Another dimer-forming 
sesquiterpene synthase is "-eudesmol synthase from Streptomyces chartreusis NRRL 3882 
with each monomer consisting of 14 "-helices connected by short loops (Kracht et al., 2019). 
However other sesquiterpene synthases have a 2 domain, "! architecture. The  " domain is 
a classic class I terpene synthase whereas the ! domain has no known function, but as with 
limonene synthase forms a component of the active site cap (Blank, Shinsky and 
Christianson, 2019).  
 
Structural differences can be seen for the same enzyme from different organisms. Both  
aristolochene synthase from Penicillium roqueforti (PR-AS) and Aspergillus terreus (AT-AS) 
were characterised biochemically and structurally with a variety of substrate and 
intermediate analogues (Figure 1-12) (Caruthers et al., 2000) (Shishova et al., 2008). The 
two enzymes share 61 % sequence similarity and have major structural differences with 
minor differences in the product profile as AT-AS is highly specific and PR-AS produces 
minor amounts of germacrene A and valencene (Caruthers et al., 2000). PR-AS is 38 kDa 
monomeric consisting of 11 "-helices with 6 helices creating a 15 Å deep and 20 Å wide 
active site cavity (Figure 1-12b). Whereas AT-AS is a tetramer, a dimer of dimers (Figure 1-
12c). Each AT-AS monomer is made up of 13 "-helices but is only 36 kDa with PR-AS 6 "-
helices making up the active site. Both active sites are complementary to aristolochene 
structure and contain all the key class I active site features. The DDXX(D, E) motif is on helix 
D and the NSE motif is on helix H. Both active sites display induced fit closure with helices 
G1, H and the F-G1 loop showing shift between the apo and bound structures forming the 
active site cap (Shishova et al., 2007) (Shishova et al., 2008) (Yu, Miller and Allemann, 
2007). Both active sites have three key aromatic residues (two phenylalanine’s and one 
tryptophan) that stabilise the eudesmane cation through aromatic $ interactions.	In PR-AS 
these residues are F112, F178 and W334 whereas in AT-AS they are F87, F153 and W308 
(Caruthers et al., 2000) (Shishova et al., 2007). 
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Figure 1-12 Structures of aristolochene synthase. (a) SALIGN of Penicillium roqueforti 
aristolochene synthase in orange (PDB 1DGP) and chain A of Aspergillus terreus 
aristolochene synthase in green (PDB 3BNX). Alignment displays only subtle differences 
away from the active site with an alignment score of 97.9%. (b) Structure of monomeric 
Penicillium roqueforti aristolochene synthase (PDB 1DGP) with farnesol bound in yellow. (c) 
Structure of the tetramer of Aspergillus terreus aristolochene synthase (PDB 3BNX) with 
each chain coloured a different shade of green. Chains A, B and C have farnesyl 
pyrophosphate coloured yellow bound and chain D has magnesium ions bound, coloured 
red.       
 
Diterpene synthases can also be classified as class I terpene synthases, for example 
cyclooctat-9-en-7-ol synthase or CotB2 which produces cyclooctat-9-en-7-ol which is further 
transformed to terpenoid cyclooctatin (Driller et al., 2018). CotB2 has the classical "-helical 
fold with both the DDxx(D, E) and NSE motifs with the active site. When comparing apo and 
substrate analogue-bound crystal structures, an induced fit closing mechanism can be 
postulated as with other class I terpene synthase.       
 
The identification of a large terpene synthase (C25/C30/C35) from Bacillus subtilis, !-
curcumene synthase (BsuTS) led to the identification of an alternative subclass of terpene 
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synthase, class IB (Fujihashi et al., 2018). One homologous !-(C25/C30/C35)-prene 
synthase class IB terpene synthase from Bacillus alcalophilus, BalTS, was crystallised 
showing an "-terpene synthase fold. BalTS forms a dimer in solution where cavities in each 
subunit fuse to form a large active site capable of holding long chain prenyl pyrophosphates 
(Fujihashi et al., 2018). As with class I terpene synthases three magnesium ions are bound 
in the active site however the two aspartate motifs differ in sequence; DYLDNLxD and 
DY(F,L,W)IDxxED (Fujihashi et al., 2018). BsuTS forms products with a single ring while 
BalTS produces linear products, however the active site residues are conserved between 
the two enzymes. This implies that the control over product determination is in the secondary 
level (Fujihashi et al., 2018). 
 
1.5.2 Class II terpene synthase structure 
Class II terpene synthases have a characteristic 2 domain architecture (! and #) with the 
interface creating the active site (McAndrew et al., 2011) (Tholl, 2015). The structures 
consist of "-helices and one aspartate motif DXDD. The interface interaction contains 
repetitive QW sequence motifs on the outer side of helices (Wendt and Schulz, 1998).  Class 
II terpene synthases ionise the substrate by protonation of the epoxide ring at a double bond 
(Tholl, 2015) (Gao, Honzatko and Peters, 2012). Along with bifunctional enzymes, some 
class II enzymes have an additional 250 amino terminal insert for correct folding (Tholl, 
2006). Class II enzymes include some diterpene synthases and triterpene synthases 
(Christianson, 2017).  
 
One example of a classical class II terpene synthase structure is ent-copalyl pyrophosphate 
synthase from Streptomyces platensis CB00739 with its !# domain architecture (Figure 1-
13c) (Rudolf et al., 2016). ent-Copalyl pyrophosphate synthase produces platensimycin and 
platencin (Rudolf et al., 2016). As with aristolochene synthase another ent-copalyl 
pyrophosphate synthase from a different species (Arabidopsis thaliana) has different 
structural features with an "!# domain architecture (Figure 1-13b) (Potter et al., 2014). The 
"-domain in Arabidopsis thaliana	ent-copalyl pyrophosphate synthase has no known function 
but structurally resembles a class I active site without the characteristic aspartate rich motifs 
(Christianson, 2017). Despite the structural differences between the two ent-copalyl 
pyrophosphate synthases the proposed mechanism is the same with corresponding key 
residues in the same position (Figure 1-13) (Christianson, 2017). 
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Figure 1-13 Structures of ent-copalyl pyrophosphate synthases. (a) SALIGN diagram of 
ent-copalyl pyrophosphate synthases from Streptomyces platensis CB00739 in pink (PDB 
5BP8) and Arabidopsis thaliana in grey (PDB 4LIX). The alignment shows a well aligned !# 
domain architecture and Arabidopsis thaliana ent-copalyl pyrophosphate synthase distinct 
separate " domain. (b) Structure of Arabidopsis thaliana ent-copalyl pyrophosphate 
synthase (PDB 4LIX) with its three domain "!# structure. (c) Structure of Streptomyces 
platensis CB00739 ent-copalyl pyrophosphate synthase with its two-domain class II terpene 
domain structure, !#.	   
 
As previously mentioned, squalene-hopene cyclase from Abicyclobacillus acidocaldarius is a 
well-studied triterpene synthase with a !# domain architecture. Squalene-hopene cyclase is 
a membrane bound enzyme with the interface active site accessible through a membrane 
passageway (Christianson, 2017). This structure is similar to membrane bound 
oxidosqualene cyclase also with a !# domain architecture and a membrane passage to the 
interface active site (Christianson, 2017).  Both of these structures, along with other 
experiments have been used to postulate the mechanism of action with the traditional 
protonation of terminal $ bond or epoxide moiety initiation. 
 
1.5.3 Bifunctional terpene synthase structures  
Bifunctional terpene synthase catalyses the tandem or coupled cyclisation reactions in two 
distinct active sites. Bifunctional terpene synthase active sites have the key terpene 
synthase structural features and can be either class I, class II or a combination. In 
bifunctional enzymes both active sites must be functional; however a channel directing 
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products between the two sites is not always necessary (Christianson, 2017). The most 
studied example of a bifunctional enzyme is geosmin synthase which has an "" domain 
structure with two class I active sites (Harris et al., 2015). There is no direct channel 
between the two active sites that cyclise farnesyl pyrophosphate to germacradienol before 
fragmentation to C12 geosmin (Harris et al., 2015). Both " domains have a characteristic 
class I terpene synthase fold binding three magnesium ions (Christianson, 2017).  
 
However other bifunctional enzymes have both class I and class II active sites together. One 
example is (E)-biformene synthase a labene-related diterpene. (E)-biformene synthase 
catalyse two consecutive reactions; cyclisation of GGPP by protonation in a class II active 
site followed by cyclisation of a bicyclic to pentacyclic product triggered by metal ion 
dependent dephosphorylation, in a class I active site (Centeno-Leija et al., 2019). Both 
active sites have the key structural features of class I and class II active sites with the "-
helical fold, aspartate motifs and magnesium ions (Centeno-Leija et al., 2019). 	       
 
1.5.4 Alternative terpene synthase structures     
Some terpene synthases do not contain the key identified features of terpene synthases. 
One well characterised example is the sesquiterpene synthase, δ-cadinene synthase which 
does not contain the NSE/DTE motif but instead contains a DVAE sequence similar to 
farnesyl pyrophosphate synthase aspartate motifs (Gennadios et al., 2009) (Gao, Honzatko 
and Peters, 2012). In addition, δ-cadinene synthase has a !" didomain structure with a 
flexible region of the N-terminal ! domain being involved in the capping of the " domain 
active site. This was shown by progressive truncation of the N-terminal leading to increased 
production of sesquiterpene alcohol due to inefficient sealing of the active site and solvent 
exposure (Gonzalez et al., 2016).  
 
Two other class I terpene synthases with unusual features are "-bisabolene synthase from 
Abies grandis and taxadiene synthase from Taxus brevifolia that both have a "!# domain 
architecture (Figure 1-14) (McAndrew et al., 2011) (Köksal et al., 2011). Both enzymes have 
a functional "-domain class I active site at the C-terminal of the protein. The N-terminal of 
each protein is a class II active site fold missing with mutated aspartate rich motifs and like 
δ-cadinene synthase, forms part of the active site cap. The fact these additional domains 
can form part of the active site cap differs from other terpene synthase that have non-
functional domains.  
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Figure 1-14 Structure of taxadiene synthase from Taxus brevifolia (PDB 3P5R). 
Taxadiene synthase has a three-domain architecture with a "!# structure. The " domain is a 
functional class I active site shown in the structure with magnesium ions in red and 2-
fluorogeranylgeranyl pyrophosphate in yellow bound in the active site. The !# domain is a 
non-functional class II active site that forms part of the cap of the class I active site. 		  
 
1.5.5 Prenylelongase structures  
Prenylelongases catalyse the formation of terpene precursors by catalysing the sequential 
condensation of DMAPP and IPP and are related structurally to class I terpene synthases. 
Both enzymes hace "-helical terpene folds with an active site containing aspartate rich 
motifs, however the sequence of these motifs differs between prenylelongases and class I 
terpene synthases (Wendt and Schulz, 1998). This is also similar to the glutamate residues 
that coordinate divalent metal ions that can stabilise the carbocation in IDI (Zheng et al., 
2007). The depth of the active site determines the length of the chain product as the active 
site acts as a well-defined template. This has been confirmed by mutagenesis increasing the 
depth of active sites which results in longer polyisoprenoid products (Christianson, 2008). 
Trans-isoprenyl pyrophosphate synthase generates a trans C-C double bond in geranyl, 
farnesyl or geranylgeranyl pyrophosphates produced by a corresponding pyrophosphate 
synthase (Gao, Honzatko and Peters, 2012). 
 
The most studied prenylelongase is the homodimer avian farnesyl pyrophosphate synthase 
consisting of 10 "-helices forming a large central cavity active site (Tarshis et al., 1994). The 
active site cavity consists of hydrophobic interactions with two conserved aspartate rich 
motifs FARM and SARM coordinating the magnesium ions (Tarshis et al., 1994). The helices 
at the lower end of the active site have short loops connecting helices whereas other helices 
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have large connecting loops of up 60 residues (Tarshis et al., 1994). The dimer interface is 
formed of a large number of hydrophobic interactions (Tarshis et al., 1994).       
 
The structural homology and similarities between successive enzymes suggest enzymes 
that catalyse successive steps in biosynthetic pathways may evolve with similar structure 
features through divergence regardless of sequence. This suggests a sequence and function 
evolves more rapidly than tertiary structures (Caruthers et al., 2000). The terpene synthase 
" fold has evolved to accommodate a variety of different reactions with subtle changes to the 
active site contour (Rynkiewicz, Cane and Christianson, 2001). Other suggestions of this 
structural homology come from terpene synthases that contain "!# domain architecture of 
both class I and class II active sites including; "-bisabolene synthase and taxadiene 
synthase. This suggests these enzymes could have evolved from a common ancestor. This 
is further shown by the bifunctional terpene synthase with the fusions of two different active 
sites. Overall the low sequence homology but high tertiary homology suggest enzymes could 
have evolved from each other time maintaining the classic fold but having large differences 
in sequence (Wendt and Schulz, 1998).        
 
1.6 Reaction mechanisms of terpene synthases       
Terpene diversity arises from the enzyme activity and subtle differences in the electrophilic 
mechanism within the active site. Reactions are either initiated by magnesium dependent 
removal of the pyrophosphate moiety or the protonation of a $ or epoxide moiety, both 
creating a cation (Gao, Honzatko and Peters, 2012). Reactions then proceed through a 
multistep reaction cascade with cationic intermediates through; protonation, deprotonation, 
hydride shifts, intramolecular proton transfers and electrophilic attack (Dickschat, 2017) 
(Tantillo, 2017) (Hong and Tantillo, 2015). These reactions combine several bond forming 
and rearranging steps and are classified as cationic SN1-like alkylations (Salmon et al., 
2015) (Wendt and Schulz, 1998). Terpene synthase reactions are chemically important as 
despite being promiscuous or high fidelity the reactions are chemo selective, regioselective, 
diastereoselective and enantioselective (Harms, Kirschning and Dickschat, 2020). As a 
result the hydrophobic active site acts as a template, controlling the reaction cascade by 
aligning the cation into productive spatial orientations and stabilising transition states (Miller 
and Allemann, 2012). It has also been postulated that the pyrophosphate anion contributes 
to the electrostatic effect created by aromatic and hydrophobic residues or could act as an 
acid/base within the reaction cascade, potentially re-joining the cation (Zhou and Peters, 
2011). Terpene synthases control the reaction cascade by raising the energy of initial 
intermediates to bypass the formation of unwanted side products (Major, 2017). The 
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reactions proceed with a delicate balance of kinetic, thermodynamic and dynamic control on 
the cationic intermediates (Dixit et al., 2017). A variety of chemical and computational 
methods have been used to study these chemically important reactions. 
 
1.6.1 Substrate analogues  
Substrate or intermediate analogues can be used in combination with x-ray crystallography 
and product determination methods. Usually substrates or intermediates are modified with 
fluorine, methyl groups, nitrogen, hydroxyl groups, deuterium and 13C labelling (Figure 1-15) 
(Prisic et al., 2007) (Cascon et al., 2012). Due to the volatile nature of terpenes, products 
can be detected with GC/MS and further characterised by NMR (Forcat and Allemann, 
2006). Isotopic labelling or isotopic sensitive branching of substrate analogues in 
combination with in vitro incubation of purified terpene synthase produces a list of 
intermediates determining the precise reaction pathway.   
 
Figure 1-15 Structures of substrate analogues used in determining terpene synthase 
reaction mechanisms. (a) Structure of 6-fluorofarnesyl pyrophosphate. (b) Structure of 2-
flurorlinalyl pyrophosphate. (c) Structure of 6-methylfarnesyl pyrophosphate. (d) Structure of 
3-aza-2,3-dihydrogeranyl pyrophosphate. (e) Structure of farnesyl hydroxy pyrophosphate. 
(f) Structure of farnesyl thiopyrophosphate.     
 
Isotopic sensitive branching involves using a substrate analogue with a single atom swapped 
for an isotope that is fed to the enzyme. The ratio of labelled products is compared to an 
unlabelled substrate (Tantillo, 2017). One key atom used in substrate analogues is fluorine, 
specifically fluoro-farnesyl pyrophosphate isomers, that have been used with a variety of 
sesquiterpenes synthases. Fluorine is a popular choice due to its small size not affecting 
binding but its electronic properties have strong inhibitory effects (Harms, Kirschning and 
Dickschat, 2020). Fluorine can be set in specific positions for targeted inhibitions at key sites 
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(Harms, Kirschning and Dickschat, 2020). PR-AS was tested with variety of fluoro-farnesyl 
pyrophosphate isomers and the results suggested a 1,10 cyclisation and germacryl cation 
which it can be blocked by the destabilisation of the product cation by the fluorine (Yu, Miller 
and Allemann, 2007) (Miller et al., 2009). Studies into (E)-!-farnesene	and isoprene 
synthase used the electron withdrawing effect of fluorine to find competitive inhibitors 
blocking the formation of trans-farnesyl cation and the proceeding reaction steps (Faraldos 
et al., 2012). The inhibitors reflect cationic intermediates with fluorine and help determine the 
reaction pathway. Both reactions go through regiospecific 1,4 conjugate elimination of either 
farnesyl pyrophosphate or dimethylallyl pyrophosphate. The strongest inhibitor for (E)-!-
farnesene are inhibitors with fluorine at position 15 including; 15-flurorfarnesyl 
pyrophosphate and 15-triflurorofarnesyl pyrophosphate (Faraldos et al., 2012).     
 
In addition to fluorine, sulfur has been used make farnesyl-S-thiolopyrophosphate which has 
be used in crystallisation to mimic farnesyl pyrophosphate binding conformations to induce 
the reaction pathway. This has also been used on AT-AS with ammonium and iminium 
analogues of carbocation proposed intermediates for reaction pathway (Chen et al., 2013). 
Binding of these analogues in crystal structures leads to a proposed mechanism of action 
including identifying key residues involved in cation stability specifically the aromatic triad of 
Y61 F81 and F147 stabilising cation $ interactions (Chen et al., 2013). Some cation 
intermediates are stabilised or directed by interactions with the pyrophosphate anion as 
suggested by the aza analogue’s interactions with the pyrophosphate anion (Chen et al., 
2013). This is consistent with the orientation of the final carbocation being proximal to the 
pyrophosphate anion and its potential key role in quenching the final carbocation 
intermediate (Chen et al., 2013). Analogues closer in structure to the final product are more 
thermodynamically favourable than less product-like analogues, however it is possible a 
high-fidelity terpene synthase can bind analogues with “incorrect” structures or 
stereochemistry (Chen et al., 2013). As a result, these studies should be used in 
combination with additional methods to determine the reaction pathway.     	   
 
Deuterium site-specific labelling, also known as following the proton, can test the feasibilityof 
potential mechanisms (Tantillo, 2017).  One example was to gain insight into the cyclisation 
mechanism of 1,8 cineol synthase from Streptomyces clavuligerus by specific labelling of the 
protons at the C1 of geranyl pyrophosphate (Dickschat, 2017). Labelled substrates were 
incubated with purified 1,8 cineol synthase and products are analysed by heteronuclear 
single quantum coherence (HSQC) spectroscopy to propose a mechanism. In addition, 
amorpha-4,11-diene synthase from Artemisia annua was studied with R- and S-deuterated 
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farnesyl pyrophosphate to determine cation intermediates to determine a mechanism of 
action (Miller and Allemann, 2012). 
 
Site-specific labelling can also use 13C-labelled substrate analogues to determine reaction 
pathways and identify potential intermediates. One example is the study of three 
sesquiterpene synthases from Streptomyces species using a variety of 13C farnesyl 
pyrophosphate isomers (Rabe, Rinkel, Klapschinski, et al., 2016). This was a fast-easy 
method to determine products and the reactions’ stereochemical courses. These incubations 
identified the products of the three enzymes; (-)-neomeranol B, isodauc-8-en-11-ol and 
intermedeol (Rabe, Rinkel, Klapschinski, et al., 2016). The stereochemical course was 
determined using HSQC spectroscopy and nuclear overhauser effect spectroscopy 
(NOESY) of the unlabelled and labelled products along with stereochemical farnesyl 
pyrophosphate isomers (Rabe, Rinkel, Klapschinski, et al., 2016). An additional example is 
the study of epi-isozizaene synthase using 13C farnesyl pyrophosphate isomers with EI-MS 
fragmentation and position-specific mass shift analysis (Rabe, Klapschinski and Dickschat, 
2016). These can be used in combination with other mass spectroscopy techniques 
including; high resolution GC/MS quadrupole time-of-flight and MS-MS for position specific 
mass shift analysis. Using this labelling every carbon atom within a fragment can be 
identified through the corresponding 13C farnesyl pyrophosphate mass shift and from this a 
mechanism can be postulated (Rabe, Klapschinski and Dickschat, 2016).     
 
1.6.2 Site directed mutagenesis     
Structural analysis of terpene synthase bound with substrate analogues has identified key 
residues involved in directing the product formation and stabilising the cation intermediates. 
These residues can then be studied by site directed mutagenesis to determine the effect on 
the product profile and the residues specific role. One of the most studied active sites is 
aristolochene synthase from both PR-AS and AT-AS. The main target of mutagenesis for 
PR-AS was the aromatic residues comparable to the aromatic triad identified in AT-AS 
targeting Y92, F112 F178 and W334 (Figure 1-16b) (Miller and Allemann, 2012) (Forcat and 
Allemann, 2006). Mutagenesis of W334 to a variety of hydrophobic residues, specifically 
valine, led to the production of intermediate germacrene A showing its role in stabilising the 
eudesmane cation which is formed following the protonation of germacrene A (Miller and 
Allemann, 2012). Mutagenesis of Y92 displays a similar eudesmane cation stabilisation role 
as Y92V gives a similar product profile to W334V. In addition the size of the residue at 
position 92 has an effect on the folding of the initial cation, with increasing residue size the 
production of aristolochene increased and as the volume decreases amounts of linear 
products increase (Miller and Allemann, 2012).  F178 was mutated to cysteine, isoleucine, 
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tyrosine and tryptophan to investigate the effect of size and aromaticity at position 178 
(Forcat and Allemann, 2006). When mutated to other aromatic residues the product profile is 
similar to wild-type PR-AS with aristolochene as the main product with minor amounts of 
germacrene A and valencene (Forcat and Allemann, 2006). Mutations removing the 
aromatic residues, like cysteine and valine, reduced the amount of aristolochene and 
increased the amount of germacrene A along with additional by-products (Forcat and 
Allemann, 2006). The results suggest F178 has a critical role in the 1,2 hydride shift from C2 
to C3, that initiates the conversion of eudesmane to aristolochene and a bulky side chain is 
key for this role (Forcat and Allemann, 2006). F112 is critically placed between W334 and 
F178 so to define its role it was mutated to alanine, producing only a small amount of 
germacrene A and some linear farnesene products (Figure 1-16c). As a result it was 
determined F112 is critical for the roles of W334 and F178 to allow the conversion of 
eudesmane to aristolochene (Forcat and Allemann, 2006). K206 is predicted to be the 
acid/base in the reaction mechanism due its proximity to Y92. When K206 was mutated to 
glutamine, production was reduced by 3 orders of magnitude and 4 fold when mutated to 
arginine (Miller and Allemann, 2012). Site directed mutagenesis was used in combination 
with labelled substrates (see section 1.6.1) to postulate a mechanism of action with specific 
stereochemistry (Miller et al., 2009). 
 
AT-AS mutagenesis focused more on the active site cleft compared to the aromatic triad on 
PR-AS. One focus was probing the trapped water molecule in the active site as a component 
of the active site contour but not actively involved in the cation quenching (Chen et al., 
2016). Site directed mutagenesis looked into the relationship between the polar amino acid 
side chains and the trapped water molecule (Chen et al., 2016). S303 and N299 were 
targeted and mutated to non-polar alanine and the water molecules remained (Figure 1-
16a). However, the structure of the S303A/N299A double mutant has no solvent molecule 
resolved showing the loss of both interactions results in the loss of the bound solvent 
molecules (Chen et al., 2016). The structures of N299A and S303A/N299A show a rotation 
of Y61 hindering the re-protonation of germacrene A to form the eudesmane cation (Chen et 
al., 2016). Other mutagenesis efforts targeted residues within the active site contour 
including V88 and T89. When mutated to the bulkier aromatic phenylalanine at both 
positions, germacrene A production was increased (Faraldos, Gonzalez, et al., 2011).  
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Figure 1-16 Active site images of aristolochene synthase positions targeted and a 
schematic of some of the products of mutagenesis. (A) Active site structural image of 
Aspergillus terreus aristolochene synthase (PDB 3BNX) bound with pyrophosphate in pink 
and yellow magnesium ion. Residues N299 and S303 that were targeted for mutagenesis 
are highlighted in pink. (B) Active site structural image of Penicillium roqueforti aristolochene 
synthase (PDB 1DGP) with farnesol bound and displayed in yellow. Residues Y92, F112, 
F178, K206 and W334 were the targets of mutagenesis and surround the bottom of the 
active site are shown in pink. (C) Structures of some of the alternative products produced by 
variant enzymes. The products labelled in purple are produced from mutagenesis at position 
Y92. The products labelled in blue are key products from the mutagenesis of W334 and 
specifically mutant W334V.         
 
In pentalene synthase, aromatic residues were also selected as a target for site directed 
mutagenesis. F76A and F77A showed significant reduction in activity along with derailment 
of cyclisation leading to the production of germacrene A (Miller and Allemann, 2012). In 
addition H309 was proposed to be the active site base in the mechanism of pentalene 
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synthase (Seemann et al., 1999). However unexpectedly all H309 mutants retained some 
activity with no significant differences in the product profile. Therefore H309 has no base role 
in catalysis and has only a minimal effect on the active site contour from the minor product 
profile changes (Seemann et al., 1999). 
 
As with all techniques for determining reaction mechanisms site directed mutagenesis can 
be combined with other techniques to give further mechanistic insight. One example is 
germacardien-4-ol synthase, a sesquiterpene synthase with a bound water molecule, 
however unlike AT-AS the active site does not contain any polar residues (Grundy et al., 
2016). As with other studies, mutations of D80, D81 and D84 (key aspartate residues) to 
glutamate showed significantly less activity and with minor functional changes producing 
germacrene A and D (Grundy et al., 2016). Whereas when mutated to asparagine the 
enzymes are inactive showing the critical role in coordinating magnesium ions (Grundy et al., 
2016). Other key residues were targeted including N218 within the NSE motif. When N218 
was mutated to glutamine the catalytic efficiency was reduced and the product profile was 
altered, similar to mutagenesis with aspartate residues, by increasing production of 
germacrene A and germacrene D. This shows that the longer side chain is perturbing the 
magnesium ion coordination (Grundy et al., 2016). Due to the lack of obvious residues, the 
enzyme was incubated with H218O to confirm the hydroxyl group came from the active site 
trapped water, however it is unclear how the water is captured. In addition, germacardien-4-
ol was incubated with a variety of substrate and intermediate analogues using the activity 
and inhibition to determine a mechanism. The postulated mechanism involves the farnesyl 
cation undergoing a 1,10 cyclisation to the germacrenyl cation before a rapid 1,3 hydride 
shift where the cation is quenched by the water molecule (Figure 1-17) (Grundy et al., 2016). 
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Figure 1-17 Schematic of the postulated mechanism of germacradien-4-ol. As with all 
class I terpene synthase the magnesium dependent pyrophosphate removal produces the 
farnesyl cation. The farnesyl cation was cyclised through a 1,10-cyclisation forming a 
germacradienyl cation which was consequently attacked by a hydroxyl group of a water 
molecule forming germacradien-4-ol.   
 
A way to expand the current repertoire of amino acid is to use non-canonical amino acids. 
This was tested with PR-AS to further investigate W334 and its effect on eudesmane cation. 
The aim was to prove if residues with lower $ electron densities than tryptophan would 
decrease the rate of reaction and a change the product profile. W334Y had a 3-fold 
decrease in efficiency with an increase in germacrene A as the phenolic hydroxyl prevents 
the optimal orientation for cation stabilisation (Faraldos, Antonczak, et al., 2011). W334H 
had a 70 fold decrease in efficiency with aristolochene activity significantly reduced but there 
was an 11 fold increase in germacrene A whereas W334L showed no activity (Faraldos, 
Antonczak, et al., 2011). Building on these results, non-canonical aromatic amino acids with 
a diverse range of properties were substituted into the enzyme using the amber suppression 
method. The amber suppression method utilises the amber stop codon, the least used stop 
codon in E. coli, and a specifically evolved amino acyl t-RNA synthetase to insert the desired 
non-canonical amino acid (Goodman et al., 1968). If germacrene A was a consequence of 
the reduced steric size in the active site, then any bulky aromatic residue at 334 would re-














results show decreasing $ densities increase the production of germacrene A (Faraldos, 
Antonczak, et al., 2011). 	        
 
1.6.3 Computer modelling and simulations    
Increasing technological advances and availability of computer modelling tools have 
produced the most recent advances in mechanistic understanding of terpene synthases. 
There are a variety of methods that can be used to study a variety of parameters relating to 
the reaction mechanism. One of the most common modelling methods is QM/MM, a hybrid 
of quantum mechanics and molecular mechanics combining accuracy and speed to model 
environments (Warshel and Levitt, 1976). Molecular mechanics uses a force field to 
calculate the forces acting on each particle. This involves finding a molecular solution or a 
structure with the minimum energy (Warshel and Levitt, 1976). One common use in terpene 
synthase is to predict intramolecular proton transfers that can be affected by various barriers 
including; ring strain, the degree of substitution, the level of delocalization and whether the 
environment is endocyclic or exocyclic (Hong and Tantillo, 2015).   
 
One example involves using modelling techniques MD, QM/MM and QM/(DFT)/MM on AT-
AS, Nictotina tabacum 5-epi-aristolochene synthase and farnesyl pyrophosphate synthase 
(Zhang et al., 2016). Initially the analysis focused on the pyrophosphate anion cleavage 
which is universal in all three reactions and is usually the rate limiting step in the reaction 
pathway. From the calculations the pyrophosphate anion cleavage and the C-C bond 
formation is a nucleophilic substitution reaction where the pyrophosphate acts as the leaving 
group and the C10-C11 double bond acts as the nucleophile (Zhang et al., 2016). 
Throughout the remaining reaction pathway, the pyrophosphate can adopt a variety of 
protonation states to assist the final product formation. The protonation state of the 
pyrophosphate can depend on the cleavage mechanism, the native active site environment, 
the magnesium ion coordination and the enzyme class (Zhang et al., 2016). These findings 
can be applied to other terpene synthases to determine the effect of the pyrophosphate on 
the remaining reaction pathway. Further, these results can be combined with additional 
QM/MM and substrate docking to identify the single possible orientation of the farnesyl 
cation in 5-epi-aristolochene synthase for productive reaction (O’Brien et al., 2016).  
 
Another example is the use of QM/MM and multidimensional free energy simulations on 
bornyl pyrophosphate synthase (Major and Weitman, 2012). This analysis showed that the 
pyrophosphate moiety has a level of control directing the reaction towards the product (Major 
and Weitman, 2012). It identifies that the bornyl cation is the branching point of the reaction 
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pathway where the enzyme pushes the reaction towards the formation of the terpinyl cation 
(Major and Weitman, 2012). The analysis proposed a multilevel catalytic pathway where 
transition states are separated by low free-energy barriers due to the thermodynamic 
properties of the enzyme (Figure 1-18). This is supplemented by the initial product like 
binding configuration of geranyl pyrophosphate (Major and Weitman, 2012). 
 
Figure 1-18 Schematic of the proposed reaction mechanism of bornyl pyrophosphate 
synthase. The proposed mechanism is initiated by the magnesium ion-dependent 
pyrophosphate removal to generate the geranyl cation. The pyrophosphate moiety re-joins 
the farnesyl cation at a different position and is subsequent removed forming a different 
cation that can be cyclised to the 2 bornyl cation. The pyrophosphate moiety cation 
quenches the cation forming bornyl pyrophosphate.          
 
Bornyl pyrophosphate synthase was used to test a computer modelling software (TerDockin) 
specifically designed to predict orientation of carbon skeletons of substrates and 
intermediate carbocations with a pyrophosphate moiety in terpene synthase active sites 
(O’Brien et al., 2018). As with QM/MM software, the binding orientation appears to be 
relevant to the reaction and shows the stereochemical preference for the enzyme. The 
reaction pathway predicted binding modes from TerDockin are consistent with previous 
experimental observations and there are no significant movements between each reaction 
step (O’Brien et al., 2018).    
 
A popular technique is in silico modelling which combines both in vivo and in vitro 
experiments and can control an unlimited number of parameters (Colquitt, Colquhoun and 
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Thiele, 2011). This technique was used on taxadiene synthase using the open and inactive 
crystal structure with substrate analogues like 2-fluorogernaylgernayl pyrophosphate. 
Modelling created a closed active site conformation enabling insight into the structure 
function relationship and productive geranylgeranyl pyrophosphate folding patterns. 
Consequently, this leads to the localisation of the intermediate carbocations and the key 
residue interactions. These results enable in silico protein engineering of the identified 
residues to alter the predicted cascade.   
 
Overall the best way to establish the complex reaction pathways of terpene synthases is to 
use a sequential combination of techniques. A useful protocol is to use substrate analogues 
to create crystal structures and find potential binding orientations. These structures can then 
be used for modelling and simulation studies. From the modelling studies, residues can be 
identified for site directed mutagenesis and potential future engineering. The observations 
from these mechanistic studies can develop chemical methods to mimic terpene synthase. 
The majority of synthetic terpene synthases are based on class II reactions while class I 
reactions are rare. One example is the biomimetic penta-cyclisation of polyenes which are 
derivative oleananes. This can be achieved under acidic conditions without enzymes (Fish 
and Johnson, 1994).  The first enantioselective cyclisation of a polyprenoid used a Lewis 
acid-assisted chiral Bronsted acid, however there was a mix diastereoisomers (Harms, 
Kirschning and Dickschat, 2020).          
 
1.7 Engineering terpene synthase  
Terpene synthases chemically interesting due to their chemical variation from limited 
substrates while being highly specific and enantioselective. As a result, terpene synthases 
are a great target for engineering and potential novel products production. There are two 
main approaches for engineering enzymes; rational engineering and non-rational 
engineering or directed evolution. Rational engineering uses structural or modelling 
information to propose mutations to be created using site-directed mutagenesis. There is an 
increased probability of mutations being beneficial or productive reducing the library size 
especially if there is no high-throughput screen available (Acebes et al., 2016). On the other 
hand directed evolution needs no structural information and small changes, that are 
sometimes random, are made over several rounds of evolution (Steiner and Schwab, 2012). 
A mix between the two approaches is semi-rational engineering that uses smaller focused 




1.7.1 Rational engineering  
One of the first examples of rational engineering was linked to the determination of the 
trichodiene synthase reaction mechanism. The first step in engineering targets the aspartate 
motif, specifically D100. The mutation D100E leads to a 22-fold loss in activity as the active 
site closure is impaired and only two of the three magnesium ions are bound (Rynkiewicz, 
Cane and Christianson, 2002). D101E had a similar effect but mutation of D104E has no 
significant change in kinetic parameters (Rynkiewicz, Cane and Christianson, 2002). All 
three mutants produced a variety of additional products including a number of linear 
products (Figure 1-19) (Cane and Xue, 1996) (Cane, Xue and Fitzsimons, 1996). Following 
this the diphosphate interaction was probed, specifically residue Y305 (Figure 1-19). The 
Y305F structure shows a significant active site deviation, losing the hydrogen bond with the 





Figure 1-19 Structural image of trichodiene synthase active site (2Q9Z) and Schematic 
of some of the alternative products for trichodiene synthase mutants. (a) Pymol image 
of structural image of the active site of trichodiene synthase highlighting the residues 
targeted in mutagenesis. (b) All mutants produced trichodiene as the predominant product, 
but mutants also produced a range of linear and cyclic products with examples of some of 
the key products and their approximate product profile ratio for mutant D100E .  
 
This initial engineering was an inspiration for further engineering that moved towards 
targeting the hydrophobic active site. One example is the selection of single point mutations 
in epi-isozizaene synthase (Li et al., 2014). Initial work focused on F96 in the hydrophobic 
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cleft and was targeted with a range of mutations creating a variety of different products. In 
addition 26 single-site mutations targeting three areas; aromatic triad F95, F96 and F198 
that encircle the active site, aromatic residues in the active site contour W203, W325 and 
F332 and aliphatic active contour residues L72 and V329 (Li et al., 2014). Overall significant 
changes were seen with decreases in activity between 11-730 fold lower however, F332A 
had the most significant change of over 800-fold (Li et al., 2014). Mutagenesis produced 6 
separate sesquiterpene synthases with alternative predominant products (Figure 1-20). In 
general, the aromatic residues within the active site are a hot spot for reprogramming or 
engineering terpene synthase. 
 
Figure 1-20 Schematic of the products of wild type and mutant epi-isozizanene 
synthase. The single substrate farnesyl pyrophosphate is shown in yellow with the wild-type 
product epi-isozizanene shown in orange. The products highlighted in blue are the 
predominant products of the mutants above showing switches of specificity. The other 
products surrounding the key products are minor products produced by the mutants.     
 
Site-directed mutagenesis can also have a specific purpose; for example, a switch in 
cyclisation from 1,10 to 1,11 (Figure 1-21). Structural alignments of multiple 1,10 and 1,11 
synthase structures or homology models were analysed and identified a triad of residues in 
germacrene A synthase to target; T410, G402 and G403 (Gonzalez et al., 2014).  Generally 
increasing the residue size at G402 progressively leads to an increase in 1,11 cyclisation 
(Gonzalez et al., 2014). G402A and G402S both produce "-humulene with the 1,11 
cyclisation however 1,10 cyclisation products are still produced (Figure 1-21). G402C 
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sterically hinders the active site and 1,11 cyclisation activity was increased to 68 % of the 
final activity. However when G402 is mutated to leucine, phenylalanine or valine 1,11 
cyclisation activity is reduced or lost (Gonzalez et al., 2014). 	This was repeated with 
germacrene D and G404, G404V produces 20% bioclogermacrene which is a cyclopropane 
ring underlining dual 1,10 and 1,11 cyclisation (Gonzalez et al., 2014).                    
 
 
Figure 1-21 Schematic of 1,10 and 1,11 cyclisation of farnesyl cation. The schematic 
depicts the 1,10-cyclisation producing the germacrenyl cation, a two ringed structure. The 
schematic also depicts a 1,11-cyclisation forming a large extended ring, humulyl cation.     
 
An additional site-directed mutagenesis focus is to select between two products. Taxadiene 
synthase naturally produces 2 taxadiene isomers; taxa-4(5),11(12)-diene and taxa-
Farnesyl cation 
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4(20),11(12)-diene (92:8). The following Taxol production pathway can act on both isomers 
but acting on taxa-4(20),11(12)-diene has higher specificity improving the production (Edgar 
et al., 2017). The first step was alanine scanning to identify residues directly involved in the 
final step in the reaction pathway, the proton abstraction. No single residue was identified as 
responsible as there was no complete product profile switch (Edgar et al., 2017). The 
number of residues targeted was increased and saturation mutagenesis was completed in 
the predicted active site cap. Some mutants showed a specificity switch, however this was 
achieved by reducing the production of the undesired isomer (Edgar et al., 2017). The most 
successful mutant was Y688L (a residue predicted to be close to the pyrophosphate moiety) 
with a 2.4-fold increase in taxa-4(20),11(12)-diene production (Edgar et al., 2017). Y688L 
was co-expressed with the remaining pathway and was combined with further upstream 
engineering, increasing Taxol production (Edgar et al., 2017).    
 
So far, most site directed mutagenesis has focused on maintaining the hydrophobicity of the 
hydrophobic active site contour, however mutagenesis strategies progressed to including 
mutagenesis with polar residues. Epi-isozizaene synthase has been a previous mutagenesis 
target and from these results residues Y69, F95, F96 and W203 were selected to create 16 
additional polar mutations (Blank et al., 2017). This mutagenesis yielded functional enzymes 
and expanded the chemo diversity with 8 new products, however activity is between 21 and 
44% of wild-type (Figure 1-22) (Blank et al., 2017). These products are acyclic and cyclic 
hydroxylated products due to the binding of a water molecule. Y69 mutations largely 
maintain the wild-type product profile. F95 mutations have a small effect of the active site 
and all mutants generate epi-isozizaene along with side products (Blank et al., 2017). 
W203H and W302Y both produce #-bisabolene and sesquisabiene, W203H also generates 
"-bisabolol (Blank et al., 2017). As with nonpolar substitution, polar substitutions at F96 





Figure 1-22 Schematic of the products of wild-type and polar mutant epi-isozizanene 
synthases. The single substrate of farnesyl pyrophosphate is shown in yellow with the wild-
type product epi-isozizanene shown in orange. The products highlighted in purple are the 
predominant products of polar epi-isozizanene synthase mutants. Some products are 
consistent with previous mutagenesis attempts, but some are novel products. The 
surrounding products are minor products produced by a number of the polar mutants.    
 
A novel way to expand the terpenoid repertories is to use terpene synthase to act on non C5 
isoprenoid substrates. The first example of this was to evolve a C11 terpene synthase from a 
monoterpene synthase. The first step was to use pathway engineering to increase the 
production of 2-methyl-gernayl pyrophosphate and an overall combination of engineering 
methods increased production by 760-fold (Ignea et al., 2018). Following this 7 monoterpene 
synthases were tested with 2-methyl-gernayl pyrophosphate, producing 36 C11 compounds 
but each monoterpene synthase still favoured geranyl pyrophosphate (Ignea et al., 2018). To 
engineer a C11-specific terpene synthase SfCinS1, a 1,8-cineole synthase from Salvia 
fruticose, was selected as the start point due to its corresponding crystal structure (Ignea et 
al., 2018). The first target was to expand the narrow fit active site to allow extended 
conformations of 2-methyl-gernayl pyrophosphate at N338 and I451 (Ignea et al., 2018). The 
best mutant is N388S-I451A with 88% of its profile being C11 products, specifically 2-
methylmycrene (Ignea et al., 2018).  Following further investigation of the SfCinS1 a residue 
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involved in the closing of the active site could be a C11 single residue switch, F571. In 
homologous monoterpene synthase this residue is typically an aromatic amino acid F or H 
(Ignea et al., 2018). F571H improved specificity for 2-methylenebornane and produced 
84.7% C11 products. F571Y produces 2-methyl-"-terpineol as its major product. Mutating 
analogous residues in other monoterpene synthase showed a similar switch to C11 
specificity (Ignea et al., 2018). This approach could now progress to other larger isoprenoid 
substrates and terpene synthase.  
 
1.7.2 Directed evolution        
Directed evolution is best suited to situation where little structural or biochemical information 
is available. This is the case for Cop2 a multi-product sesquiterpene synthase from Coprinus 
cinereus which was engineered with the aim of improving the product selectivity (Lauchli et 
al., 2014). Error prone PCR was the mutagenesis strategy was used to produce random 
mutants which were screened through a cyclization activity assay using a non-natural 
substrate, vinyl methyl ether producing methanol. Methanol was detected with alcohol 
oxidase and purpald reagent which was analysed by measuring the absorbance at 500 nm 
(Lauchli et al., 2014). The most successful mutant found through screening was 17H2 
(L59H, T65A and S310Y) with a 77% specificity toward germacrene-D-4-ol and produced no 
"-cardinol. When the mutations were made separately small changes were seen showing 
the mutations are synergistic for significant changes (Lauchli et al., 2014). All of the 
mutations are predicted to be near the active site but do not line the active site or directly 
interact with the substrates (Lauchli et al., 2014).  
 
Another directed evolution method is to target specific positions with degenerate codons 
meaning a selection of amino acids could be inserted at the position. Using an automated 
pipeline and liquid handling coupled to GC/MS, libraries can be screened at high throughput. 
This method was used on monoterpene "-pinene synthase variant (VAR3-PinS) which 
produces an equal mixture of linear, monocyclic and bicyclic monoterpenes (Leferink et al., 
2019). 16 positions were targeted within the three areas of plasticity, previously identified in 
"-pinene synthase, in the hydrophobic active site. To target these positions the NBT 
degenerate codon (a codon that could introduce more than one amino acid randomly) was 
selected covering polar and hydrophobic residues including; G, A, V, I, L, F, P, C, T, S and R 
(Leferink et al., 2019). 1000 colonies were screened with 65 unique sequences and results 
were validated with using larger culture volumes and traditional expression shake flasks. The 
positions were scored based on the spread of amino acids found at these positions (Leferink 
et al., 2019). The highest scoring positions produce the greatest product diversity, 
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specifically residue 335, which corresponds to other key product determination residues in 
monoterpene synthases (Leferink et al., 2019). The results also identify the key residues in 
bicyclic products (557-563) and in linear products (443,447 and 448) determination (Leferink 
et al., 2019).     
 
Directed evolution can also be used to evolve other biochemical properties including 
thermostability. This was completed on BcBOT2 (presilphiperforlan-8	!-ol synthase) and 
utilised the high throughput screen with a vinyl methyl ether modified substrate, alcohol 
oxidase and purpald reagent (Lauchli et al., 2014). 2800 BcBOT2 mutants were produced by 
error-prone PCR with an average of 3 base pairs mutated per mutant. Following library 
generation, it is treated for 10 minutes at 45 ºC. The most improved mutant was mutant 
19B7, which is missing 3 C-terminal amino acids and K58R mutation. The T50 was increased 
from 42 to 47 ºC with no change in expression, activity or specificity. 19B7 was then used as 
the template to further increase the T50 to 54 ºC with the additional mutation H383R.  
 
1.7.3 Semi-rational engineering       
Semi-rational engineering combines the use of structural information to create targeted 
libraries and the use of screening or mutagenesis methods in directed evolution. An 
additional directed evolution method is structure-based combinatorial protein engineering 
(SCOPE) uses structural information coupled with DNA manipulation techniques creating 
multiple crossover libraries from non-homologous genes (Figure 1-23) (O’Maille, Bakhtina 
and Tsai, 2002). One example used amorpha-4,11-diene synthase from Artemisia annua 
that produces cyclic terpenes and (E)- !-farnesene synthase that produces linear terpenes 
including (E)- !-farnesene but with similar mechanisms (Salmon et al., 2015). Structural 
analysis identified 24 positions to target within a 6 Å radius of the active site. SCOPE was 
used to create diversity in 9 libraries with varying number of mutations with each library 
screened 3 times (Salmon et al., 2015). 32 mutants from each library were sampled with 94 
% inactive, 5 % wildtype activity, 1% cyclic activity. Y420L was the most common cyclic 
mutation producing 15 cyclic terpenes and this activity was abolished when the mutation is 
removed (Figure 1-24) (Salmon et al., 2015).  This mutation can be combined with Y430A to 
enhance cyclic catalytic efficiency (Salmon et al., 2015). V467G reverts any cyclase activity 
to farnesene activity while reducing efficiency (Salmon et al., 2015). Also with accumulating 
number of mutations there was an exponential decline in efficiency therefore, a select 





Figure 1-23 Schematic of the structure-based combinatorial protein engineering 
(SCOPE) process. The schematic identifies positions to target using a crystal structure or a 
homology model. The structure included is epi-isozizaene synthase that was used to create 
the homology model of amorpha-4,11-diene synthase. Libraries for each position are 
designed and produced using DNA manipulation techniques. A selected number of mutants 
from each library were screened. In this example mutants were screened with the malachite 
green activity assay and GC/MS product profile analysis. Mutants identified could then be 





Figure 1-24 Schematic of Y402L SCOPE products. (a) Structure of sesquithujene. (b) "-
exo-bergamotene. (c) Structure of an amorphadiene isomer. (d) Structure of #-cumene. (e) 
Structure of arcurcumene. (f) Structure of cis- "-bergamotene. (g) Structure of zingiberene. 
(h) Structure of β-bisabolene. (i) Structure of β-curcumene. (j) Structure of β-
sesquiphelladrene. (k) Structure of "-bisabolene. (l) Structure of "-bisabolol.  
 
Another example of semi-rational design is the probing of the plasticity residues in #-
humulene synthase. #-humulene synthase is a promiscuous terpene synthase that can 
produce over 52 products with a variety of regio-chemistries and stereo-chemistries 
(Yoshikuni, Ferrin and Keasling, 2006).  To determine the best areas to target a homology 
model was produced using the structure of 5-epi-aristolochene synthase. From the structural 
homology model 19 residues in active site contour were selected for saturation libraries 
(Yoshikuni, Ferrin and Keasling, 2006). The product profiles of each mutant were normalised 
against the wild-type product profile to spot altered specificity. This analysis identified 4 key 
residues that significantly shifted selectivity of #-humulene synthase; W315, M447, S484 and 
Y566. The residues were further investigated using an algorithm to predict a product 
specificity change. The algorithm was successful in predicting a β-bisabolene synthase with 
both predictions successfully switching specificity and maintaining activity 
(M447H/A336V/I562T and M447H/A336V/I562V) (Yoshikuni, Ferrin and Keasling, 2006). 
Plasticity residues behaved as if they were independent and can be the driving force behind 
molecular evolution, while the mutations were additive (Yoshikuni, Ferrin and Keasling, 
2006).      
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Overall the mutagenesis effort has led to a variety of product specificity and enzyme property 
changes while giving insight into how terpene synthases control product diversity and 
reaction mechanisms. This knowledge was used to create an aromatic enzyme-mimicking 
supramolecular capsule to catalyse the cyclisation of a sesquiterpene (Zhang et al., 2018). 
Isolongifolene was produced by an artificial enzyme mimic that combined the terpene 
synthase features of encapsulating the substrate in a hydrophobic environment and 
controlling the orientation of the substrate (Zhang et al., 2018). 
 
1.8 Metabolic engineering for the production of terpenes 
As terpenes have such a wide range of uses, they are targets for pathway optimisation to 
increase their production. Pathway optimisation can target substrates and products and can 
be done in native and non-native species. Metabolic engineering uses genetic engineering 
tools to modulate existing or heterologous pathways in cells to overproduce target chemicals 
with high yields, rates and with reduced stereochemistry issues (Chen, Zhang and Lindley, 
2019). Metabolic engineering involves understanding metabolism to keep the overall 
metabolic flux harmonized and utilise the molecular biology and high throughput analytical 
tools and techniques to create a systematic approach (Ajikumar et al., 2008).  
 
Native expression and engineering of terpenes especially in plant cell culture has a number 
of associated challenges. One of the largest challenges is the fact that large number of 
terpenoid pathway elements are undefined including regulation and rate limiting steps 
(Roberts, 2007). Few plant genomes have been fully sequenced, and this can pose 
problems moving between whole plant and plant cell culture studies and using traditional 
genetic methods. Without sequencing information there are no known plant inducible 
promoters unlike in heterologous platforms (Roberts, 2007).  In addition plant cells can have 
a large variability in terpene productions and are generally 2-3 % of the plant dry weight 
(Roberts, 2007).  
 
There has only been one notable example of engineering endogenous plant terpenoid 
pathways - the increase in mint oil production in Mentha x piperita (Withers and Keasling, 
2007). Over expression of DXP reductoisomerase by 50 % increased essential oil 
production. Essential oils are a complex mix of terpenoids and the ratio of peppermint in 
essential oils can be modulated by the production of menthofuran. The production of 
methofuran is targeted through transcriptional regulation of menthofuran synthase as it down 
regulates pulegone reductase (Mahmoud and Croteau, 2003). 
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There are two main heterologous industrial production platforms; E. coli and S. cerevisiae 
(Chen, Zhang and Lindley, 2019). These production platforms are generally safer, higher 
yielding and sustainable as extraction from plant material is expensive due to the low yields 
and complicated extraction methods (Chen, Zhang and Lindley, 2019). Heterologous 
expression produces higher yields as there is no feedback regulation as a native control but 
high yields can lead to toxicity (Chang and Keasling, 2006). Heterologous hosts may 
produce the precursor and substrates but it is hard to predict the levels and how to balance 
the flux of metabolites (Chang and Keasling, 2006).  
 
1.8.1 Balancing pathways and building blocks  
A large focus of engineering terpenes involves increasing the supply of precursors through 
overexpression and heterologous expression. There are three key stages which can be 
targeted for engineering; transcription, translation and post-translational modifications. To 
target at the level of transcription involves the balancing of promoters to control the levels of 
mRNA. The use of model organisms as industrial platforms is successful as promoters have 
been well characterised to fine tune the balance of mRNA. The use of promoters can be 
used to upregulate the desired genes while also using weak promoters to downregulate 
genes that could divert resources (Chen, Zhang and Lindley, 2019). For example the 
temperature sensitive promoter GalM9 was used to increase the production of astaxanthin 
synthase in S. cerevisiae when the temperature of the culture is lowered post induction 
(Chen, Zhang and Lindley, 2019). The second stage to target is translation specifically 
targeting the ribosomal binding site and the 5’-UTRs. Mutations of 3 or more nucleotides in 
the ribosomal binding site region can alter translation initiation rate by 50-fold. Post 
translation involves the co-localisation of enzyme to increase local substrate concentration 
and facilitate substrate channelling. One way to do this is to fuse two sequential enzymes in 
the pathway, in close proximity the diffusional limitations are reduced increasing the reaction 
rate. Overall all three stages need to be engineered in a push and pull manner to increase 
precursors and co-factor availability without reaching a toxic level. This can generally 
improve pathway flux when the balance is reached and is functioning (Chen, Zhang and 
Lindley, 2019).            
 
The first stage in increasing production is to identify the rate limiting steps of the pathways to 
increase the overall flux of precursor production. The rate limiting steps in the 
methylerythritol phosphate pathway are either the reactions of DXS, DXR or IspC and IPP-
DMAPP isomerase (Figure 1-4) (Chang and Keasling, 2006). To overcome rate limiting 
steps, combinations of precursor feeding, modulation of gene expression and gene deletion 
experiments were used. Increased expression of DXS and IPP-DMAPP isomerase 
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increased the precursor pool and balanced the ratio G3P and pyruvate were combined with 
carotenoid synthase expression increasing the yield 10-fold (Ajikumar et al., 2008). This 
level was further increased when combined with overexpression of geranylgeranyl 
pyrophosphate synthase to a 50-fold improvement (Ajikumar et al., 2008). The flux of the 
pathway remains limited by the intracellular regulatory mechanisms of the organism.             
 
Heterologous expression of a pathway can overcome the intracellular regulation limits. The 
methylerythritol phosphate pathway is unique to eubacteria and plants but it is not suitable 
for heterologous expression in S. cerevisiae due to the lack of iron clusters for IspG and 
IspH (Chen, Zhang and Lindley, 2019). Whereas the mevalonate pathway has been 
successfully heterologously expressed in 2 synthetic operons (Figure 1-4) (Chang and 
Keasling, 2006) (Withers and Keasling, 2007). MevT is a plasmid that encode the enzymes 
that convert acetyl-coA to mevalonate. MBis is a plasmid that converts mevalonate to 
farnesyl pyrophosphate (Chang and Keasling, 2006) (Withers and Keasling, 2007). 
Expression of just the pathway leads to precursor accumulation toxicity, however co-
expression with codon optimised terpene synthase relieves the toxicity (Chang and Keasling, 
2006).  An example of this is the co-expression of codon optimised amorphadiene synthase 
to reduce toxicity and the testing of the mevalonate pathway in an E. coli strain deficient in 
isoprenoid synthesis (Martin et al., 2003).     
 
This mevalonate pathway spilt has been further studied in E. coli for the optimisation of 
protoilludene production.  Protoilludene derivatives have medically relevant properties being 
used as antitumor and antimicrobial activities but purification of protoilludene has low yields 
(Yang et al., 2016). MvU is a plasmid containing the sequences for the enzymes; acetyl-coA 
acetyltransferase, HMG-CoA reductase, HMG-CoA synthase. MvL is a plasmid containing 
the sequences for the enzymes; mevalonate kinase, phosphomevalonate kinase, 
pyrophosmevalonate decarboxylase, IPP isomerase. The third section is the farnesyl 
pyrophosphate and codon optimised protoilludene synthase (Yang et al., 2016). The balance 
between the expression of the MvU and MvL was altered to increase the overall production 
of protoilludene. For MvL the gene order was arranged in order of activity level from low to 
high. In addition, MvL was further optimised by random sequential permutations throughout 
the plasmid (Yang et al., 2016). Whereas MvU expression was modulated by changes to the 
promoter causing varied transcription levels. Also a homolog of mevalonate kinase was 
substituted in which further increased protoilludene (Yang et al., 2016).  
 
Increasing the supply of acetyl-CoA for the native mevalonate pathway in S. cerevisiae 
would therefore increase the production of amorphadiene. To increase acetyl-CoA the 
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method focused on primary metabolism using a pyruvate dehydrogenase bypass (Shiba et 
al., 2007). The pyruvate dehydrogenase bypass converts pyruvate to acetyl-CoA using a 
combination of pyruvate decarboxylase, cytosolic acetaldehyde dehydrogenase and acetyl-
CoA synthase (Shiba et al., 2007). The combination of enzymes was heterologously 
overexpressed and tested with a variety of promoters to find the optimal balance (Shiba et 
al., 2007). Engineered S. cerevisiae strains have been tested with heterologous expression 
of novel terpene synthase found through mining bacterial genome data and characterised 13 
novel cyclic terpenes (Yamada et al., 2015). This shows engineered platforms can be used 
to facilitate the discovery or characterisation of terpene synthase and can be used alongside 
computer predictive frameworks predicting function or activity (Chen, Zhang and Lindley, 
2019).   
 
1.8.2 Terpene synthase pathway engineering examples 
The most significant engineering effort is for the production of anticancer Taxol by targeting 
taxadiene synthase and the following enzymes. Taxol is natively produced by Taxus 
chinenis and is extracted from bark of yew trees. However, this extraction is only 0.001 - 
0.002 % efficient and therefore cannot meet the demand (Engels, Dahm and Jennewein, 
2008). Taxadiene synthase and Taxol production have been metabolically engineered in 
both S. cerevisiae and E. coli. S. cerevisiae engineering initially involved the heterologous 
genes for the biosynthetic enzymes, that constitute the early Taxol pathway, isoprenoid 
pathway and regulatory factors inhibiting competitive pathways (Figure 1-25) (DeJong et al., 
2006). S. cerevisiae natively uses the mevalonate pathway and its main feedback regulation 
is HMG-CoA reductase. To target HMG-CoA regulation the N-terminal regulation domain is 
removed to stop the negative feedback regulation. Expression of this truncated version 
increased taxadiene production by 50 % (Figure 1-25) (Engels, Dahm and Jennewein, 
2008). An additional method to increase flux is to reduce competing pathways that include 
sterol production using geranylgeranyl pyrophosphate synthase from S. acidocaldarius to 
compete for resources with farnesyl pyrophosphate synthase. S. acidocaldarius 
geranylgeranyl pyrophosphate synthase can utilise DMAPP and IPP building blocks to 
produce geranylgeranyl pyrophosphate. This was combined with a previously characterised 
transcription factor UPC2 allele mutant that allows steroid uptake in aerobic conditions to 
utilise steroid uptake from the culture medium (Figure 1-25) (Engels, Dahm and Jennewein, 
2008) (DeJong et al., 2006).  Also taxadiene synthase was expressed without the N-terminal 
plastid target sequence to improve expression (DeJong et al., 2006). Despite this there was 
insufficient geranylgeranyl pyrophosphate so the geranylgeranyl pyrophosphate synthase 
gene was put under the control of the strong constitutive phosphate glycerol kinase promoter 
using glucose as an activator in yeast fermentation (DeJong et al., 2006). A combination of 
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all of these engineering steps led to a 40-fold increase in taxadiene levels to 8.7 mg/L 
(Figure 1-25) (DeJong et al., 2006) (Engels, Dahm and Jennewein, 2008). 
 
Figure 1-25 Schematic of the engineering attempts for taxadiene production in S. 
cerevisiae. The engineering efforts included expression of S. acidocadarius geranylgeranyl 
pyrophosphate synthase under the strong glycerol kinase promoter and the removal of the 
plastid targeting sequence from Taxus chinenis taxadiene synthase. In addition, the UPC2 
allele mutant allows steroid uptake from culture medium in aerobic conditions. The was 
combined with the expression of the truncated HMG-CoA reductase. Overall the engineering 
efforts produce 8.7 mg/L of taxadiene.    
 
Taxol production was also engineered in E. coli utilising the native methylerythritol 
phosphate pathway. The methylerythritol phosphate pathway consists of 8 genes with 4 rate 
determining gene expressions modulating the production of IPP. Downstream of this 
pathway is a two gene heterologous pathway to produce taxadiene (Ajikumar et al., 2010). 
The balance of both pathways needs to be achieved so the downstream steps can 
accommodate the upstream production levels. The balance is achieved by using a variety of 
promoters and gene copy numbers to modulate each step. The strongest promoter was 
used for the downstream steps but alongside a low copy number to increase the taxadiene 
heterologous pathway (Figure 1-26) (Ajikumar et al., 2010). The upstream enzymes were 
expressed at lower levels and were chromosomally integrated for stability. High levels of 
specific intermediates can lead to inhibition, so the lower expression levels increase the 
overall production without overwhelming the culture (Ajikumar et al., 2010). In addition, a 
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variety of chimeric P450 enzymes were co-expressed in engineered strains for the oxidation 
of taxadiene to taxadiene-5	"-ol (Figure 1-26). This combination of methods allows E. coli to 
produce 1 g/L in fed-batch bioreactor fermentations (Ajikumar et al., 2010). Other Taxol 
production engineering strategies in E. coli include removing the signal peptide of taxadiene 
synthase as in S. cerevisiae to increase soluble expression, enzyme fusions and 
overexpression of rate limiting steps (Huang et al., 2001). In addition, fusions of IPP 
isomerase and geranylgeranyl pyrophosphate synthase with a 21 amino acids linker were 
overexpressed to increase taxadiene synthase substrate production (Figure 1-26) (Huang et 
al., 2001). Along with previous methods rate limiting enzymes in the methylerythritol 
phosphate pathway including DXP synthase genes were collected on one plasmid to 
increase soluble protein to overcome the rate limiting steps (Huang et al., 2001).  
 
Figure 1-26 Schematic of engineering taxadiene production in E. coli. The engineering 
efforts included the removal of the plastid targeting sequence from Taxus chinenis taxadiene 
synthase and engineering the methylerythritol phosphate pathway. In addition, a fusion 
protein of IPP isomerase and geranylgeranyl pyrophosphate synthase reducing the 
substrate diffusion rate. Also, the chimeric P450 enzyme oxidise taxadiene to taxadiene-5	"-
ol the next step in the Taxol pathway. Overall the engineering efforts yielded 1 g/L taxadiene 
or taxadiene-5	"-ol.      
 
Amorphadiene is another medically relevant terpene that is chemically functionalised to the 
terpenoid artemisinin which has antimalarial activity. Production of artemisinic acid is 
engineered in S. cerevisiae through engineering the mevalonate pathway, amorphadiene 
synthase, and novel cytochrome P450 monooxygenase. The first target was to upregulate 
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farnesyl pyrophosphate synthesis with the upregulation of truncated soluble HMG-CoA 
reductase (Ro et al., 2006). This is combined with reducing the steroid production by 
increasing steroid uptake with UPC2-1 mutant allele, with the down regulation of squalene 
synthase (ERG9) (Chang and Keasling, 2006) (Ro et al., 2006). This was combined with a 
novel cytochrome P450 to convert amorphadiene to artemisinic acid. Cytochrome P450 
fragments from Artemisia annua were isolated and a P450 of close linage was found that 
could catalyse hydroxylation of terpenoids. This is active on amorphadiene and was put 
under control of a galactose-inducible promoter with its native redox partner NADPH (Ro et 
al., 2006). This engineered strain of S. cerevisiae produces artemisinic acid two orders of 
magnitude higher than the native host. The extraction of artemisinic acid was simple as it is 
released from the cells and can be separated with alkaline buffer washing (Ro et al., 2006) 
(Chang and Keasling, 2006). 
 
Bisabolane fuel is an alternative to D2 diesel fuel and is produced by hydrogenating 
bisabolene (McAndrew et al., 2011). Bisabolene production was engineered in both E. coli 
and S. cerevisiae and from both of these sources bisabolene can be extracted with a solvent 
layer and hydrogenated to bisabolane (McAndrew et al., 2011). Abies grandis bisabolene 
synthase is a specific terpene synthase and following the screening of a selection of 
bisabolene synthases it was taken forward due to it high level of bisabolene production 
(Peralta-Yahya et al., 2011). Further optimisation was achieved by codon optimising the 
sequences of the methylerythritol phosphate pathway enzymes and changing the promoters 
to increase production. The overall yield achieved 912 mg/L which is only 4 % of the 
theoretical yield (Peralta-Yahya et al., 2011). Following this production optimisation in S. 
cerevisiae, engineering in E. coli used previously engineered strains as the starting point as 
well. The engineered strain involved a truncated HMG-CoA reductase, an overexpressed 
farnesyl pyrophosphate synthase and overexpression of a global transcription regulator of 
the sterol pathway. Also squalene synthase, an enzyme involved in a competitive pathway, 
was downregulated increasing available farnesyl pyrophosphate (Peralta-Yahya et al., 
2011). The Abies grandis bisabolene synthase was put under the galactose promoter on a 
high copy number plasmid. Overall E. coli engineering achieved bisabolene production 
levels of 994 mg/L.            
 
Pathway engineering can be combined with terpene synthase engineering to further improve 
the production of a specific terpene in the case of diterpene levopimaradiene. The first step 
was to target diterpenoid and its precursor biosynthesis through the methylerythritol 
phosphate pathway. This engineering involved overexpression of the methylerythritol 
phosphate pathway 10-fold to a point where the downstream pathway is insufficient to cope 
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with the precursor level (Leonard et al., 2010).  To increase the capacity of the downstream 
pathway both geranylgeranyl pyrophosphate synthase and levopimaradiene synthase were 
codon optimised and functionally expressed however, there was still significant precursor 
build up. To further increase the capacity both geranylgeranyl pyrophosphate synthase and 
levopimaradiene synthase were engineered. First levopimaradiene synthase was 
engineered using a homology structure to identify 15 potential key residues within the active 
site. At these positions a saturation or targeted library was produced. The key mutations 
were M593L increasing 2-fold, M593I increasing 3.7-fold and Y700F, M or W increasing 5-
fold. A combination of M593I/Y700F increased production 10-fold (Leonard et al., 2010). 
There is no structural information on geranylgeranyl pyrophosphate synthase so directed 
evolution was used and screened with a lycopene biosynthetic pathway and a colorimetric 
assay with an increasing terpene production increasing the intensity of the red produced 
(Leonard et al., 2010). The 15 best mutants were screened with the M593I/Y700F 
levopimaradiene synthase. The best mutation combination with an increase of 17.7-fold was 
S239C and G295D (Leonard et al., 2010). Overall with 10-fold overexpression of the 
methylerythritol phosphate pathway, S239C/G295D geranylgeranyl pyrophosphate synthase 
and M593I/Y700F levopimaradiene synthase expression of levopimaradiene is increased 
2600-fold over wildtype (Leonard et al., 2010). 
 
1.9 Project background 
This thesis will focus on selecting and characterising a sesquiterpene synthase (Chapter 3) 
with the goal of engineering this sesquiterpene synthase for the production of novel products 
(Chapter 4). Through this engineering we hope to gain further insight into the mechanism of 
action and cation control within the sesquiterpene synthase active site. 
 
Sesquiterpene synthase selection was based on the following criteria: ability to 
heterologously express in E. coli, availability of a crystal structure to allow for rational 
mutagenesis and no previous extensive engineering. After shortlisting four sesquiterpene 
synthases, two were selected based on the chemical structure and chemical potential of the 
primary product. The selected sesquiterpene synthase will be rationally engineered with the 
aim of producing novel sesquiterpene.  The aims of this project were as follows. 
 
1.9.1 To select a suitable sesquiterpene synthase as target for engineering.  
Sesquiterpene synthase were selected based on their ability to heterologously express in E. 
coli to a sufficient level along with a suitable purification method (Section 3.1). In addition, 
the sesquiterpene synthase must have a solved crystal structure without having undergone 
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extensive engineering to allow for a broad rational mutagenesis strategy. Following the 
shortlisting of the sesquiterpene synthase the chemical structure and chemical potential of 
the product was taken into account for narrowing the choice. From this two sesquiterpene 
synthases were taken forward for expression and purification tests to select the 
sesquiterpene synthase (Section 3.3).  
 
1.9.2 To kinetically characterise the selected sesquiterpene synthase  
Using the malachite green assay and purified enzymes pyrophosphate release from terpene 
synthases can be detected when coupled with a pyrophosphatase, creating inorganic 
phosphate ions. These inorganic phosphate ions from a complex with malachite green and 
ammonium molybdate that forms a green complex that can be measured at 620 nm. The 
selected sesquiterpene synthase was be tested with a range of farnesyl pyrophosphate 
concentrations with a set enzyme concentration of a set amount of time and this data could 
be used to calculate the kinetic parameters. These wild type parameters can then be 
compared to any generated variants (Section 3.4).  
 
1.9.3 To complete alanine scanning and screen development 
The first step of rational engineering uses alanine scanning at select residues across the 
hydrophobic cleft of the active site. These alanine mutants can then be used to asses 
screening methods for further mutagenesis. One screening option is to use the malachite 
green activity assay to test whether the mutants are active but does not confirm the 
products. An additional screening method is using GC/MS on either purified protein or cell 
culture samples with a solvent overlay. This method can detect the product profile of the 
enzymes to detect any changes. Following the screening test the alanine mutants can be 
evaluated and be used in further rational engineering (Section 4.2).  
 
1.9.4 To complete further rational engineering of sesquiterpene synthase      
Using the results from the alanine mutants, further study of the crystal structure and the 
throughput of the selected screening method a set of mutants was compiled and created 
using site directed mutagenesis. The selected mutants were screened, and any interesting 
results were flagged, the mutants were characterised, and these positions were further 
explored. The aim of further mutagenesis is to produce a sesquiterpene synthase that 
produce novel sesquiterpene (Section 4.3).   
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Chapter 2 - Materials and Methods 
2.1 Materials 
2.1.1 Chemicals 
Table 2-1 List of chemicals used in methods described.   
Chemical Supplier 
1,2-Dithiothreitol DTT Fluorochem, Derybshire, UK 
Acetone Fisher Scientfic, Loughborough, UK 
Acrylamide 30% Sigma-Aldrich, Dorset, UK 
Agar Melford Laboratories, Suffolk, UK 
Agarose Melford Laboratories, Suffolk, UK 
Ammonium Acetate Fisher Scientific, Loughborough, UK 
Ammonium molybdate Sigma-Aldrich, Dorset, UK 
Ammonium Persulfate Acros Organics (Fisher Scientific) 
Ammonium Sulphate  Sigma-Aldrich, Dorset, UK 
Ampicillin Sigma-Aldrich, Dorset, UK 
Bisabolene Sigma-Aldrich, Dorset, UK 
Bovine serum albumin Bio-Rad, Hertfordshire, UK 
Bradford Reagent  Bio-Rad, Hertfordshire, UK 
Bromophenol Blue Sigma-Aldrich, Dorset, UK 
CAPS Calbiochem (Merk Millipore) 
Chloramphenicol  Sigma-Aldrich, Dorset, UK 
Chloroform-d Sigma-Aldrich, Dorset, UK 
Coomassive Brilliant Blue Bio-Rad, Hertfordshire, UK 
Cumene  Sigma-Aldrich, Dorset, UK 
Dimethyl sulphoxide, DMSO Sigma-Aldrich, Dorset, UK 
Dodecane Sigma-Aldrich, Dorset, UK 
Ethanol Fisher Scientific, Loughborough, UK 
Ethylenediamine tera acetic acid, EDTA Sigma-Aldrich, Dorset, UK 
Farensyl pyrophosphate Isoprenoids, Tampa, USA 
Glacial acetic acid  Sigma-Aldrich, Dorset, UK 
Glycerol Alfa Aesar, Lancashire, UK 
Glycine Sigma-Aldrich, Dorset, UK 
HEPES Fluorochem, Derybshire, UK 
Imidazole Acros Organics (Fisher Scientific) 
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InstantBlue Expendeon, Cambridge, UK 
Isopropyl β-D-1-thiogalactopyranoside, 
IPTG 
Generon, Berkshire, UK 
Kanamycin Sigma-Aldrich, Dorset, UK 
Lysozyme (Mammalian) Sigma-Aldrich, Dorset, UK 
Malachite green oxalate salt Sigma-Aldrich, Dorset, UK 
MES Monohydrate Alfa Aesar, Lancashire, UK 
Phenylmethylsulfonyl fluoride, PMSF Sigma-Aldrich, Dorset, UK 
Pierce™ Protease Inhibitor Tablets, EDTA-
free 
Thermo Fisher Scientific, Loughborugh, UK 
Propan-2-ol Fisher Scientific, Loughborough, UK 
Sodium Chloride, NaCl Across Organics (Fisher Scientific) 
Sodium dodecyl sulphate, SDS Sigma-Aldrich, Dorset, UK 
Sodium hydroxide, NaOH Fisher Scientific, Loughborough, UK 
Sodium phosphate  Sigma-Aldrich, Dorset, UK 
Sodium pyrophosphate Sigma-Aldrich, Dorset, UK 
Sodium Sulphate Sigma-Aldrich, Dorset, UK 
SYBRsafe DNA stain  Bio-Rad, Hertfordshire, UK 
Tetracycline Sigma-Aldrich, Dorset, UK 
Tetramethylethylenediamine, TEMED Sigma-Aldrich, Dorset, UK 
Tris Base Fisher Scientific, Loughborogh, UK 
Tryptone Melford Laboratories, Suffolk, UK 
Yeast Extract Sigma-Aldrich, Dorest, UK 
β-mercaptoethanol Sigma-Aldrich, Dorset, UK 
 
All restriction enzymes and Q5® High-Fidelity Polymerase, Quick-Load® 1 kb Extend DNA 
Ladder, yeast inorganic pyrophosphatase and broad range Colour Prestained Protein 
Standard were purchased from NEB. Pfu DNA polymerase was purchased from Agilent. 
Deyoxynucleotide triphosphate (dNTPs) and 100 bp and 1 kb DNA ladders were purchased 
from Promega.  
 
2.1.2 Consumables and chromatography reagents and kits 
Miniprep kits were purchased from Promega or NEB. Qiaquick® PCR purification Kit and 
Qiaquick® Gel extraction kit was purchased from Qiagen. Viviaspin® centrifugal 
concentrators were purchased from Generon.  
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Unless otherwise stated all chromatography resins and prepacked columns were purchased 
from GE Healthcare.   
 
2.1.3 Media and antibiotics 
All growth media was prepared by weighing out the appropriate ingredients (Table 2-2) 
before dissolving them in deionsed water. Media was then sterilised by autoclaving at 121°C 
for 20 minutes at 15 psi. The media was the stored at room temperature until use. 
Table 2-2 Growth media components  
Solution  Ingredients  
Lysogeny Broth (LB) 10 g/L Tryptone 
5 g/L Yeast Extract  
10 g/L Sodium Chloride  
2 TY Media 16 g/L Tryptone 
10 g/L Yeast Extract  
5 g/L Sodium Chloride 
SOC Media  5 g/LYeast Extract 
20 g/L Tryptone 
0.5 g/L Sodium Chloride 
2.5mL/L 1M Potassium Chloride 
10mL/L 1M Magnesium Chloride 
20mL 1M Glucose  
LB Agar Plates  10 g/L Tryptone 
5 g/L Yeast Extract  
10 g/L Sodium Chloride 
20 g/L Agar Bacteriological 
 
Antibiotic stocks were prepared by weighing out the appropriate amount as described in 
Table 2-3. The antibiotic was dissolved in deionised water or ethanol and filtered using 
0.22µM. The antibiotic solution was aliquoted into aliquots between 0.15 and 1ml and stored 








Table 2-3 Antibiotic solutions and concentrations  
Antibiotic Stock Concentration and 
Preparation 
Working Concentration 
Ampicillin 100 mg/ml in dH2O 100 µg/ml 
Chloramphenicol 25 mg/ml in ethanol 25 µg/ml 
Kanamycin 50 mg/ml in dH2O 50 µg/ml 
Tetracycline 10 mg/ml in dH2O 10 µg/ml 
 
2.1.4 Bacterial strains 
E. coli strains used in this work are described below in Table 2-4. All transformations were 
performed using the manufactures guidelines. 
Table 2-4 E. coli strains and genotypes.  




DNA Manipulation  Tetr∆(mcrA)183 ∆(mcrCB-hsdSMR-
mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac Hte [F´ proAB lacIq Z∆M15 
Tn10(Tetr) Amy Camr] 
BL21-Gold(DE3) 
(Agilent) 
Protein Expression (B F- ompT hsdS(rB– mB–) dcm+ Tetr  gal 
λ(DE3) endA Hte 
BL21-CodonPlus 
RIPL 
Protein Expression E. coli B F– ompT hsdS(rB – mB – ) 






B F- dcm+ Hte ompT hsdS(rB- mB-) gal λ 
(DE3) [pLysS Camr]a endA Tetr 
 
2.1.5 Vectors, genes and primers 
Primers were synthesised by Intergrated DNA Technologies, Inc. Codon optimised selina-
4(15),7(11)-diene was synthesized by GenScript into a pET-28a vector. pET His6 Sumo TEV 
LIC cloning vector (1S) was a gift from Scott Gradia (Addgene plasmid # 29659; 
http://n2t.net/addgene:29659; RRID:Addgene 29659). pET-TEV was a kind gift from 
Professor Radford (Faculty of Biological Science, University of Leeds, UK).  
 
2.1.6 Production of competent cells  
A 10mL culture of the desired strain was grown at 37°C shaking at 200 rpm overnight. 100 
mL of LB was inoculated with a 1:20 ratio using the 10 mL overnight culture. Cultures were 
grown at 37°C shaking at 200 rpm until the OD600nm is between 0.40 and 0.45. At this point 
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the cells were centrifuged at 4000 rpm for 10 minutes at 4°C with cold rotors. The 
supernatant was discarded, and the pellet resuspended in 10 mL of sterile chilled 100 mM 
calcium chloride. This was incubated on ice for 10 minutes before being centrifuged as 
before. The supernatant was discarded, and the pellet was reuspended in 2 mL of 100 mM 
calcium chloride, 30% (v/v) glycerol. The cells were aliquoted into 100 µL aliquots on 
eppendorfs on dry ice. The cells were stored at -80°C.     
 
2.2 DNA methods 
2.2.1 Primers 
Primers were designed for a variety of purposes using the NEB Tm calculator and sometimes 
the QuikChange primer design online tool to design primers for mutagenesis. Primers are 
shown in the Table 2-5.  
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Table 2-5 The primers used in DNA cloning and mutagenesis. 
Primer Function Primer Name Direction  Primer Sequence (5’ to 3’) 
Addition of stop codon to 
pET His6 Sumo TEV LIC 
cloning vector (1S) 
SeDS_1 Fwd ggtggtggtggtggtggatgattgcggccgcaagcttg 
SeDS_2 Rev caagcttgcggccgcaatcatccaccaccaccaccacc 
Mutate F55 to E SeDS_F55E_Fwd Fwd ggcagaatacgcgcgctctcggtaccgatgtcttggg 
SeDS_F55E_Rev Rev cccaagacatcggtaccgagagcgcgcgtattctgcc 
Mutate F55 to H SeDS_F55H_Fwd Fwd gcagaatacgcgcgctatgggtaccgatgtcttggg 
SeDS_F55H_Rev  Rev cccaagacatcggtacccatagcgcgcgtattctgc 
Mutate F55 to I SeDS_F55I_Fwd Fwd agaatacgcgcgctaatggtaccgatgtcttgg 
SeDS_F55I_Rev Rev ccaagacatcggtaccattagcgcgcgtattct 
Mutate F55 to L F55L Fwd Fwd cccaagacatcggtaccttaagcgcgcgta 
F55L Rev Rev tacgcgcgcttaaggtaccgatgtcttggg 
Mutate F55 to M SeDS_F55M_Fwd Fwd gcagaatacgcgcgctcatggtaccgatgtcttgg 
SeDS_F55M_Rev Rev ccaagacatcggtaccatgagcgcgcgtattctgc 
Mutate F55 to Q SeDS_F55Q_Fwd Fwd ggcagaatacgcgcgctctgggtaccgatgtcttggg 
SeDS_F55Q_Rev Rev cccaagacatcggtacccagagcgcgcgtattctgcc 
Mutate F55 to Y  F55Y Fwd Fwd caagacatcggtacctatagcgcgcgtattctg 
F55Y Rev Rev cagaatacgcgcgctataggtaccgatgtcttg 
Mutate L78 to C SeDS_L78C_Fwd Fwd gccatcgtccacaccaaagcaccacaggatgaaatccgc 
SeDS_L78C_Rev Rev gcggatttcatcctgtggtgctttggtgtggacgatggc 
Mutate L78 to E SeDS_L78E_Fwd Fwd catcgtccacaccaaactcccacaggatgaaatccg 
SeDS_L78E_Rev Rev cggatttcatcctgtgggagtttggtgtggacgatg 
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Mutate L78 to G SeDS_L78G_Fwd Fwd catcgtccacaccaaacccccacaggatgaaatccg 
SeDS_L78G_Rev Rev cggatttcatcctgtgggggtttggtgtggacgatg 
Mutate L78 to I SeDS_L78I_Fwd Fwd gccatcgtccacaccaaatatccacaggatgaaatccgc 
SeDS_L78I_Rev Rev gcggatttcatcctgtggatatttggtgtggacgatggc 
Mutate L78 to Q SeDS_L78Q_Fwd Fwd catcgtccacaccaaactgccacaggatgaaatcc 
SeDS_L78Q_Rev Rev ggatttcatcctgtggcagtttggtgtggacgatg 
Mutate L78 to T SeDS_L78T_Fwd Fwd ccatcgtccacaccaaacgtccacaggatgaaatccgc 
SeDS_L78T_Rev Rev gcggatttcatcctgtggacgtttggtgtggacgatgg 
Mutate L78 to W SeDS_L78W_Fwd Fwd ccatcgtccacaccaaaccaccacaggatgaaatccgc 
SeDS_L78W_Rev Rev gcggatttcatcctgtggtggtttggtgtggacgatgg 
Mutate F79 to E SeDS_F79E_Fwd Fwd gtggccatcgtccacaccctccagccacaggatgaaatc 
SeDS_F79E_Rev Rev gatttcatcctgtggctggagggtgtggacgatggccac 
Mutate F79 to H SeDS_F79H_Fwd Fwd ggccatcgtccacaccatgcagccacaggatgaaat 
SeDS_F79H_Rev Rev atttcatcctgtggctgcatggtgtggacgatggcc 
Mutate F79 to I SeDS_F79I_Fwd Fwd ccatcgtccacaccaatcagccacaggatgaaa 
SeDS_F79I_Rev Rev tttcatcctgtggctgattggtgtggacgatgg 
Mutate F79 to M SeDS_F79M_Fwd Fwd ggccatcgtccacacccatcagccacaggatgaaa 
SeDS_F79M_Rev Rev tttcatcctgtggctgatgggtgtggacgatggcc 
Mutate F79 to Q SeDS_F79Q_Fwd Fwd gtggccatcgtccacaccctgcagccacaggatgaaatc 
SeDS_F79Q_Rev Rev gatttcatcctgtggctgcagggtgtggacgatggccac 
Mutate Y152 to F SeDS_Y152F_Fwd Fwd aaacaacgctaaagaagaactcacgcagcgcatc 
SeDS_Y152F_Rev Rev gatgcgctgcgtgagttcttctttagcgttgttt 
Mutate Y152 to G SeDS_Y152G_Fwd Fwd ggttgatgcgctgcgtgagggcttctttagcgttgtttgg 
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SeDS_Y152G_Rev Rev ccaaacaacgctaaagaagccctcacgcagcgcatcaacc 
Mutate Y152 to H SeDS_Y152H_Fwd Fwd aacaacgctaaagaagtgctcacgcagcgcatcaa 
SeDS_Y152H_Rev Rev ttgatgcgctgcgtgagcacttctttagcgttgtt 
Mutate Y152 to I SeDS_Y152I_Fwd Fwd ccaaacaacgctaaagaagatctcacgcagcgcatcaacc 
SeDS_Y152I_Rev Rev ggttgatgcgctgcgtgagatcttctttagcgttgtttgg 
Mutate Y152 to L SeDS_Y152L_Fwd Fwd gttgatgcgctgcgtgagttattctttagcgttgtttggg 
SeDS_Y152L_Rev Rev cccaaacaacgctaaagaataactcacgcagcgcatcaac 
Mutate Y152 to M SeDS_Y152M_Fwd Fwd ggttgatgcgctgcgtgagatgttctttagcgttgtttggg 
SeDS_Y152M_Rev Rev cccaaacaacgctaaagaacatctcacgcagcgcatcaacc 
Mutate Y152 to S SeDS_Y152S_Fwd Fwd ccaaacaacgctaaagaagctctcacgcagcgcatcaacc 
SeDS_Y152S_Rev Rev ggttgatgcgctgcgtgagagcttctttagcgttgtttgg 
Mutate Y152 to T SeDS_Y125T_Fwd Fwd ccaaacaacgctaaagaaggtctcacgcagcgcatcaacc 
SeDS_Y152T_Rev Rev ggttgatgcgctgcgtgagaccttctttagcgttgtttgg 
Mutate Y152 to W SeDS_Y152W_Fwd Fwd cccaaacaacgctaaagaaccactcacgcagcgcatcaac 
SeDS_Y152W_Rev Rev gttgatgcgctgcgtgagtggttctttagcgttgtttggg 
Mutate Y152 to V SeDS_Y152V_Fwd Fwd ggttgatgcgctgcgtgaggtcttctttagcgttgtttgg 
SeDS_Y152V_Rev Rev ccaaacaacgctaaagaagacctcacgcagcgcatcaacc 
Mutate T184 to C SeDS_T184C_Fwd Fwd gcagaaccacgctgcacgcgccgtcataca 
SeDS_T184C_Rev Rev tgtatgacggcgcgtgcagcgtggttctgc 
Mutate T184 to D SeDS_T184D_Fwd Fwd ggcagaaccacgctgtccgcgccgtcatacag 
SeDS_T184D_Rev Rev ctgtatgacggcgcggacagcgtggttctgcc 
Mutate T184 to L SeDS_T184L_Fwd Fwd atcggcagaaccacgcttagcgcgccgtcatacagac 
SeDS_T184L_Rev Rev gtctgtatgacggcgcgctaagcgtggttctgccgat 
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Mutate T184 to N SeDS_T184N_Fwd Fwd gcagaaccacgctgttcgcgccgtcatac 
SeDS_T184N_Rev Rev gtatgacggcgcgaacagcgtggttctgc 
Mutate T184 to S SeDS_T184S_Fwd Fwd cagaaccacgctgctcgcgccgtcata 
SeDS_T184S_Rev Rev tatgacggcgcgagcagcgtggttctg 
Mutate T184 to V SeDS_T184V_Fwd Fwd ggcagaaccacgctgaccgcgccgtcatacag 
SeDS_T184V_Rev Rev ctgtatgacggcgcggtcagcgtggttctgcc 
Mutate T184 to Y SeDS_T184Y_Fwd Fwd atcggcagaaccacgctatacgcgccgtcatacagac 
SeDS_T184Y_Rev Rev gtctgtatgacggcgcgtatagcgtggttctgccgat 
Mutate V187 to D SeDS_V187D_Fwd Fwd cagcatcggcagatccacgctggtcgc 
SeDS_V187D_Rev Rev gcgaccagcgtggatctgccgatgctg 
Mutate V187 to F SeDS_V187F_Fwd Fwd agcatcggcagaaacacgctggtcgcg 
SeDS_V187F_Rev Rev cgcgaccagcgtgtttctgccgatgct 
Mutate V187 to G SeDS_V187G_Fwd Fwd cagcatcggcagacccacgctggtcgc 
SeDS_V187G_Rev Rev gcgaccagcgtgggtctgccgatgctg 
Mutate V187 to I SeDS_V187I_Fwd Fwd cgcgaccagcgtgattctgccgatgct 
SeDS_V187I_Rev Rev agcatcggcagaatcacgctggtcgcg 
Mutate V187 to L SeDS_V187L_Fwd Fwd gcatcggcagaagcacgctggtcgc 
SeDS_V187L_Rev Rev gcgaccagcgtgcttctgccgatgc 
Mutate V187 to M SeDS_V187M_Fwd Fwd cgcgaccagcgtgatgctgccgatgctgg 
SeDS_V187M_Rev Rev ccagcatcggcagcatcacgctggtcgcg 
Mutate V187 to N SeDS_V187N_Fwd Fwd ccagcatcggcagattcacgctggtcgcgc 
SeDS_V187N_Rev Rev gcgcgaccagcgtgaatctgccgatgctgg 
Mutate V187 to S SeDS_V187S_Fwd Fwd gcgcgaccagcgtgagtctgccgatgctgg 
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SeDS_V187S_Rev Rev ccagcatcggcagactcacgctggtcgcgc 
Mutate V187 to T SeDS_V187T_Fwd Fwd ccagcatcggcagagtcacgctggtcgcgc 
SeDS_V187T_Rev Rev gcgcgaccagcgtgactctgccgatgctgg 
Mutate V187 to T repeat  SeDS_V187T2_Fwd Fwd gcgcgaccagcgtgactctgccgatgctgg 
SeDS_V187T2_Rev Rev ccagcatcggcagagtcacgctggtcgcgc 
Mutate V187 to Y SeDS_V187Y_Fwd Fwd gcgcgaccagcgtgtatctgccgatgctgg 
SeDS_V187Y_Rev Rev ccagcatcggcagatacacgctggtcgcgc 
Mutate S217 to C SeDS_S217C_Fwd Fwd caggtaatgatgaagcacgccatctccgcaac 
SeDS_S217C_Rev Rev gttgcggagatggcgtgcttcatcattacctg 
Mutate S217 to D SeDS_S217D_Fwd Fwd cccaggtaatgatgaagtccgccatctccgcaaccg 
SeDS_S217D_Rev Rev cggttgcggagatggcggacttcatcattacctggg 
Mutate S217 to L SeDS_S217L_Fwd Fwd gtcccaggtaatgatgaatagcgccatctccgcaaccgc 
SeDS_S217L_Rev Rev gcggttgcggagatggcgctattcatcattacctgggac 
Mutate S217 to N SeDS_S217N_Fwd Fwd ccaggtaatgatgaagttcgccatctccgcaac 
SeDS_S217N_Rev Rev gttgcggagatggcgaacttcatcattacctgg 
Mutate S217 to T  SeDS_S217T_Fwd Fwd ccaggtaatgatgaaggtcgccatctccgcaa 
SeDS_S217T_Rev Rev ttgcggagatggcgaccttcatcattacctgg 
Mutate S217 to V SeDS_S127V_Fwd Fwd cccaggtaatgatgaagaccgccatctccgcaaccg 
SeDS_S217V_Rev Rev cggttgcggagatggcggtcttcatcattacctggg 
Mutate S217 to Y SeDS_S217Y_Fwd Fwd gtcccaggtaatgatgaaatacgccatctccgcaaccgc 
SeDS_S217Y_Rev Rev gcggttgcggagatggcgtatttcatcattacctgggac 
Mutate I220 to E SeDS_I220E_Fwd Fwd aagatatcgttgtcccaggtctcgatgaagctcgccatctccg 
SeDS_I220E_Rev Rev cggagatggcgagcttcatcgagacctgggacaacgatatctt 
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Mutate I220 to F SeDS_I220F_Fwd Fwd tcgttgtcccaggtaaagatgaagctcgccatc 
SeDS_I220F_Rev Rev gatggcgagcttcatctttacctgggacaacga 
Mutate I220 to L SeDS_I220L_Fwd Fwd tcgttgtcccaggtaaggatgaagctcgccatc 
SeDS_I220L_Rev Rev gatggcgagcttcatccttacctgggacaacga 
Mutate I220 to M SeDS_I220M_Fwd Fwd ttgtcccaggtcatgatgaagctcgccatctcc 
SeDS_I220M_Rev Rev ggagatggcgagcttcatcatgacctgggacaa 
Mutate I220 to Q SeDS_I220Q_Fwd Fwd aagatatcgttgtcccaggtctggatgaagctcgccatctccg 
SeDS_I220Q_Rev Rev cggagatggcgagcttcatccagacctgggacaacgatatctt 
Mutate I220 to T SeDS_I220T_Fwd Fwd tatcgttgtcccaggtagtgatgaagctcgccatc 
SeDS_I220T_Rev Rev gatggcgagcttcatcactacctgggacaacgata 
Mutate I220 to V SeDS_I220V_Fwd Fwd tcgttgtcccaggtaacgatgaagctcgccatc 
SeDS_I220V_Rev Rev gatggcgagcttcatcgttacctgggacaacga 
Mutate T221 to C SeDS_T221C_Fwd Fwd tcgttgtcccagcaaatgatgaagctcgccatctcc 
SeDS_T221C_Rev Rev ggagatggcgagcttcatcatttgctgggacaacga 
Mutate T211 to D SeDS_T221D_Fwd Fwd atcgttgtcccagtcaatgatgaagctcgccatctccgc 
SeDS_T211D_Rev Rev gcggagatggcgagcttcatcattgactgggacaacgat 
Mutate T221 to L SeDS_T221L_Fwd Fwd gatatcgttgtcccatagaatgatgaagctcgccatctccgcaacc 
SeDS_T221L_Rev Rev ggttgcggagatggcgagcttcatcattctatgggacaacgatatc 
Mutate T221 to N SeDS_T221N_Fwd Fwd tcgttgtcccagttaatgatgaagctcgccatctc 
SeDS_T221N_Rev Rev gagatggcgagcttcatcattaactgggacaacga 
Mutate T221 to S SeDS_T221S_Fwd Fwd cgttgtcccagctaatgatgaagctcgccatc 
SeDS_T211S_Rev Rev gatggcgagcttcatcattagctgggacaacg 
Mutate T221 to V SeDS_T221V_Fwd Fwd atcgttgtcccagacaatgatgaagctcgccatctccgc 
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SeDS_T221V_Rev Rev gcggagatggcgagcttcatcattgtctgggacaacgat 
Mutate T221 to Y SeDS_T221Y_Fwd Fwd gatatcgttgtcccaataaatgatgaagctcgccatctccgcaacc 




2.2.2 Polymerase chain reaction (PCR) 
Both Q5® High fidelity polymerase and Pfu DNA polymerase were used throughout this 
work. Both were used following the manufactures guidelines.  
 
2.2.3 PCR Purification  
Purification of PCR products was completed using QIAquick PCR Purification kit as 
described by the supplier’s guidelines. 
 
2.2.4 Agarose gel electrophoresis 
0.6-1% agarose gel were produced by weighing out accurately the agarose and dissolving 
the agarose in 1X TAE buffer (40 mM Tris-acetate, 1 mM EDTA pH 8.0) using the 
microwave. After the solution had cooled 10,000X SYBRsafe DNA stain was added and the 
solution was poured into a cast. When the gel had set the gel was placed in that tank and 
covered in 1X TAE buffer for sample insertion.  
Samples were prepared using 6x Gel loading dye purple (NEB). Either 1kb Quick load 
extend (NEB) or 1kb ladder (Promega). After the gel was ran at 90 volts to 100 volts for 30 to 
1 hour and 30 minutes. Following running the gel the gel was imaged under UV light.    
 
2.2.5 DNA gel extraction 
Bands were excised from the gel under UV light by a scalpel. QIAquick Gel Extraction Kit 
(Qiagen) was used a described in the suppliers’ guidelines. 
 
2.2.6 Restriction digestion 
Restriction digests were carried out as described in the supplier’s guidelines. 3-10 µL of 
DNA was added and 10-20 µL of PCR products were added to 30-50 µL restriction digests 
for an approximate concentration between 10-20 ng/µL. The enzymes used were; Hind III (1 
µL – 20 units of enzyme), Eco RI (3 µL – 60 units of enzyme) and XhoI (2 µL - 40 units of 
enzyme). The volume was made up to 30-50 µL (depending on the reaction) with nuclease 
free water. If the digestion products were to be used further the digestion was terminated by 
incubating at 80 °C for 20 minutes. 
 
2.2.7 Transformation and DNA plasmid purification 
Cloning and mutagenesis products were transformed into Escherichia coli (E. coli) XL-10 




DNA was purified using either the Wizard® Plus SV Minipreps DNA Purification Kit 
(Promega) or the Monarch® Plasmid Miniprep Kit (NEB) from cultures. Using a 200 µL tip a 
colony was picked from transformation products and used to inoculate 5 mL of LB media 
with the corresponding antibiotic which was incubated at 37°C shaking at 250 rpm overnight. 
Cells were harvested by centrifugation at 13,000 x g for 5 minutes. Following this the kits 
protocol was followed and the product DNA was stored at -20°C.   
 
2.2.8 Measuring DNA concentration and sequencing 
DNA concentration was measured using a Nanodrop spectrophotometer (Thermo-Scientific). 
1 µL of DNA was used after cleaning with deionised water and blanking the 
spectrophotometer. The concentration is measured using A260nm reading and using Beers law 
to calculate given in ng/μl. 
DNA was sequenced by, Beckman Coulter Genomics with the primers in Table 5 or 
universal primers. DNA (15 μl at 100 ng/μl) and primers (10 μM) were sent for the express 
single sequence service and the results was analysed using BioEdit Sequence Alignment 
Editor. 
2.3 Protein expression and purification  
2.3.1 Protein expression of selina-4(15),7(11)-diene synthase for purification 
One colony from a transformation into BL21-DE3 cells or a glycerol stock was used to 
inoculate 5 mL of 2x TY media which was incubated for 6-8 hours shaking at 200 rpm at 
37°C. 1 mL of this culture was used to inoculate 50 mL of 2x TY media which was incubated 
overnight shaking at 200 rpm at 37°C. 10 mL of this overnight culture was used to inoculate 
1L of 2x TY media. 500 mL cultures were incubated at 37°C until reaching OD600nm 0.4 when 
the temperature was lowered to 20°C. When the OD600nm reached 0.6-0.8 the cultures were 
induced with 1 mM IPTG and the temperature was lowered further to 18°C and incubated 
overnight. 1 mL samples were taken before induction and before harvesting and stored at -
20°C. Cells were harvested at 10°C by centrifuging at 8,000 x g for 20 minutes, the pellet 
was stored at -80°C.  
 
2.3.2 Protein expression of selina-4(15),7(11)-diene synthase for GC/MS 
One colony from a transformation into BL21-DE3 cells or a glycerol stock was used to 
inoculate 5 mL of 2x TY media which is incubated overnight shaking at 200 rpm at 37°C. 1 
mL of this culture was used to inoculate 50 mL of 2x TY media which was incubated shaking 
at 200 rpm at 37°C. 50 mL cultures were incubated until OD600nm reached 0.6-0.8. At this 
point the temperature was lowered to 25°C, the culture induced with 1 mM IPTG and the 
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culture layer with 2.5 mL of dodecane. The induced culture was then incubated shaking at 
200 rpm at 25°C for over 72 hours.  
 
2.3.3 Protein expression of TEV protease 
One colony from a transformation into BL21-CodonPlus RIPL cells or a glycerol stock was 
used to inoculate 50 mL of LB media which is incubated overnight shaking at 200rpm at 
37°C. 10 mL of overnight culture was used to inoculate 1L of LB media which was then 
incubated shaking at 200rpm at 37°C. When OD600nm reached 0.6 when the cultures were 
induced with 1 mM IPTG. Expression was allowed for 4 hours at 30°C before cells were 
pelleted at 8,000 x g for 20 minutes and the pellet was stored at -80°C. 
 
2.3.4 Purification of selina-4(15),7(11)-diene synthase 
The cell pellet was thawed and resuspended in lysis buffer (20 mM Tris-HCl pH 8.0, 500 mM 
NaCl, 10 mM MgCl2, 25 mM imidazole, 10% glycerol, 0.1 mg/ml lysozyme, 0.05 mg/ml 
DNase, EDTA-free protease inhibitors). The pellet was homogenised using the homogeniser 
before disrupting the cells using the cell disruptor at 30 kpsi. After cell disruption cell lystate 
centrifuged at 50,000 g for 30 minutes at 10°C. Supernatant was applied to HisTrap FF 
crude (GE Healthcare, USA) that was pre-equilibrated with wash buffer (20 mM Tris-HCl pH 
8.0, 500 mM NaCl, 10 mM MgCl2, 25 mM imidazole, 10% glycerol). After the supernatant 
was applied the column was washed with 10 column volumes of wash buffer before elution 
of selina-4(15),7(11)-diene synthase with 2 volumes of elution buffer (20 mM Tris-HCl pH 
8.0, 500 mM NaCl, 10 mM MgCl2, 400 mM imidazole, 10% glycerol). Samples of each stage 
were taken for analysis on sodium-dodecayl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE gel). This His column elution was pooled and cleaved by 0.1 mg/ml TEV 
protease in 5L dialysis of TEV cleveage buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl, 10 
mM MgCl2, 10% glycerol, 14mM β-mercaptoethanol) overnight at 4°C. Following TEV 
Cleavage overnight sample concentrated for application onto size exclusion column. Hiload 
16/600 Superdex 75pg (GE Healthcare, USA) was equilibrated with size exclusion (20 mM 
Tris-HCl pH 7.5, 100 mM NaCl, 10 mM MgCl2, 10% glycerol, 5mM DTT) before the sample 
is applied. After a void volume of 40 mls, fraction collecting began collecting 1.8 ml fractions. 
Fractions were analysed on an SDS-PAGE. The fractions containing SEDS were pooled and 
dialysed three times into 5L of SEDS storage buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 
10 mM MgCl2, 10% glycerol) before snap freezing in liquid nitrogen to be stored at -80°C.  
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2.3.5 Protein purification of selina-4(15),7(11)-diene synthase mutants for activity 
screening 
The cell pellet was thawed and resuspended in lysis buffer (20 mM Tris-HCl pH 8.0, 500 mM 
NaCl, 10 mM MgCl2, 25 mM imidazole, 10% glycerol, 0.1 mg/ml lysozyme, 0.05 mg/ml 
DNase, EDTA-free protease inhibitors). The pellet was homogenised using the homogeniser 
before disrupting the cells using the cell disruptor at 30 kpsi. After cell disruption cell lystate 
centrifuged at 50,000 g for 30 minutes at 10°C. Supernatant was applied to nickel resin that 
was pre-equilibrated with wash buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 10 mM MgCl2, 
25 mM imidazole, 10% glycerol). After the supernatant was applied the resin was washed 
with 50 ml of wash buffer. The SEDS mutants were eluted with 5 ml of elution buffer (20 mM 
Tris-HCl pH 8.0, 500 mM NaCl, 10 mM MgCl2, 400 mM imidazole, 10% glycerol). Before 
testing the elution was cleaved with 0.1 mg/ml TEV protease in 5L dialysis of TEV cleveage 
buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl, 10 mM MgCl2, 10% glycerol, 14mM β-
mercaptoethanol) overnight at 4°C. 
 
2.3.6 Protein purification of TEV protease 
Cell pellet thawed and resuspeneded in TEV lysis buffer (25 mM sodium phosphate pH 8.0, 
200 mM NaCl, 10% glycerol, 25 mM imidazole, PMSF). Pellet was homogenised using the 
homogeniser before cell disrupting at 30 kpsi. After cell disruption cell lystate centrifuged at 
20,000 g for 30 minutes at 10°C. Supernatant was filtered with 22 µM filter before application 
to HisTrap FF crude (GE Healthcare, USA) that was pre-equilibrated with TEV wash buffer 
(20 mM sodium phosphate pH 8.0, 200 mM NaCl, 25 mM imidazole, 10% glycerol). After the 
supernatant was applied the column was washed with 10 column volumes of wash buffer 
before elution with 2 column volumes of TEV elution buffer (20 mM sodium phosphate pH 
8.0, 200 mM NaCl, 500 mM imidazole, 10% glycerol). The elution sample was concentrated 
before application on to a pre-equlibrated SEC column with TEV SEC buffer (25 mM sodium 
phosphate pH 8.0, 200 mM NaCl, 13 mM β-mercaptoethanol, 10% glycerol). The SEC 
column used is a Hiload Superdex 75pg 26/60. Column ran at 1 ml/min and 1.8ml fraction 
began collecting after the column void volume. Samples were collected at all stages of the 
purification for analysis by SDS-PAGE.  Fractions containing TEV protease were pooled 
before snap freezing in liquid nitrogen to be stored at -80°C.  
 
2.3.7 SDS-PAGE 
All samples are diluted appropriately with cell culture samples diluted using their OD600nm 
values for dilution factors. The insoluble fraction resuspended in 500 µL using the sonicator 
and was diluted by a factor of 10 along with the soluble fraction. The cell lysate is diluted by 
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a factor of 20. All diluted samples were diluted with 1x PBS (137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4 and KH2PO4). All wash and elution samples were not diluted. 10 µL of each 
sample is mixed with 10 µL of 2x sample loading buffer (200 mM Tris-HCl, pH 6.8, 20% (v/v) 
glycerol, 8% (w/v) SDS, 0.4% (w/v) bromophenol blue and 20% (v/v) β-mercaptoethanol). 
The sample were incubated at 95°C for 10 minutes and then spun down 13,000 x g for 3 
minutes. SDS PAGE gels were produced as described in Table 2-6. Samples alongside a 
molecular weight ladder were run on gel in SDS-PAGE running buffer (25 mM Tris, 250 mM 
glycine, 0.1% (w/v) SDS, pH 8.3). Gels were run at 100 volts for 15 minutes until a clear line 
of dye is seen across the gel and then the voltage was increase to 200 volts and run for 45-
90 minutes. Gels were stained for 15 minutes using InstantBlue (Expedeon) rocking before 
being de-stained with deionised water. The gel was imaged and after could be sent for mass 
spectrometry.  
 
Table 2-6 SDS-PAGE gel components           
Component 12% Separation Gel 4% Stacking Gel 
Deionised Water 3.2 mL 3.6 mL 
1.5 M Tris-HCl pH 8.8 2.6 mL - 
1 M Tris-HCl pH 6.8 - 625 µL 
10% SDS 100 µL 50 µL 
Acrylamide Bisphosphate 
30% 
4 mL 650 µL 
10% (w/v) Ammonium 
persulfate* 
100 µL 50 µL 
TEMED* 12.5 µL 12.5 µL 
 
2.3.8 Protein concentration determination 
Protein concentration was determined using a Nanodrop spectrophotometer (Thermo-
Scientific. 2 µL of protein was used after cleaning with deionised water and blanking the 
spectrophotometer. The concentration was calculated using the other protein setting with the 
molar extinction coefficient and protein molecular weight.      
 
2.3.9 Mass spectrometry  
All mass spectrometry (MS) analysis was performed by Dr James Ault and Rachel George at 
the Astbury Centre for Structural and Molecular Biology, University of Leeds, UK.  
Accurate molecular mass was determined by LC/MS. A 70 µl sample of greater than 20 µM 
was submitted for analysis. For protein identification through peptide fingerprinting a protein 
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sample was ran on a 12% SDS-PAGE gel and stained for 15 minutes with InstantBlue 
(Expendeon). The protein band was excised and digested with trypsin for 18 hours. LC-
MS/MS was used to identify the peptides that were then screened against the 
UniProtKB/SwissProt databases and sequences of codon SeDS provided to the MS 
department.   
2.4 Malachite green assay  
 
2.4.1 Initial activity testing 
The initial activity assays were completed with purified protein as described in 2.3.4. The 
components of the reaction are described in Table 2-7 and were all prepared before the 
assay. The malachite green components, highlighted in green in Table 2-7, were combined 
to from the malachite green colour reagent before initiating the assay. The farnesyl 
pyrophosphate and the assay buffer were added to a 96 well plate on ice in a determined 
order. The plate was incubated at 30 °C for up to 20 minutes with each time point initiated by 
the addition of the specific enzyme concentration. For each enzyme concentration the assay 
was completed in triplicate with a negative control without enzyme. Following the 20-minute 
incubation the plate was developed with the addition of 12 µL malachite green colour 
reagent. Before the absorption was measured at 620 nm the plate was incubated for 15 





Table 2-7 Components of initial activity malachite green assays 
 
2.4.2 Kinetic characterization   
Kinetic characterisation of SeDS enzymes was completed with at set concentration of 
enzyme and farnesyl pyrophosphate concentrations ranging from 5 µM and 160 µM. Each 
kinetic assay was performed alongside a standard curve of sodium pyrophosphate 
concentrations to convert absorbance to pyrophosphate concentration. Reaction 
components are described in Table 2-8 and were set up on ice. The malachite green colour 
reagent was produced by mixing the appropriate amount of the malachite green and 
ammonium molybdate. For calibration curve reactions sodium pyrophosphate was aliquoted 
into a 96 well plate on ice and reactions were initiated at set time points by the addition of 
assay buffer. For assay reactions farnesyl pyrophosphate concentrations and assay buffer 
were aliquoted and the reactions were initiated with the addition of the SeDS enzyme and 
incubated at 30 °C. The reactions were initiated at the set points and incubated for the 
stated amount of time. Following the incubation, the reaction was quenched by the addition 
of 100 µL of the malachite green colour reagent. The plate was then incubated at room 












10 mM 100 µM and 200 
µM 
5 (of dilution) 
Enzyme 2.5 µM 
Concentrations 
ranged between 
25 and 10000 nM 
20 
Assay Buffer 
50 mM MES, 50 mM CAPS, 
100 mM Tris, 10 mM MgCl2, 
60 mU Inorganic 
Pyrophosphatase 
25 mM MES, 25 
mM CAPS, 50 
mM Tris, 5 mM 
MgCl2 




1.83 mM (in 3M sulphuric 
acid) 1.44 mM - 
Ammonium 
Molybdate 
60.87 mM 11.98 mM - 
Tween 20 11% 0.17% - 
Malachite Green 
Colour Reagent 
1.44 mM Malachite green, 11.98 mM Ammonium 




Table 2-8 Components of kinetic assay reactions 
  
2.5 Product Analysis  
2.5.1 GC/MS 
GC/MS samples are diluted in ethyl acetate spiked with 15 µg/ml trans-carophyllene. 250 ml 
of this diluted sample is added to a glass vial for analysis.  
The dodecane layer (2.5.2) was sampled after 72 hours using a glass syringe. This sample 
was centrifuged at 13,000 x g for 1 minutes. 100 µL of the dodecane layer was added to 100 












10mM 5µM and 160µM 5 
Added to plate 
before assay 
initiated 
SeDS 20µM 500nM 20 
Added to each 
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green (in 1M HCl), 










A 10 mg/mL stock solution of bisabolene was produced using 10 µL of bisabolene (density 
0.89 g/mL) with 899 µL of ethyl acetate. The stock was diluted by a factor of 100 with ethyl 
acetate making the first concentration 100 µg/mL. This solution was used to create 
successive dilutions by a factor of 2. Samples were analysed using the program EMI. 
GC/MS was carried using a HP-5MS column (30 m length x 0.32 mm diameter x 0.25 !m 
film thickness) (ThermoTrace Ultra).	Parameters were inlet pressure, 77.1 kPa, He 23.3 
mL/min, injection volume, 2 µL, transfer line, 300 °C, and electron energy 70 eV. The GC 
was programmed as follows: 5 min at 50 °C increasing at 10 °C/min to 320 °C and operated 
in splitless mode. The carrier gas was He at 1 mL/min and a HP-5MS column fused silica 
capillary column was used. Instrumental parameters were (1) inlet pressure, 77.1 kPa, He 
23.3 mL/min, (2) injection volume, 2 µL, (3) transfer line, 300 °C, and (4) electron energy 70 
eV. The GC was programmed as follows: 5 min at 50 °C increasing at 10 °C/min to 250 °C 









Chapter 3 – Selection, Expression and Characterisation of 
a Sesquiterpene Synthase  
 
The aim of this work was to select a sesquiterpene synthase for expression and 
characterisation. The sesquiterpene synthase will then be used in engineering or 
mutagenesis experiments with the aim of producing a novel, previously uncharacterised 
terpene (See section 4.1). In order to determine whether our engineering attempts have 
been successful, kinetic characterisation of the wild-type and variant enzymes will be carried 
out, but this will require sufficient quantities of purified enzyme to be generated and so, the 
chosen sesquiterpene synthase must be able to be expressed recombinantly in E. coli and 
be purified using affinity chromatography to produce enough enzyme for kinetic studies. We 
will also need to quickly screen for active variants, and particularly those with altered product 
profiles. Since it is possible to quickly extract the terpene products from bacterial cultures by 
growing samples overlaid with organic solvents, it should be possible to us GC/MS of the 
solvent extract to quickly and easily assess the level and identity of the enzyme products. 
This chapter will describe the choice of system and the initial expression and 
characterisation.  
 
3.1 Terpene synthase selection  
Terpenes consist of a broad range of compounds composed of C5 units (Gao, Honzatko and 
Peters, 2012). For this work, sesquiterpenes, also known as C15 terpenes, were selected as 
the target length terpene for engineering. Sesquiterpenes are produced from farnesyl 
pyrophosphate with over 400 characterised sesquiterpene products (Yamada et al., 2015). 
Monoterpenes were not selected due to their small size, limiting the potential chemistry 
available and the number of scaffolds available. Larger lengths were not selected because 
there would be a large potential chemistry available which could be overwhelming when 
using targeted mutagenesis (Figure 1-2).  
 
Criteria for selecting the synthase to engineer included ability to express heterologously in E. 
coli, availability of a crystal structure to aid with targeted engineering and an enzyme that 
has not been extensively engineered previously. Using an enzyme that has not previously 
been extensively engineered will expand the field of terpene synthase engineering and 
produce novel insights. Four sesquiterpene synthases were shortlisted; α-bisabolene 
synthase, hedycaryol synthase, germacradienol synthase and selina-4(15),7(11)-diene 
synthase (McAndrew et al., 2011) (Baer, Rabe, Citron, et al., 2014) (Jiang, He and Cane, 
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2006) (Baer et al., 2014) (Figure 3-1). This list was further shortened by comparing the 




Figure 3-1 Structures of the major products of the four shortlisted sesquiterpene 
synthases. (a) Bisabolene produced by α-bisabolene synthase. (b) Hedycaryol produced by 
hedycaryol synthase. (c) Germacradienol produced by germacradienol synthase. (d) Selina-
4(15),7(11)-diene produced by selinadiene synthase  
 
Both hedycaryol and germacradienol (Figure 3-1 B and C) have one medium-sized ring 
structure compared to bisabolene and selina-4(15),7(11)-diene which both have two distinct 
component scaffolds either two rings or linear chains. Due to the extended chemistry 
potential with a double ring structure, α-bisabolene synthase and selina-4(15),7(11)-diene 
synthase were both considered further. Both these products lack oxygen and as part of our 
engineering we considered whether introduction of more space in the active site might allow 
quenching of intermediate biosynthetic carbocation by water. This could lead to substituted 
products that might be easier to detect if the natural product was non-hydroxylated and 
produced by elimination to an alkene. This potential has been shown with δ-cadiene 
synthase where a L405S variant produces germacrene D-4-ol. The L405S mutant targeted 














3.1.1 Selina-4(15),7(11)-diene synthase 
Selina-4(15),7(11)-diene synthase (SeDS) from Streptomyces pristinaespiralis ATCC 25486 
is a tetrameric enzyme with each monomer consisting of one class I active site (Figure 3-2 to 
3-4) (see section 1.4.1). SeDS produces selina-4(15),7(11)-diene as over 90% of its product 
profile (major product) and a germacrene B as a minor product (Figure 3-5) (Baer et al., 
2014).  Selina-4(15),7(11)-diene synthase has been crystalized in the apo form with (Mg2+)3 
and diphosphate or with 2,3-dihydrofarnesyl pyrophosphate and (Mg2+)3 (Figure 3-2) (Baer et 
al., 2014).  Each monomer is an α domain with 11 anti-parallel α-helices connected by short 
linker sequences. The active site consists of helices B, C, H and K with linker helix G. The 
DDXXD motif is on helix C with the NSE triad on helix H (see section 1.4.1). The NSE triad 
coordinates the magnesium ion at the top of the active site and hydrophobic residues 
structure the active site cleft (Figure 3-3). Helices C and K are the helices rearranged on 
substrate binding in an induced fit reaction mechanism (Baer et al., 2014).  The G linker helix 
has two distinct states shown in the crystal structure between the apo and bound 
conformations and closes into the active site when substrate is bound (Figure 3-4) (Baer et 
al., 2014). Other selinadiene synthases have been identified across many species producing 
variations in the arrangement of the two double bonds on the key selinane scaffold including, 
selina-4(14),7(11)-diene synthase from Humulus lupulus (Hartley and Fawcett, 1969). Both 
selina-4(14),7(11)-diene and selina-3,7(11)-diene were isolated from hop varieties in micro-
quantities. From these extractions the compounds structures were resolved using gas-liquid 






Figure 3-2 Structure of tetrameric selina-4(15),7(11)-diene synthase from 
Streptomyces pristinaespiralis ATCC 25486 (PDB 4OKZ). (a) Selina-4(15),7(11)-diene 
synthase is naturally tetrameric (chain A shown in cyan, chain B shown in orange, chain C 
shown in magenta and chain D in green). In the crystal structure, each monomer has an 
enclosed active site containing three magnesium ions, depicted as red spheres, and a non-
hydrolysable farnesyl pyrophosphate mimic, dihydrofarnesyl pyrophosphate (yellow). It is 
postulated that all four active sites are catalytically competent. (b) Active site on chain A of 
figure A with the key residues coordinating the magnesium ions and the cations produced, 
depicted as sticks coloured by elements as identified by Ligplot (Wallace, Laskowski and 




Figure 3-3 Schematic of the active site of selina-4(15),7(11)-diene with farnesyl 
pyrophosphate. 2D schematic of the active site of SeDS highlighting the residues that 
interact with the substrate. Residues labelled in blue interact with the pyrophosphate and 
magnesium ions with the predicted hydrogen bonds depicted a cyan lines. The residues 
labelled with purple form the hydrophobic cleft that shapes the cation formed by the removal 







Figure 3-4 Structural comparison of the apo and bound conformations of selina-
4(15),7(11)-diene synthase from Streptomyces pristinaespiralis ATCC 25486 (PDB 
4OKM and 4OKZ). Both figures show an active site view of chain A with the key active site 
helices coloured. Helix B is coloured cyan. Helix C is violet, helix G1 is purple, the G helix 
break is blue, helix G2 is teal, helix H is pink and helix K is orange. Magnesium ions are 
coloured in red. (A) Structure of the bound conformation (PDB 4OKZ) has a non-
hydrolysable farnesyl pyrophosphate mimic, dihydrofarnesyl pyrophosphate in yellow. (B) 
Structure of the apo conformation (PDB 4OKM) has diphosphate bound in yellow. The G1 
helix depicted in purple has the most significant change between the two structures.   
 
A catalytic mechanism has been proposed for SeDS in light of the reported crystal 
structures, computer modelling and mutagenesis studies (Figure 3-5) (Baer et al., 2014) 
(Das, Dixit and Major, 2016). It is not known which residues involved in the specific 
restructuring of the farnesyl cation. Baer and co-workers designed SeDS mutants based on 
three groups of catalytic residues mutating a total of 8 positions, producing 28-point mutants 
in a bid to gain further mechanistic insight into the enzyme’s action. The three groups were 
formed from; hydrophobic residues that line the active site, residues that coordinate the 
catalytic magnesium ions, and residues involved in induced fit changes that occurred upon 
substrate binding. Mutations in the first group of hydrophobic residues resulted mainly in 
changes to the distribution of the major and minor products but some variants also showed 
alternative product profiles producing linear products including; (E)-β-farnesene and (2Z,6E)-	
⍺-farnesene (Baer et al., 2014). Mutations to the magnesium ion coordination residues and 
induced fit residues, however, showed reduced activity with some induced fit residue 
mutants being completely inactive including: D82N, D82E, E159Q E159D. (Baer et al., 
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2014). Consequently this proved the induced fit mechanism showing that the coordination of 
magnesium ions alone is not sufficient to initiate the reaction (Baer et al., 2014). In summary, 
the hydrophobic residues contouring the active site are the residues that determine the 
product profile and mutations in the region can lead to alternative products. So far, 
engineering has only led to linear products with no novel terpenes, however further residues 
are available for targeting, making SeDS a good target for further engineering.  	
 
Figure 3-5 Reaction schematic of selina-4(15),7(11)-diene synthase from Streptomyces 
pristinaespiralis. The reaction is initiated with the removal of the pyrophosphate moiety 
coordinated by the magnesium ions producing an allyl carbocation. The allyl carbocation is 
cyclised to create a double ring moiety before deprotonation and re-protonation of the ring. 





3.2.2 α-Bisabolene synthase 
α-Bisabolene synthase (⍺BS) produces bisabolene for 90% of its product profile with its 
postulated mechanism shown below (Figure 3-6) (Christopher L Steele et al., 1998). 
Bisabolene is produced by a variety of species with a variety of species-specific roles. Abies 
grandis ⍺ bisabolene synthase (Ag⍺BS) is the most studied bisabolene synthase to date and 
is induced as a stress response to wounds in plants (Christopher L Steele et al., 1998). 
Other uses include as a food additive and as a precursor to hernandulcin, a natural 
sweetener from plant Phyla dulcis (PubChem, 2019). In biotechnology, hydrogenated 
bisabolene (bisabolane) has desirable properties similar to D2 diesel fuel and so thanks to 
its potential as a biofuel, bisabolene biosynthetic engineering for increased production has 
been investigated in Streptomyces venezuelae (Phelan et al., 2015). Protein engineering 
work included; optimising the gene for expression, removing the genes that compete for 
intracellular resources (including acetyl-coA, pyruvate and glyceraldehyde-3-phosphate) and 
optimisation of native isoprenoid producing pathway (Phelan et al., 2015). Bisabolene 
synthase has been mined and characterised from variety of species but only Ag⍺BS has 
been expressed in E. coli (Fujisawa et al., 2010) (Bohlmann et al., 1998).  
 
Figure 3-6 Schematic of the postulated reaction mechanism for bisabolene synthase. 
The pyrophosphate undergoes metal dependent ionisation and is removed away from the 
farnesyl carbocation which is delocalized over C1, 2, and 3. The pyrophosphate anion 
electrophilically attacks at position C3 to assist  the cyclisation (McAndrew et al., 2011). The 
bisabolene synthase active site rearranges the cation so C1 is positioned near the C7-C8 
double bond for the nucleophilic attack leaving C8 a cation.  This C8 cation leads to acidic 
hydrogens surrounding this leading to deprotonation at position C10. An alternative 
mechanism has been suggested where the pyrophosphate anion does not electrophilically 
attack, but the enzyme can rearrange the cation for cyclization. 
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α-Bisabolene synthase from Abies grandis is a monomeric enzyme with a unique structure 
which can be divided into three α-helical domains; α, β and γ (Figure 3-7). The α domain 
contains the class I active site with the key catalytic motifs including the DDXXD motif 
(McAndrew et al., 2011). At the β and γ domain interface, is a non-functional class II active 
site lacking the key conserved catalytic DXDD motif (McAndrew et al., 2011). This shows 
close phylogenetic relationship to a bi-functional diterpene synthase; for example Abies 
grandis abietadiene synthase compared to monofunctional terpene synthase (McAndrew et 
al., 2011) (see section 1.5.4). Ag⍺BS has been crystalized in the apo form and in complex 
with magnesium ions and a range of compounds including, geranlyl thiopyrophosphate and 
farnesyl thiopyrophosphate (McAndrew et al., 2011). The farnesyl carbocation was directed 
into the hydrophobic cleft. Hydrophobic residues may direct C1 to the π orbital of the C7-C8 
double bond to undergo nucleophilic attack producing the C1-C7 bond. This produces a 
bisabolyl cation with cationic C8 leading to more acidic C7, C9 and C10 which can 
subsequently lead to the loss of a hydrogen at position C10 (McAndrew et al., 2011).  
 
 
Figure 3-7 Structure of bisabolene synthase from Abies grandis (PDB 3SAE). The α 
domain is coloured magenta with the class I active site highlighted with the three magnesium 
ions displayed as green spheres and the farnesyl pyrophosphate mimic, farnesyl 
thiopyrophosphate in blue. The β domain is coloured cyan and the γ domain is coloured 
orange with the inactive class II active site in the interface between the domains.  
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3.2 Construction of selina-4(15),7(11)-diene synthase plasmid expression 
vector 
Here, in preliminary work, both Ag⍺BS and SeDS genes were codon-optimised, using the 
Genscript codon optimisation programme, for expression in E. coli and made synthetically 
based on previous work. This construct was taken forward for expression testing (McAndrew 
et al., 2011) (Baer et al., 2014). Following expression trials of both constructs, selina-
4(15),7(11)-diene synthase was identified as the best candidate with a good level of soluble 
expression as described in previous work (Baer et al., 2014). Whereas the expression of 
bisabolene synthase was problematic as despite using a codon optimised sequencing and 
optimising expression, 90% of expressed protein still remained in the insoluble fraction 
(Figure 3-8). This would hinder the throughput of screening options since larger expression 
cultures would be needed and/or expression levels might be too low to detect products in 
culture media (section 4.2.5).  
 
Figure 3-8 SDS PAGE expression gel of Abies grandis bisabolene synthase. Expression 
test of Abies grandsis bisabolene synthase in 50 ml culture, in BL21 DE3 cells, induced with 
1 mM IPTG and expressed at 20 ºC. A pre induction and post induction sample were taken 
along with samples of the cell lysate produced after cell disruption. Following cell disruption, 
the cell lysate was separated using centrifugation creating a soluble and insoluble fraction. 
The large band in insoluble fraction correspond to the expected band of Abies grandis 




As previously discussed, the SeDS gene from Streptomyces pristinaespiralis ATCC 25486 
(WP 005317515) was optimised for expression in E. coli using the Genscript programme, 
synthetically made (Genscript) and cloned into a pET 28a vector digested with the restriction 
enzymes BamHI and Hind III (Baer et al., 2014). The synthetic gene was sequenced before 
further work was carried out .The previous E. coli expression work was used as a basis for 
the expression plasmid design (Rabe, Citron and Dickschat, 2013). This used a His6-SUMO-
Ser-Gly tag to purify the protein and a protocol that includes a tag cleavage step (Baer et al., 
2014). As a result the expression vector pET His6 SUMO TEV (Addgene) was selected as 
the suitable expression vector with the added benefit of a TEV cleavage site to remove the 
purification tag (Baer et al., 2014). The vector includes the option of both an N- and C-
terminal His6 tag. The N-terminal His6 tag is followed by a SUMO tag and a TEV protease 
site with a small serine glycine loop for effective cleavage. Primers were designed to add a 
double stop codon to stop the expression of the C-terminal His6 tag (Figure 3-9a) (Table 2-
5). Mutagenesis was confirmed through sequencing before cloning with synthetic SeDS 
gene (Figure 3-9a). Cloning of the expression vector and gene was completed using ligation 
dependent cloning, with the specific restriction sites added to the synthetic gene based on 
the expression vector; BamHI and HindIII corresponding to the selected expression vector. 
Cloning was successfully confirmed by sequencing. This produced the SeDS expression 




Figure 3-9 Sequencing results for cloning of selina-4(15),7(11)-diene synthase and its 
cloning vector. (A) Sequencing results of the double stop codon (highlighted in the box) in 
expression vector pET His6 SUMO TEV to prevent the expression of the C-terminal His tag 
before cloning in SeDS. (B) Sequencing results of SeDS gene in expression vector pET His6 




Figure 3-10 Schematic of the selina-4(15),7(11)-diene synthase expression vector 
(pET_SeDS_exp). The SeDS expression vector uses the lac operon to provide a promoter 
for the expression and has a kanamycin resistance gene for selective expression. The 
SUMO tag can help solubilise SeDS while the His6 will be used as an affinity purification tag.  
 
3.3 Recombinant selina-4(15),7(11)-diene synthase expression and 
purification  
The pET_SeDS_exp vector was transformed into E. coli BL21 (DE3) competent cells for 
overexpression. Expression was conducted as described in 2.3.1 based on previous E. coli 
expression (Baer et al., 2014). 2xTY media was inoculated with a starter culture and 
incubated at 37°C, shaking at 200rpm until it reached an OD600nm of 0.4. At this OD600nm the 
temperature of the incubator was lowered to 18°C. Following further incubation of 
approximately 1 hour, when the OD600nm reached 0.6, cultures were induced with 1mM IPTG 
and incubated further overnight. Cells were pelleted at 9,000 g for 20 minutes before being 
stored at -80°C. Cells are thawed with lysis buffer containing lysozyme, DNase and protease 
inhibitor tablets. Cells were homogenised before being disrupted at 30 kpi in the cell 
disruptor (Constant systems).  Following cell lysis and pelleting of the cell debris, the His6 
tag in the expression vector was utilised in affinity chromatography purification (Figure 3-11). 
Following affinity chromatography, the His6 and SUMO tag were removed by cleavage with 
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TEV protease (produced in-house) to prevent the tag affecting the folding and organisation 
of the tetrameric structure.  
 
Figure 3-11 Purification of selina-4(15),7(11)-diene synthase. Purification of SeDS using 
nickel affinity chromatography. SeDS was eluted in four 2.5ml fractions using 400mM 
imidazole. Band confirmed with protein identification mass spectrometry using a tryptic 
digest of the band. All elution fractions were pooled for tag cleavage with TEV protease. 
Other bands seen in elution fractions are E. coli contaminant proteins with the largest band 
at approximately 20 kDa predicted to be the E. coli contaminant protein SlyD (Robichon et 
al., 2011).  
 
Following tag cleavage, size exclusion chromatography was performed to improve the purity 
of SeDS and remove the TEV protease (as TEV protease also contains a His tag). 
According to the calibration curve of the HiLoad 26/600 Superdex S75 an SeDS monomer 
would elute at approximately 50 ml, so size exclusion chromatography was performed in 
reduced conditions to keep the samples oligomeric state consistent (Figure 3-12). Following 
size-exclusion chromatography, fractions containing SeDS were pooled and dialysed to 
remove DTT. Purity of approximately 75% was achieved which is suitable for kinetic studies 
but not for structural studies.  Positive ESI mass spectrometry was used to confirm the size 




Figure 3-12 Size-exclusion chromatography of selina-4(15),7(11)-diene synthase. (a) 
Elution profile of chromatography performed with HiLoad 26/600 Superdex 75 column with a 
flow rate of 1 ml/min in 20 mM Tris-HCL pH 7.5, 100 mM NaCl, 10 mM MgCl2 and 10 mM 
DTT. One large peak was observed (SeDS) with two smaller connected peaks (TEV and 
other E. coli contaminant proteins). (b) SDS PAGE gel analysis of size exclusion 
chromatography fractions showing SeDS was purified to over 75% purity which is suitable 




Figure 3-13 Positive ESI mass spectrometry of selina-4(15),7(11)-diene synthase. The largest peak at 42604 Da corresponds to wild type 
SeDS with additional contaminant or adducts seen at a significantly lower abundance.  
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3.4 Development of an assay for kinetic characterisation  
To further confirm that SeDS was successfully expressed and to kinetically characterise the 
enzyme, the malachite green assay was selected to quantify the enzymes activity (Scott et 
al., 2010). The malachite green assay is used to detect phosphate production and has been 
used to measure the activity for a wide range of enzymes including; ATPases, GTPases, 
terpene synthases and other phosphatases (Scott et al., 2010) (Shatton et al., 1983). In this 
assay, phosphate is detected as it forms a complex with malachite green and molybdate 
forming the malachite phosphomolybdate complex (Baginski, Epstein and Zak, 1975). The 
colorimetric response can be quantified as the concentration of phosphate is in a linear 
relationship with the absorbance between 600-650 nm (Scott et al., 2010).  The reaction is 
an end point assay as both malachite green and ammonium molybdate are stored in acidic 
conditions and inactivate the enzyme on addition. The inactivation of the enzyme limits the 
use of the assay and increase the risk of error. The malachite green assay has been 
extensively used in activity studies of ATPases or GTPases (Niwa et al., 2012). For terpene 
synthase activity the enzyme is coupled to an inorganic pyrophosphatase to break down the 
pyrophosphate released in all terpene synthase mechanisms, to two phosphate ions (Figure 
3-14) (Vardakou et al., 2014).   
 
Figure 3-14 Schematic of malachite green with selina-4(15),7(11)-diene synthase. 
Selina-4(15),7(11)-diene synthase converts farnesyl pyrophosphate to selina-4(15),7(11)-
diene and pyrophosphate. Consequently, the pyrophosphate is broken down into component 
phosphate ions. These phosphate ions react with molybdate and malachite green to form 
the malachite green phosphate complex. This green complex can be detected by measuring 
the absorbance with a filter between 600-650 nm.  
 
3.4.1 Initial selina-4(15),7(11)-diene synthase activity test 
Initial activity tests were performed before final optimisation of the assay to confirm 
purification of SeDS. Assay conditions and specifically the malachite colour dye solution 
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have been adapted from previously described methods (Vardakou et al., 2014). The assay 
was carried out in 25mM MES, 25mM CAPS, 50mM Tris, 5mM MgCl2 pH 7.5 with the 
reaction components in Table 3-1.  
Table 3-1 Table of malachite green assay components used for initial activity tests. 
Components were added and used in three stages (coloured in table) 
 
Each assay component was prepared individually before the assay into 6 different solutions 
highlighted in yellow and green in Table 3-1. The reaction was initiated by combining the 
farnesyl pyrophosphate, with the assay buffer before the addition of SeDS and incubation of 
these components for a total of 20 minutes at 30°C. The malachite green components 
(highlighted in green) were combined to create the malachite green colour reagent. After the 
20-minute incubation the plate was moved to room temperature for the addition of 12 µl 
malachite green colour reagent. Subsequently the reactions were incubated for 15 minutes 
before the absorption was measured at 620 nm. Each SeDS concentration assay was 
completed in triplicate with a negative control of farnesyl pyrophosphate in the absence of 
SeDS. All reactions were performed in clear round bottom, 96 well plates.  
The reaction results showed that with an increase in SeDS concentration the absorbance at 
620 nm increases (Figure 3-15). This proved that the SeDS was active but further 
optimisation of the malachite green assay and the kinetic conditions was completed before 
calculation of kinetic parameters.  




Pyrophosphate 10 mM 
100 µM and 200 
µM 5 (of dilution) 
SeDS 2.5 µM 
Concentrations 
ranged between 
25 and 10000 nM 
20 
Assay Buffer 
50 mM MES, 50 mM CAPS, 
100 mM Tris, 10 mM MgCl2, 
60 mU Inorganic 
Pyrophosphatase 
25 mM MES, 25 
mM CAPS, 50 
mM Tris, 5 mM 
MgCl2 
30 mU Inorganic 
Pyrophosphatase 
25 
Malachite Green 1.83 mM (in 3M sulphuric acid) 1.44 mM - 
Ammonium 
Molybdate 60.87 mM 11.98 mM - 
Tween 20 11% 0.17% - 
Malachite Green 
Colour Reagent 
1.44 mM Malachite green, 11.98 mM Ammonium 





Figure 3-15 Initial activity test of selina-4(15),7(11)-diene synthase. The concentration of 
SeDS was plotted against the baselined absorbance of each reaction after 20 minutes.  
Each SeDS concentration was baselined against the control with no farnesyl pyrophosphate. 
As the concentration of SeDS increases the absorbance at 620 nm increases with the 
absorbance until the absorbance plateaus after 500 nM SeDS for both farnesyl 
pyrophosphate concentrations.  
 
Figure 3-15 shows that at higher SeDS concentrations the absorbance plateaus showing the 
maximum rate has been achieved. To achieve conditions for kinetic characterisation either 
the incubation length needs to be shortened for the initial rate of reaction due to the plateau 
or that the concentration of farnesyl pyrophosphate is too high for these reaction conditions. 
For the assay to detect sufficient pyrophosphate release the enzyme concentration should 
be 250 nM or above. This concentration produces a sufficient absorbance to be above the 
level of error and variation below 0.1 absorbance units, while still being within the linear 
range of activity at 200 µM farnesyl pyrophosphate.   
  
3.4.2 Optimisation of malachite green assay  
The malachite green assay was developed from previously described methods using 
terpene synthases (Vardakou et al., 2014). Initial optimisation of the malachite green assay 
used a thermostable pyrophosphatase with an optimal temperature of 75°C due to the 
availability of the enzyme. Both sodium pyrophosphate and sodium phosphate dilutions were 
used as positive controls and tests to optimise the assay conditions before using terpene 
synthase. The parameter to optimise was the concentration of the thermostable 
pyrophosphatase to ensure the reaction hydrolysing pyrophosphate is not the rate limiting 
step. A range of thermostable pyrophosphatase concentrations were tested to find the 
minimum concentration needed (Figure 3-16). The tests were performed in the assay buffer 























sodium phosphate or pyrophosphate (2 x final concentration) (Vardakou et al., 2014). Three 
repeats were conducted for each concentration of sodium pyrophosphate. The reactions 
were set up on ice in a 96 well plate and incubated at 75°C for 20 minutes before the 
addition of the malachite green colour reagent. Following a further 15-minute incubation at 
room temperature the plate was scanned with a 620 nm filter. (Table 3-1).  
 
Figure 3-16 Testing 20 mUml-1to 75 mUml-1thermostable pyrophosphatase.  
Thermostable pyrophosphatase tested with 20 mUml-1to 75 mUml-1with 50 to 0 µM sodium 
pyrophosphate, incubated at 75 °C for 20 minutes. Concentrations of 50 mUml- and above 
produce the same curve giving the optimal concentration as 50 mUml-1. 
 
Figure 3-16 shows that concentrations above 50 mUml-1 would be suitable to make sure the 
hydrolysis of pyrophosphate is not the rate limiting step. To test whether these conditions 
would work in a coupled reaction the thermostable pyrophosphatase was coupled to the 
action of Q5 polymerase. This polymerase releases pyrophosphate as a by-product of the 
reaction, similar to terpene synthase. A 25µl example PCR reaction was set up (10µl Q5 
reaction buffer, 5µl 2mM dNTPs, 2µl 200ng/µl DNA, 0.5µl Q5 polymerase) and incubated 
with 25µl assay buffer (Table 3-1) with 50mU pyrophosphatase. The reaction was incubated 




































Figure 3-17 Polymerase malachite green coupling test. Using a basic PCR reaction (10µl 
Q5 reaction buffer, 5µl 2mM DNTPs, 2µl 200ng/µl DNA, 0.5µl Q5 polymerase) releasing 
pyrophosphate from the nucleotides. This pyrophosphate could be detected by the action of 
the thermostable pyrophosphatase and malachite green reagent. Control reaction is a 
replicate of the pyrophosphatase reaction without a polymerase.  
 
Following a successful coupled reaction with inorganic pyrophosphatase and Q5 
polymerase, initial activity assay testing was completed with both terpene synthases; SeDS 
and Ag⍺BS. However further optimisation was needed before kinetic characterisation 
including; incubation at 30°C for terpene synthase reaction, the volume of malachite dye 
solution and ways to reduced variation seen on results. Throughout this optimisation issues 
arose including; high backgrounds and evaporation of reactions due to the high reaction 
temperature of the thermostable pyrophosphatase and the two incubation steps. Therefore, 
an alternative non-thermostable pyrophosphatase as sourced with an optimum temperature 
equal or similar to SeDS to prevent the two separate incubation steps and the problems this 
causes.  
 
Inorganic pyrophosphatase (yeast) (NEB) has an optimal temperature of 30°C equal to 
SeDS, therefore only one incubation period is needed before the addition of the malachite 
green colour reagent. As with the thermostable pyrophosphatase initial optimisation began 
by developing the previously described method (Vardakou et al., 2014). Initial reaction 
conditions were the same as above except the incubation was at 30°C with a range of 




















Figure 3-18 Inorganic pyrophosphatase concentration test with 20-minute incubation. 
Inorganic pyrophosphatase between 10 mUml-1 and 60 mUml-1 was tested with a range of 
sodium pyrophosphate concentration between 0-50 µM. Data used was collected with 20-
minute incubation at 30 °C.  
 
Optimisation of inorganic pyrophosphatase concentration suggests 60 mUml-1 for 20 minutes 
produces a sodium pyrophosphate standard curve with a linear response showing the 
enzyme is not rate limiting (Figure 3-18). This concentration of inorganic pyrophosphatase 
was then taken forward for further optimisation of this assay to couple with the SeDS 
reaction.   
 
3.4.3 Development of a method for kinetic characterization of selina-4(15),7(11)-diene 
synthase  
Following the initial activity test of SeDS (Section 3.4.1) both farnesyl pyrophosphate and 
SeDS concentrations needed to be optimised to measure the initial rate of reaction to 
consequently calculate kinetic parameters. This concentration of enzyme should be for a 
substrate concentration that covers the range above and below the Km. Following the initial 
activity test (Figure 3-15) further concentrations of both SeDS and farnesyl pyrophosphate 
were tested along with incubation period at 30°C. Optimisation included testing a range of 
SeDS concentrations between 500 nM and 4 µM, a range of farnesyl pyrophosphate 
concentrations between 5 µM and 200 µM. This was alongside varying the reaction 
incubation length between 10 and 60 minutes and taking time points within.  
However, with each optimisation overlapping error bars were seen, suggesting further 
optimisation of the assay method was needed and not the reaction concentrations. From a 
literature search malachite green can form precipitates which could alter absorbance 
readings. The literature suggested two methods to overcome the precipitation issue; filtering 






























the malachite green colour reagent before quenching the reaction and dissolving the 
malachite green in more concentrated, 6 M sulphuric acid (Shatton et al., 1983) (Baykov, 
Evtushenko and Avaeva, 1988). Both methods were tested with a 25 µM sodium 
pyrophosphate standard and 60 mUml-1 inorganic pyrophosphatase. However, neither 
method made any difference to the accuracy of the absorbance values. Therefore, other 
assay components were investigated including pH of the malachite green assay buffer. 
Malachite green is pH sensitive and has previously been used as a pH indicator along with a 
phosphate indicator (The Merck Index Online, 2020). Below pH 2.0 malachite green is 
yellow, between pH 2.0 and 11.5 malachite green is green. Above 11.6 it is a blue green 
before going colourless at pH 14.0. The malachite green for this assay is stored in acid so 
below pH 2.0 and its addition can affect the pH so increasing the buffer capacity, to 500 mM 
Tris, can prevent this pH effect (The Merck Index Online, 2020).   
 
Nonetheless, variability was still seen affecting initial rate calculations thought to be due to 
small bubbles seen in some wells containing SeDS and not in sodium pyrophosphate control 
wells. Therefore, alternative malachite green colour reagent compositions were investigated 
and tested. This could mean different ratio of components, different volumes added to 
quench the reaction and additional stabilising elements. 11 solutions were selected from the 
literature and tested in standard conditions with two sodium pyrophosphate concentrations 
and inorganic pyrophosphatase (Appendix) (Carter and Karl, 1982) (Cogan, Birrell and 
Griffith, 1999) (Feng et al., 2011) (Geladopoulos, Sotiroudis and Evangelopoulos, 1991) 
(Guo et al., 2018) (Hua et al., 2018) (Itaya and Ui, 1966) (Lanzetta et al., 1979) (Maehama 
et al., 2000) (Niwa et al., 2012) (Shatton et al., 1983).   
 
Following this test, a new malachite green colour reagent was taken forward for kinetic 
parameter optimisation. This new reagent has reduced ammonium molybdate and 
hydrochloric acid while increasing the concentration of malachite green and removing the 
detergent, Tween-20 (Table 2-8). The optimisation continued as described above to find the 
optimal conditions to calculate the initial rate of reactions. The Michealis-Menten principles 
suggest the ideal condition for calculating kinetic parameters is to test substrate 
concentrations either side of the Km  (Voet, D., Voet, J.G. & Pratt, 2008). Following further 
optimisation, the final experimental farnesyl pyrophosphate concentration range was 5 µM to 




Figure 3-19 500nM SeDS farnesyl pyrophosphate broad range test. A broad range of 
farnesyl pyrophosphate concentrations between 5 µM and 160 µM. The reactions were 
tested over 10 minutes with 500 mM Tris-HCl (pH 7.5) and new malachite green solution, 
which is a mix 0.12 % malachite green in 1M HCl and 4.2 % ammonium molybdate in 4.5 M 
HCl in the ratio 3:1. Each absorbance was baselined with the average of the corresponding 
FPP Blank. 
 
The results and farnesyl pyrophosphate concentrations tested in Figure 3-18 looked to cover 
a kinetic concentration range and potentially cover a range of concentrations above and 
below the predicted Km so were taken forward for kinetic analysis with Michealis-Menten 
equation (Johnson and Goody, 2011). The predicted Km was calculated using GraphPad 
Michaelis-Menten analysis using the data in Figure 3-19.  
 
3.4.4 Kinetic characterisation of selina-4(15),7(11)-diene synthase 
Subsequently the optimised malachite green assay conditions were used to kinetically 
characterise wild type SeDS. To complete kinetic analysis each of the 6 farnesyl 
pyrophosphate concentrations were tested in triplicate for each time point. Alongside this 
each time point has a negative control of substrate with no enzyme and positive controls of 
sodium pyrophosphate concentrations that make up a standard curve for each assay. The 































Table 3-2 – Components for kinetic characterisation of selina-4(15)-7(11)-diene 
synthase
Both reactions and controls were set up on ice in a 96 well plate before being incubated at 
30°C for up 10 minutes with reactions initiated at each time point. The reactions were 
stopped with 100 µl of the malachite green colour reagent described in Table 3-2 before 
being incubated for an additional 30 minutes at room temperature. The plate was then 
analysed by measuring the absorbance at 620 nm. For accurate kinetic characterisation the 
conditions were repeated three times with three separate substrate and enzyme stocks and 
the kinetic parameters were calculated (Figure 3-20, Table 3-3).   
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Figure 3-20 Kinetic characterisation of selina-4(15),7(11)-diene synthase. (a, c, e) The 
three repeats time vs absorbance at 620nm for 6 farnesyl pyrophosphate concentration 
between 5 µM and 160 µM with 500 nM of SeDS. For each concentration the initial rate of 
reaction was calculated using GraphPad linear regression. (B, D, F) Michaelis-Menten curve 
using the farnesyl pyrophosphate concentration against the initial rate of reaction in 







Table 3-3 Kinetic parameters of wild-type selina-4(15),7(11)-diene synthase 
 Vmax (µMmin-1) Km (µM) kcat (min-1) 
Repeat 1 0.90 ± 0.04 12.07 ± 2.2 1.81 
Repeat 2 0.45 ± 0.01 10.93 ± 1.1 0.99 
Repeat 3 0.62 ± 0.04 14.64 ± 3.5 1.25 
 
Kinetic analysis gives a range of Km between 10 µM and 15 µM and Vmax between 0.4 and 
0.9 µMmin-1 and a kcat between 0.9 and 1.8 min-1 (Table 3-3). The range between the 
different repeats is small and is due to kinetic parameters being estimated from experimental 
data (Vetter, Burcham and Doherty, 2014). The malachite green assay is a discontinuous 
assay which increase the potential error due to the increased number of reactions needed 
for a kinetic test. The kinetic values were calculated using an appropriate standard curve 
taken alongside the kinetic experiments to convert absorbance values to concentration of 
pyrophosphate. GraphPad Michaelis-Menten analysis was used to calculate the kinetic 
parameters.  As a result, kinetic parameters can be compared from different experiments 
removing the potential experimental absorbance shifts, occurring from external conditions. 
Therefore, these reaction conditions and kinetic parameters were taken forward and used to 
compare the effect of engineering efforts.  
 
3.5 GC/MS characterisation of product profile 
Terpenes are volatile compounds that can be analysed using gas chromatography mass 
spectrometry in organic solvent layers. This method has been used throughout previous 
work with terpene synthase product profile analysis. No standard of selina-4(15),7(11)-diene 
or germacrene B was available (Figure 3-5). Therefore, a standard of bisabolene from 
bisabolene synthase and α-humulene was used to test GC/MS methods and methods of 
extraction (Figure 3-21 and Figure 3-22). The final GC/MS method used is described in 




Figure 3-21 GC/MS output for 50 ug bisabolene (mixed isomers) (a) The GC/MS output 
of bisabolene standards with retention time against abundance. A large peak is seen at 15.0 
minute which corresponds to the mass spectrometry fragmentation pattern in b. The largest 
mass is 204.2 Da which corresponds to the mass of a sesquiterpene or farnesyl 
pyrophosphate without the pyrophosphate moiety. Other peaks correspond to other 
bisabolene isomers and contaminants present in bisabolene and in ethyl acetate. (b) Mass 
fragmentation pattern of the peak at 15 minutes showing fragments produced when 




Figure 3-22 GC/MS output for 50 ug α-humulene. (a) The GC/MS output of α-humulene 
standards with retention time against abundance. Two peaks with masses of 204 Da were 
seen at 14.8 and 15.3 minutes. The mass of 204.2 Da corresponds to the mass of a 
sesquiterpene or farnesyl pyrophosphate without the pyrophosphate moiety. (b and c) The 
mass fragmentation patterns for the peaks at 14.8 minutes and 15.3 minutes respectively. 
Mass fragmentation patterns represent the molecular ions produced when α-humlene is 
broken up in the detector.  	
 
Following confirming a GC/MS method and testing it with sesquiterpene standards, purified 
SeDS was tested. The method of sample collection for SeDS, optimised from previous 
methods, is to quench the 200 µl reaction of enzyme and farnesyl pyrophosphate using snap 
freezing in liquid nitrogen (Styles et al., 2017). Following this, 150 µl ethyl acetate was added 
and the sample vortex until thawed. To separate the organic layer, it was spun down at 
2,100g. The organic layer was sampled and analysed by GC/MS (Figure 3-23) (Styles et al., 
2017). 




Figure 3-23 GC/MS output of product profile of selina-4(15),7(11)-diene synthase. (a) 
The GC/MS output of the products formed by selina-4(15),7(11)-diene synthase, with 
retention time against abundance. 2 mM farnesyl pyrophosphate was incubated with 5 µM 
SeDS, incubated overnight at 30°C (b) The mass spectrometry fragmentation pattern of the 
largest peak  at 16.3 minutes is predicted to be selina-4(15),7(11)-diene. (c) The mass 
spectrometry fragmentation pattern of the smaller peak at 16.5 minutes and is predicted to 
be germacrene B.  
 
The product profile in Figure 3-23 show two products with a mass of 204 Da that 
corresponds to a sesquiterpene product with no additional atoms. The two different products 
correspond to the mechanism suggesting the larger peak is selina-4(15),7(11)-diene (Figure 
3-23 b) and the smaller peak is germacrene B (Figure 3-23 c) due to previous work (Baer et 
al., 2014). After confirming the product profile using purified protein the method was adapted 
to extraction from expressing cultures. This culture expression method was adapted from 
work with Saccharomyces cerevisiae where post induction with IPTG a culture is layered 
with organic solvent with a density lower than water. The terpenes produced are released 
from the cells and following a period of expression the organic solvent containing the 




Figure 3-24 GC/MS output of product profile of selina-4(15),7(11)-diene synthase from 
culture overlay. (A) The GC/MS output of the products produced by selina-4(15),7(11)-
diene synthase, with retention time against abundance. The sesquiterpene peaks are 
highlighted by the cyan box. (b) The mass spectrometry fragmentation pattern of the largest 
peak at 16.3 minutes predicted to be selina-4(15),7(11)-diene. (c) The mass spectrometry 
fragmentation pattern of the smaller peak at 16.5 minutes and is predicted to be germacrene 
B.  
 
As both products have the same mass and no standards are available for either product, the 
only way is to confirm the products by NMR.  
 
3.6 Summary 
This chapter described the steps taken to choose a sesquiterpene synthase to engineer. 
Subsequently the chosen sesquiterpene was expressed, purified, kinetically characterised 
and identification of the products was attempted  
 
The SeDS gene from Streptomyces prostinaespiralis ATCC 25486 was optimised for 
expression in E. coli, synthetically made and cloned into a pET His6 SUMO TEV vector with 
a double stop codon (Figure 3-10). SeDS was expressed and purified using nickel affinity 
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chromatography and size exclusion chromatography (Figure 3-11 and Figure 3-12). The size 
was confirmed by mass spectrometry.  
 
Size exclusion was performed in reducing conditions but these reducing conditions were 
removed to allow SeDS to achieve tetrameric formation for activity testing. Initial activity 
testing used a partially optimised version of the malachite green enzyme assay to validate 
the purification of active SeDS (Figure 3-15). The initial activity test confirmed purification 
produced an active enzyme and estimated a starting concentration of 250 µM for further 
malachite green assay optimisation. 
 
The malachite green assay was optimised, testing a range of  assay conditions and 
components. Initial testing used a thermostable pyrophosphatase, however large variances 
and errors were seen. These errors were due to the necessary two incubation periods for 
the terpene synthase reaction. The thermostable pyrophosphatase was used to validate the 
coupling of the assay to another reaction to Q5 polymerase (Figure 3-17). Going forward, an 
inorganic pyrophosphatase from yeast was used for the remaining optimisation where the 
minimum excess concentration is 60 mUml-1 (Figure 3-18). Subsequent optimisation before 
kinetic conditions could be determined included; pH of reactions with increasing the buffer 
capacity of the assay buffer and the components of the malachite green colour reagent.  
 
Following the optimisation of the malachite green assay for the phosphate range that SeDS 
was active in the kinetic conditions were optimised. The kinetic parameters were calculated 
using the initial rates of reaction that cover a range of substrate concentrations above and 
below the Km. Both the SeDS concentration and the farnesyl pyrophosphate concentration 
range were optimised along with the reaction incubation length. This optimisation led to the 
following conditions; 500 nM SeDS, 5 µM to 160 µM farnesyl pyrophosphate with a ten-
minute reaction incubation (Figure 3-19). The kinetic parameters were calculated; Km 
between 10µM and 15µM and Vmax between 0.4 and 0.9µM min-1. 
 
To confirm the product profile of SeDS gas chromatography mass spectrometry was used. 
Using methods adapted from previous work, two peaks with corresponding sesquiterpene 
masses were seen in the GC/MS output using both purified protein and SeDS expressing 
cultures (Figure 3-23 and Figure 3-24) (Baer, Rabe, Citron, et al., 2014) (Styles et al., 2017).  
In summary this chapter shows the expression, purification, kinetic characterisation and 





Chapter 4 - Investigating the specificity of selina-
4(15),7(11)-diene synthase variants 
 
The aim of this work was to probe the function of a variety of residues within the active site 
of selina-4(15),7(11)-diene synthase (SeDS) with the goal of producing novel products. Due 
to the low to medium throughput of potential screening methods a targeted engineering 
approach was taken. It was envisaged that a series of targeted mutations would be created 
and screened using either GC/MS or the malachite green assay (Section 4.2 and 4.3). Any 
mutation with interesting or altered product profiles would then be further characterised.  
 
4.1 Aims of mutagenesis 
The aim of this work was to produce novel compounds by engineering SeDS however, due 
to the low to medium throughput of potential screening methods, a targeted approach using 
site directed mutagenesis was taken and the workflow is overviewed in Figure 4-1. Alanine 
scanning was selected as an initial screening technique to probe the function of a variety of 
active site residues. Alanine scanning involves selecting a number of residues to target and 
mutate to alanine, a neutral residue with no extended side chain, and screening the effect 
(Weiss et al., 2000). These select alanine variants were also used to optimise the GC/MS 
and malachite green assay screening and for further mutagenesis. As a result of alanine 
scanning, a set of residues were selected for further mutagenesis. Following completion of 
further mutagenesis any interesting variants were taken forward for further characterisation 
and study.  
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Figure 4-1 Flow chart of the engineering process for selina-4(15),7(11)-diene synthase. 
Flow chart depicts the process taken in engineering SeDS in stages. Initial mutagenesis 
used alanine scanning and these variants were used to determine the best initial screening 
method. Following alanine scanning, residue positions will be narrowed down and a set of 
mutagenesis rules determined for further engineering.   
 
4.2 Alanine mutagenesis  
4.2.1 Residue selection  
The selection of residues for mutagenesis was aided by SeDS crystal structures including a 
structure with substrate mimic, dihydrofarnesyl pyrophosphate (PDB 4OKZ) (Baer, Rabe, 
Fischer, et al., 2014). This crystal structure was analysed using pymol software along with 
using a ligand interaction analysis tool Ligplot (Wallace, Laskowski and Thornton, 1995) 
(Laskowski and Swindells, 2011) (Figure 4-2 and 4-3). This online tool generates a 2D 
schematic of the protein and ligand interactions from a PDB file. Ligplot figures can display a 
variety of intermolecular interactions to show the different potential interactions with the 
ligand. The algorithm involves the flattening of rings and the unrolling of the 3D structure 
around rotatable bonds meaning the atoms connected to this bond are in the same plane, 
without disrupting the bond lengths in the process. In addition, the algorithm uses the 3D 
coordinates of the PDB file to process the hydrogen bond information for the ligand and 
Residue selection using ligand interaction tools
Alanine scanning of selected residue testing 
GC/MS and malachite green assay screening 
Select residues for further mutagenesis 
Create a set of mutagensis rules to focus 
engineering effort 
Screen further mutagenesis and characterise 
any interesting mutants for further analysis 
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protein. Following these stages, clean up stages improve the results to minimize overlap 
giving a clear 2D image (Laskowski and Swindells, 2011). Ligplot software has been widely 
used including in the aid of designing peptide locks and interactions of lysozyme with 
monocationic and dicationic liquids (Ernst et al., 2020) (Islam et al., 2020).    
 
Figure 4-2 Ligplot+ analysis diagram of selina-4(15),7(11)-diene synthase active site 
from Streptomyces pristinaespiralis ATCC 25486 (PDB 4OKZ). Selina-4(15),7(11)-diene 
synthase had been crystallised with an inactive substrate mimic dihydrofarnesyl 
pyrophosphate (shown in purple). The selina-4(15),7(11)-diene synthase active site has 
three magnesium ions coordinated by the NSE/DTE motif. Magnesium ions coordinate the 
pyrophosphate moiety of the substrate whereas the hydrophobic region of the active site 
coordinates the cation and hydrophobic substrate end with a variety of hydrophobic 
interactions. Hydrophobic interactions are depicted by red lines and the seven residues 
highlighted with red circles were selected for alanine mutagenesis.  
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Figure 4-3 Selina-4(15),7(11)-diene synthase active site from Streptomyces 
pristinaespiralis ATCC 25486 (PDB 4OKZ) with residues for alanine mutagenesis. The 
active site of chain 1 of SeDS with magnesium ions depicted as red spheres and an un-
hydrolysable farnesyl pyrophosphate mimic, dihydrofarnesyl pyrophosphate in yellow. The 
residues depicted as sticks coloured by elements are the key residues to coordinate the 
cation produced in the reaction mechanism as identified by Ligplot and by Pymol structural 
analysis (Wallace, Laskowski and Thornton, 1995) (PDB 4OKZ). The residues identified are 
all hydrophobic residues found in the bottom of the active site that control the quenching of 
the cation and the structure of the final products. A and B show different views of the active 
site. 
 
Figure 4-2 shows the Ligplot analysis identifying 7 key residues that interact hydrophobically 
with the ligand. All residues, excluding the residue A183, were taken forward, in addition to 
S217 and I220 selected from pymol analysis of the active site.  
 
4.2.2 Mutant creation  
Alanine mutants were created using site directed mutagenesis with primers designed using 
the Agilent online quick change tool (Table 2-5) (Agilent Technologies, 2013) (Novoradovsky 
et al., 2005). Mutagenesis was completed using PfU Ultra High-fidelity DNA polymerase 
(Agilent) and used the Agilent quick change 2 protocol (Section 2.2.2). Mutagenesis was 
confirmed by sequencing before transformation for expression. For each mutant a 50 ml 
expression test was completed in wild-type expression conditions to confirm expression 
before large scale expression (Section 2.3). The expression test samples were lysed and the 
lysate was processed through a mini His spin column to bind any expressed His tagged or 
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binding proteins. The results of the expression test were analysed by SDS PAGE gel (Figure 
4-4).      
 
 
Figure 4-4 Expression testing of selina-4(15),7(11)-diene synthase alanine mutants. 
Each alanine mutant was expressed in a 50ml culture and samples were analysed by SDS 
PAGE gel image. Each mutant shows a band at the expected position in elution samples; 
however, each elution sample is heavily contaminated. The largest band at around 20 kDa is 
E. coli contaminant protein SlyD. The expression levels vary between the mutants with 





Figure 4-4 shows the expression level of each mutant varied, with mutants Y152A and 
G182A having the lowest expression. From the expression level it was estimated that 4 L of 
large-scale expression would produce a sufficient amount of enzyme for an initial malachite 
green assay test (Section 2.4). Each alanine mutant was purified using the gravity flow 
purification protocol (Section 2.3.5).    
 
4.2.3 Production, purification and confirmation of alanine mutants 
After producing and confirming the alanine mutants, two screening methods were used to 
assess the activity and the product profile of the variants. The malachite green assay can be 
used to test a variant’s activity levels based on the consumption of substrate FPP and the 
consequent pyrophosphate production. The assay is performed at a concentration of FPP 
above the wild-type Km over the course of 10 minutes. Using these standard conditions and 
concentration, an estimate of the mutant’s initial activity in absorbance units per minute can 
be calculated and compare the expected activity of the alanine mutants. This assay will 
show whether the mutant is active, but the screening method has some pitfalls. This assay 
needs purified protein lowering the throughput of the assay and its benefit as a screening 
method. To screen for the product profile, GC/MS in culture screening can be used. This 
method has a medium throughput and can be done in culture. However, there is limitations 
as the culture need to be incubated for 72-hour post induction for the optimum concentration 
of terpenes for analysis. Both screening methods were tested and evaluated for reliability 
and the value of the results to determine the screening protocol for further mutagenesis. 
 
4.2.4 Malachite green assay screening  
The first stage in developing the screening assay was to determine whether full purification 
or whether the His elution could be used in the assay (Section 3.4). A single farnesyl 
pyrophosphate concentration was be tested giving comparable initial activity. This would 
reduce the accuracy of the protein concentration but would significantly reduce the time and 
increase the throughput of this screening method. Therefore, going forward alanine variants 
were purified alongside wild-type SeDS using the gravity flow purification method (Section 
2.3.5). Following this, wild-type SeDS was tested in the assay conditions with and without 
TEV cleavage (Figure 4-5). 
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Figure 4-5 Testing the activity of cleaved and uncleaved selina-4(150,7(11)-diene 
synthase samples. SeDS was purified using a gravity flow purification method. The His 
elution was spilt in two fractions, one fraction was cleaved with TEV protease and one 
fraction was not cleaved. Following cleavage both fractions were buffer exchanged into 
SeDS storage buffer (50 mM Tris, 100 mM NaCl, 10 mM MgCl2, 10 % glycerol). Both 
samples were tested with the malachite green assay with 40 µM FPP and 500 nM enzyme 
over the course of 10 minutes.  
 
Figure 4-5 shows that un-cleaved SeDS (orange) is still active and therefore the cleavage of 
a SUMO tag is not necessary consequently improving the throughput of the malachite green 
assay. The rates of both enzymes were expected to be same, however the addition of TEV 
reduced the activity rate. This could be due to TEV protease interacting within a step of the 
assay or the acidic termination of the reaction. In the full purification the TEV protease is 
separated in the size exclusion chromatography step removing the potential for any assay 
interactions. Consequently, each mutant was tested in these standard conditions without 
























SeDS + TEV Clevage




Figure 4-6 Alanine variant testing with the malachite green assay. Each alanine variant 
was tested at 40 µM FPP with 500 nM enzyme over the course of 10 minutes along with a 
wild-type control. From this data an initial rate in absorbance units per minute was calculated 
and this rate is plotted above. The mutants with the fastest rate were F55A, L78A and F79A.  
 
Figure 4-6 displays the results of the initial activity tests for each alanine variant showing 
varying activity levels. The error bars show the error associated with the purity of the protein 
and the limitations of the discontinuous assay. However, the error was not statistically 
significant, and the results were used to select variants to take forward. The three most 
active variants, F55A, L78A and F79A were taken forward for further activity testing and to 
validate the assay method (Figure 4-6). For further testing a larger scale expression and 
wild-type purification was completed for each variant (Section 2.3.4 ). Variant purification 
was confirmed by mass spectrometry. Initial testing of these purified variants using the same 
conditions reported in Section 3.4 for the wild-type enzyme confirmed the variants had a 
lower activity. In order to obtain accurate values for the kinetic parameters for these variants 
it was therefore necessary to increase the enzyme concentration or the length of the assay. 

















































    
 
Figure 4-7 Kinetic characterisation of F55A SeDS. (A) The F55A variant at 2.5 µM was 
assayed at six farnesyl pyrophosphate concentrations between 5 µM and 160 µM. For each 
concentration the initial rate of reaction was calculated using GraphPad linear regression. 
(B) Michealis-Menten curve using the initial rate of reaction (in #moles of pyrophosphate 
produced per minute) plotted against the farnesyl pyrophosphate concentration with the 





Figure 4-8 Kinetic characterisation of L78A SeDS. (A) The L78A variant at 3 µM was 
assayed at six farnesyl pyrophosphate concentrations between 5 µM and 160 µM. For each 
concentration the initial rate of reaction was calculated using GraphPad linear regression. 
(B) Michealis-Menten curve using the initial rate of reaction (in #moles of pyrophosphate 
produced per minute) plotted against the farnesyl pyrophosphate concentration with the 






Figure 4-9  Kinetic testing of F79A. F79A was tested at 2.5 µM enzyme with various FPP 
concentrations between 5 µM and 160 µM. F79A displayed relative inactivity in these higher 
enzyme conditions.  
 
For both F55A and L78A kinetic parameters were calculated by using the same substrate 
concentrations but increasing the enzyme concentration to five- or six-times the wild-type 
concentration (Figure 4-7 and 8) (Table 3-2). F55A shows an increase in Km of 
approximately 10-fold compared to wild-type SeDS, whereas L78A has a Km similar to wild-
type SeDS (Table 3-3). However, F79A was too inactive to calculate kinetic parameters in 
any of these conditions (Figure 4-9). To calculate these parameter the reaction time could be 
increased. However, the further activity testing of F79A reduces the validity of this screening 
method. This suggests that future mutants should be further purified to be tested in the 
malachite green assay.  
 
4.2.5 GC/MS screening  
GC/MS screening was initially completed using an E. coli culture overlay method. A 100 ml 
culture of each alanine variant in E. coli BL21-DE3 cells was expressed and induced with 1 
mM IPTG at an OD600nm 0.6. After induction 2 mls of dodecane is layered on the culture and 
the culture is expressed for 72 hours. During the expression period, terpenes are produced 
and released by the cells and extracted into the organic solvent layer. This means that 
amount produced is related to both the activity of the enzyme and its expression level. 
Following the expression period, the organic layer is sampled and diluted in ethyl acetate, 
spiked with 40 µg/ml cumene as an internal standard, and analysed by GC/MS (Section 2.5).  
The GC/MS output provides relative abundance with respect to the sample provided. 
Therefore, to quantify and compare GC/MS results an internal standard at a set 
concentration was added to al GC/MS samples. All GC/MS results are standardised against 

























relevant abundance of cumene to 1,000,000 and creating a dilution factor to standardise the 
remaining data against. For easiest presentation of the results of the GC/MS analysis the 
section of resulting chromatogram between retention times of 13.3 and 19.9 minutes is 
presented (after standardisation to the internal cumene standard). This allows the peaks of 
the enzymically produced terpenes to be viewed best. (Figure 4-10 and 11). All peaks within 
this range with a mass between 200 and 300 Da are then flagged for further investigation.  
 
Figure 4-10 Example GC/MS output of terpene products of wild-type selina-4(15),7(11)-
diene synthase. Highlighted in the output are the peaks that correspond to cumene and 
dodecane. The highlighted green box shows the peaks between 13.3 and 19.9 minutes that 
will be displayed in further GC/MS analysis to easily compare results. Also displayed are the 
structures of the two products of selin-4(15),7(11)-diene synthase; selina-4(15),7(11)-diene 




Figure 4-11 GC/MS output of terpene products of for alanine variants of SeDS. GC/MS 
output for each alanine variant between 13.3 and 19.9 minutes. All abundances have been 
standardised against the internal standard 40 µg.mL-1 cumene peak and replotted. The 
yellow box highlights the selina-4(15),7(11)-diene and germacrene B peaks and the dotted 
lines highlight the two products. The samples have varying abundances of each product with 
F79A showing no abundance at this level for either product or any additional products.   
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From Figure 4-11 no alanine variant showed any novel terpene peaks in these conditions, 
but all showed production of the wild-type products at varying levels. Therefore, the mutation 
to alanine does not significantly affect the product profile of the variants excluding F79A. 
F79A appears inactive in these conditions which correlates with kinetic studies (Figure 4-9). 
Using the standardised data these results can be quantified by calculating approximate 
percentage total activity compared to wild-type SeDS and the ratio of the two wild-type 
products, by calculating the area under the peak (Figure 4-12).  
 
Figure 4-12 GC/MS analysis of alanine variants of SeDS. (a) Bar chart showing the total 
activity as a percentage of the total amount of both products in (µg) when compared to wild-
type selina-4(15),7(11)-diene synthase. Activity is based on the enzyme’s activity level and 
its expression level. All variants show lower activity than wild-type with F79A showing no, or 
low, activity. (b) Bar chart showing the ratio of two wild-type products for each alanine 
variant. The ratios do not take into account the total amount of production in relation to wild-




As previously mentioned, GC/MS activity levels are affected by both the enzyme activity 
level and the enzyme expression level. All variants show a lower total production of both 
products when compared to wild-type SeDS. F79A has the most significant reduction in 
activity compared to any other position. However, F79A has the most significant change in 
product profile distribution with a near 50:50 ratio. 
 
As F55A, L78A and F79A were kinetically characterised, GC/MS analysis was conducted on 
the purified protein to verify the results of the GC/MS screening method from the overlay 
method (Figure 4-13).   
 
Figure 4-13 GC/MS output of terpene products of F55A, L78A and F79A variants of 
SeDS. (a) The GC/MS output of product profiles of the F55A, L78A and F79A purified 
variants . For presentation, the data of F55A has been shifted by 200000 abundance units 
and the following values were shifted by 0.5 minutes and 400000 abundance units. (b) The 
GC/MS output of terpene products of F55A, L78A and F79A, with retention time against 
abundance cut between 13.3 and 19.9 minutes for clarity. F55A was shifted by 200000 
abundance units and the following values were shifted by 0.5 minutes and 400000 
abundance units. (A and B) 2 mM farnesyl pyrophosphate was incubated with 5 µM enzyme 
incubated overnight at 30°C for F55A and L78A. Both peaks correspond to mass of 204 Da 
and have the same retention time as wild type. (a, b and c) The GC/MS output of F79A 
product profile separated, with retention time against abundance. 2 mM farnesyl 
pyrophosphate was incubated with 10 µM enzyme incubated overnight at 30°C. (c) F79A 
data cut between 13.3 and 19.9 minutes and the abundance y-axis was rescaled to see the 
peaks clearly.  
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Figure 4-13 shows the GC/MS results confirming the culture overlay GC/MS results showing 
the same product profiles. Both F55A and L78A produce wild-type products in a similar ratio 
to the wild-type SeDS, however the level of activity is undermined as the reactions go to 
completion overnight unlike the kinetic analysis showing lower activity. Whereas, F79A is 
inactive in all three studies suggesting the mutation has a drastic effect on enzyme activity 
and potentially change in product ratio (Figure 4-12 B). There are additional peaks in the 
product profile of F79A that have masses between 200 and 300 Da but there were 
insufficient amounts to take this forward.    
 
4.2.6 Alanine mutagenesis summary   
Overall eight alanine variants were created at residues within the hydrophobic cleft of the 
active site as identified by Ligplot and pymol analysis. These variants were screened with 
both the malachite green assay and GC/MS methods to evaluate the protocol for further 
mutagenesis screening with the result displayed in Table 4-1 (Figure 4-1).  
The results show that F79 is the most interesting residue tested with the alanine scanning. It 
has the most significant change in both activity level and products ratio (Table 4-1). This 
change in product profile to 50:50 (selina-4(15),7(11)-diene : germacrene B) is the most 
appealing change with the aim of producing novel products, nonetheless the amino acid 
substitution does lead to a significant loss in activity. F79A is near the magnesium ions close 
to the mouth of the active site (Figure 4-14) and therefore could control how the cation 
moves deeper within the hydrophobic cleft of the active site. Residues F55 and L78 are also 
close to F79 at the mouth of the active site but alanine scanning showed they do not have 
the same role. Mutation of phenylalanine to alanine significantly reduces the size of the 
amino acid, potentially increasing the volume of the active site cleft, in turn giving more room 
for the flexible substrate to be orientated differently in the active site. This might cause the 
substrate cation to be misplaced in the hydrophobic cleft resulting in reduced activity and 
changes in product profile as the new orientation might not favour selina-4(15),7(11)-diene 
over germacrene B as in wild-type SeDS. Also, this rationale suggests why there was a 
reduction in activity as nothing is controlling the cation to be correctly positioned alongside 
any catalytic residues in the hydrophobic cleft. In addition, when aligning SeDS to 5-epi-
aristolochene synthase with germacrene A and pyrophosphate bound (PDB 5IK6), F79A in 
SeDS is found in the same position as Y520 and Y376 in 5-epi-aristolochene synthase. This 
suggests a bulky residue containing a benzene ring may be crucially involved in correct 





Table 4-1 Summary table of alanine variant testing 





Ratio of products (selina-
4(15),7(11)-diene: 
germacrene B) 
Wild-type 0.0097 100 99:1 
F55A 0.0071 75.3 95:5 
L78A 0.0035 80.3 97:3 
F79A 0.0027 1.7 53:47 
Y152A 0.0021 61.4 95:5 
G182A 0.00043 63.6 95:5 
V187A 0.0026 46.8 95:5 
S217A 0.0020 65.3 94:6 

















Figure 4-14 Selina-4(15),7(11)-diene synthase active site from Streptomyces 
pristinaespiralis ATCC 25486 (PDB 4OKZ) with F79A highlighted compared to the 
tobacco 5-epi-aristolochene synthase active site (PDB 5IK6). (A) The active site of chain 
1 of SeDS with magnesium ions depicted as red spheres and an un-hydrolysable farnesyl 
pyrophosphate mimic, dihydrofarnesyl pyrophosphate in yellow. The residues depicted as 
sticks coloured by elements are the key residues to coordinate the cation produced in the 
reaction mechanism as identified by Ligplot and by Pymol structural analysis (Wallace, 
Laskowski and Thornton, 1995) (PDB 4OKZ). F79 (shown in pink) appears to be closer to 
the magnesium ions in the active site along with F55 and L78 (shown in orange). (B) Active 
site of 5 epi-aristolochene synthase with key residues highlighted as sticks (from Leview 
analysis) (PDB 5IK6). Magnesium ions are depicted as red spheres with diphosphate 
depicted as orange spheres. Germacrene A is depicted as yellow sticks in the hydrophobic 
cleft of the active site. 
 
Along with identifying key residues to target, alanine scanning was used to compare two 
screening methods and optimise a screening protocol for further mutagenesis. The 
malachite green assay needs purified protein reducing the throughput of the assay. Also, the 
results for variant F79A were not accurate with two other methods showing the variant is 
near inactive. Low accuracy in this assay could be due to potential interactions with E.coli 
contaminant proteins not separated in the purification method used. GC/MS screening can 
be done with culture samples and an organic layer increasing the throughput of the 
screening method. The GC/MS produced reliable results with the in culture and purified 
protein GC/MS corroborating the kinetic characterisation. The only drawback of GC/MS 
screening is the 72-hour incubation required. In conclusion, the experiments demonstrate 
that the best protocol for initial screening is to use GC/MS to provide information on product 
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profile (to identify those variants with altered profiles) and to give some indication of activity 
level  which can be further confirmed and quantified using the malachite green assay and 
GC/MS on purified protein. 
 
4.3 Further mutagenesis 
4.3.1 Mutant selection   
Based on the results of alanine scanning and Leview analysis, positions were selected for 
further mutagenesis (Figure 4-15). Leview uses a similar algorithm to Ligplot to analyse 
residue ligand interactions (Caboche, 2013). Analysis was performed to validate the Ligplot 
analysis or find any additional positions to target.  
 
Figure 4-15 Leview analysis diagram of the active site of selina-4(15),7(11)-diene 
synthase from Streptomyces pristinaespiralis ATCC 25486 (PDB 4OKZ). Selina-
4(15),7(11)-diene synthase was crystallised with inactive substrate mimic dihydrofarnesyl 
pyrophosphate.  The selina-4(15),7(11)-diene synthase active site has three magnesium 
ions coordinated by the NSE/DTE motif. Magnesium ions coordinate the pyrophosphate 
moiety of the substrate whereas the hydrophobic region of the active site binds the cation 
and hydrophobic substrate end with a variety of hydrophobic interactions. Residues are 
coloured based on their hydrophobic properties with green residues non-polar and pink 




Using a combination of results described above and active site analysis tools, residues were 
selected for further mutagenesis. Leview analysis identified all residues mutated in alanine 
scanning, excluding G182 which was highlighted by Ligplot (Figure 4-15). G182 was tested 
in alanine mutagenesis and had the lowest expression level and activity level of all the 
variants and no significant effect on the product profile of the enzyme (Figure 4-12). 
Therefore, residue G182 was not taken any further in mutagenesis studies. In addition to the 
residues identified with Ligplot and previously mutated, additional analysis was completed 
with Leview software and identified two polar residues in the secondary layer of the active 
site, T184 and T221. Consequently, the remaining residues tested in alanine scanning were 
taken forward for further mutagenesis along with two polar residues further away from the 
active site, T184 and T221.   
 
Both ligand protein interaction analysis software identified residue A183 which was not 
included in previous alanine scanning. Due to its close proximity to many other residues 
being screened it was not taken forward for screening but was noted for potential further 
screening.  
 
Consequently, nine residues were taken forward for further mutagenesis, but with this 
number of residues and the screening capabilities, full saturation libraries at each residue 
were not practical. As a result, a set of mutation rules or criteria was created to direct the 
mutagenesis effort. Therefore, if any residues produce significant results further mutations 
can be made at this position. The criteria were designed to have the maximum effect by 
making the most significant changes in size, polarity and charge with the aim of changing 
the product profile. The general approach followed was;  
• Every selected residue will be mutated to aliphatic residues (L, I or V) 
• Small amino acids changed to larger bulkier amino acids of similar charge and 
properties.  
• Bulky amino acids changed to smaller amino acids of similar charge or properties 
• Non-polar amino acid changed to polar amino acid of similar size 
• Polar amino acid change to non-polar amino acid of similar size  
• Reverse charge of charged residues 




Both F55 and F79 have previously been mutated to tryptophan, tyrosine and leucine with 
only leucine changing the product profile to produce small amounts of linear products 
including; (E)-β-farnesene and (2Z,6E)- α-farnesene (Baer, Rabe, Fischer, et al., 2014). These 
results corroborate the alanine scanning results showing the key role of the ringed amino 
acids at the top of the hydrophobic cleft; however, these mutations were not repeated. 
Therefore, both F55 and F79 were mutated to isoleucine to see if the rearrangement of the 
atoms of a leucine also has an effect on the product profile. Also, mutations to glutamine and 
methionine maintain a similar size or space but the addition of chemical groups changes the 
polarity of the residue. To change the charge of the residue in the position of the natural 
phenylalanine while retaining a similar size, the residues were mutated to histidine and 
glutamic acid.  
 
To change the polarity of the residue at L78 it was substituted by cysteine, threonine and 
glutamine with the additions of different chemical groups and by glutamic acid to add a 
negative charge. To affect the size or orientation of the residue at position 78 while 
maintaining the same polarity and charge it was mutated to tryptophan, glycine and 
isoleucine. For Y152 it was substituted by serine and threonine to change the size while still 
containing a hydroxyl group. To just change the polarity the ringed residue was mutated to 
tryptophan and phenylalanine, both benzene ring containing residues. In addition, Y152 was 
mutated to isoleucine, which changes both size and polarity and histidine to change the 
charge at this position.  
 
For both threonine residues, T184 and T221, changes were made to hydroxyl containing 
residues serine and tyrosine, to change the size without affecting the polarity and charge. To 
affect the charge of these residues it was changed to aspartic acid, whereas to change the 
polarity it was substituted by valine and cysteine, removing or substituting the hydroxyl group 
of the side chain. To change the size while maintaining other properties, V187 was mutated 
to phenylalanine with a benzene ring, small residue glycine and leucine. To change the 
polarity V187 was changed to threonine and asparagine while it was changed to aspartic 
acid to alter the charge. For S217 it was replaced by valine, cysteine, asparagine and 
leucine to change the polarity of the residue by substituting or removing the hydroxyl group. 
Also, to change the size while maintaining other properties it was changed to threonine and 
to change the charge, to aspartic acid. Finally, I220 was changed to leucine, phenylalanine 
and valine to maintain properties but affect the size of the residue. To change the polarity at 
I220 it was changed to residues with additional chemical groups specifically threonine, 
glutamine and methionine. To change the charge of I220 it was mutated to glutamic acid. 
The mutagenesis strategy is summarised in Table 4-2.  
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Table 4-2 Summary table of further mutagenesis    
Position  Size Change Polarity Change Charge Change 
F55 
 
 Glutamine  Histidine 
 Methionine Glutamic acid 
Isoleucine  
L78 Tryptophan Cysteine Glutamic acid 
Glycine  Threonine  
Isoleucine Glutamine   
F79  Glutamine  Histidine 
 Methionine  Glutamic acid 
Isoleucine  
Y152 Serine Tryptophan Histidine 
Threonine Phenylalanine  
Isoleucine  
T184 Serine Valine Aspartic acid 
Tyrosine Cysteine  
 Asparagine  
 Leucine  
V187 Phenylalanine  Threonine  Aspartic acid  
Glycine Asparagine   
Leucine   
S217  Threonine Valine Aspartic acid 
 Cysteine   
 Asparagine   
 Leucine  
I220 Leucine Threonine  Glutamic acid  
Phenylalanine  Glutamine   
Valine  Methionine   
T221  Serine  Valine  Aspartic acid  
Tyrosine  Cysteine   
    
 
4.3.2 GC/MS screening of variants     
Variants were produced using site directed mutagenesis using the same protocol as used 
with the alanine variants (4.2.2). After confirming the mutations with sequencing, variants 
were screened using E. coli in culture GC/MS screening. As with previous GC/MS 
147 
 
screening, the data has been cut to improve visibility of terpenes and the abundance relates 
to both the activity of the enzyme and the expression level of the enzyme (Figure 4-10, 16-
18). 
 
Figure 4-16 GC/MS analysis of terpene products for variant SeDSs at positions F55, 
L78, F79 and Y152. GC/MS output of terpene products between 13.3 and 19.9 minutes 
standardised against the relative abundance of the internal standard cumene (not shown in 
figures). For each variant peaks between 200 and 300 Da are annotated. The yellow box 
signifies the selina-4(15),7(11)-diene and germacrene B peaks and the dotted lines highlight 
the two products. (a) The GC/MS output for the mutations at position F55. (b) The GC/MS 
output for mutations at position L78. (c) The GC/MS output for mutations at position F79. (d) 
The GC/MS output for the mutations at position Y152.  No mutation shows any novel 





Figure 4-17 GC/MS analysis of terpene products for variant SeDSs at positions T184, 
V187, S217 and I220. GC/MS output between 13.4 and 19.9 minutes standardised against 
the relative abundance of the internal standard cumene (not shown in figures). For each 
mutation and peaks between 200 and 300 Da are annotated. The yellow box signifies the 
selina-4(15),7(11)-diene and germacrene B peaks and the dotted lines highlight the two 
products. (a) The GC/MS output for the mutations at position T184. (b) The GC/MS output 
for mutations at position V187. (c) The GC/MS output for mutations at position S217. (d) The 
GC/MS output for the mutations at position I220.  No mutation shows any novel products, 




Figure 4-18 GC/MS analysis of terpene products for variant SeDSs at position T221. 
GC/MS output between 13.4 and 19.9 minutes standardised against the relative abundance 
of the internal standard cumene (not shown in figures). For each mutation and peaks 
between 200 and 300 Da are annotated. The yellow box signifies the selina-4(15),7(11)-
diene and germacrene B peaks and the dotted lines highlight the two products.  No mutation 
shows any novel products.  
 
As shown in Figures 4-16 to 4-18, no variant produced any alternative products to a 
detectable level. Some variants produced altered amounts of each of the wild-type products 
so an alternative way to display these results is to calculate the amount of each product and 
plot these against each other. The area under each peak in the GC/MS profile was 




Figure 4-19 Selina-4(15),7(11)-diene and germacrene B abundance for each variant. 
Graph plotting the abundance of each of the wild-type products of selina-4(15),7(11)-diene 
synthase for both wild-type and variant enzymes. Scatter diagram of the abundance of 
selina-4(15),7(11)-diene against germacrene B. The y-axis for germacrene abundance was 
reduced by a factor of 4 to improve the clarity.  Wild-type SeDS was also included and 
highlighted in orange. The values circled and in bold are residues selected for the biggest 
change in product specificity.   
 
From both analysis V187F and Y152F have the most significant change in product specificity 
and profile. V187F shows a complete switch in specificity from selina-4(15),7(11)-diene to 
germacrene B (Figure 4-17 and 4-19). Y152F shows a switch to a near 50:50 ratio between 
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the two products (Figure 4-16 and 4-19). These variants were taken forward for further 
characterisation including activity assays.  
 
In addition, other variants were selected for further characterisation, to investigate these 
positions and to validate the screening results. Y152W was selected for further analysis as 
its product profile is similar to V187F with a switch in specificity, but either has a lower 
activity or lower expression compared to V187F. Both alanine variants of V187 and Y152 
were taken forward for further analysis of these positions. Also, T221D has a common 
product profile similar to most variants with either low activity or expression with some 
production of both products, as a way to test the screening methods with GC/MS on purified 
protein. Likewise, L78E was taken forward as one mutation with a similar product profile as 
wild-type SeDS to validate screening.  
 
4.3.3 Variant characterisation  
Variants V187F, Y152F, Y152W, Y152A, V187A, T221D and L78E were selected from 
GC/MS screening and taken forward for further characterisation. Each variant was 
expressed on a large scale and purified with wild-type methods for kinetic studies and 
GC/MS verification (Section 2.3.4). Initial activity tests were performed over an extended 
period of time due to potential activity of some variants being significantly lower based on 
GC/MS results. Variants were tested over 5 hours with the same standard substrate and 
enzyme concentration as in alanine variant testing, a concentration above the wild-type Km 
(40 µM FPP) and at 500 nM enzyme. An initial rate against time was calculated for each 
variant in µM min-1, using the standard curve, to compare all experimental tests completed 







Figure 4-20 Initial activity test for variants selected for further testing. Initial activity of 
each variant at 40 µM farnesyl pyrophosphate over the course of 5 hours. Each absorbance 
value was converted to pyrophosphate produced in µM using the standard curves performed 
alongside each experiment. From this an initial rate was calculated per minute to easily 
compare rates.  
 
The initial activity test showed that Y152F and V187F have the highest activity out of the 
variants characterised. Also, it validates the GC/MS screening results showing V187F 
having a higher activity to Y152W.  Following this initial kinetic test, variants were analysed 
using GC/MS on purified enzyme. Enzyme and substrate were incubated overnight at 30 ºC 












































Figure 4-21 GC/MS output for V187F, Y152F V187A, T221D, Y152W and Y152A using 
purified protein. (A) GC/MS output of 10 µM of enzyme and 2 mM farnesyl pyrophosphate 
incubated overnight at 30 ºC before terpenes were sampled by snap freezing and extraction 
in ethyl acetate. Each result is shifted by 200000 abundance units and all results after 
V187F were shifted 0.5 minutes. (B) The GC/MS output between 13.3 and 19.9 minutes.  
Each result is shifted by 200000 abundance units and all result after V187F were shifted 0.3 
minutes. 
 
Figure 4-21 shows all results confirm with the culture overlay method except Y152W which 
shows none of the expected terpene peaks for selina-4(15),7(11)-diene and germacrene B. 
Y152W enzyme appears inactive in both Figure 4-20 and 4-20, suggesting the enzyme has 
significantly lower activity than expected. As the in-culture GC/MS screen is over 72 hours 
there was no way to estimate the enzyme activity level. To confirm that the peaks at the 
same retention time correspond to the expected products; selina-4(15),7(11)-diene and 
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germacrene B, GC/MS samples of V187F were spiked with wild-type SeDS samples. If the 
peaks do correspond to the same products, the relative abundance will increase (Figure 4-
22).  
 
Figure 4-22 GC/MS outputs of spiking V187F samples with wild-type selina-4(15),7(11)-
diene synthase products. (a) GC/MS output of 5 µM of wild-type selina-4(15),7(11)-diene 
synthase and 2 mM farnesyl pyrophosphate incubated overnight at 30 ºC before terpenes 
were sampled by snap freezing and extraction in ethyl acetate. (b) GC/MS output of 10 µM 
of V187F and 2 mM farnesyl pyrophosphate incubated overnight at 30 ºC before terpenes 
were sampled by snap freezing and extraction in ethyl acetate. (c) GC/MS output of V187F 
and wild type selina-4(15),7(11)-diene synthase in a ratio of 4:1. (d) GC/MS output of V187F 
and wild type selina-4(15),7(11)-diene synthase in a ratio of 3:2.  
 
GC/MS spiking confirmed that the predicted peaks are the wild-type products; selina-
4(15),7(11)-diene and germacrene B. As Figure 4-22 shows the peak increases with 
increased amount of wild-type GC/MS sample present further confirming the peaks to be for 
the same products. Following confirmation of the product profiles, Y152F and V187F were 
taken forward for kinetic characterisation.  As with previous characterisation of alanine 
variants F55A and L78A, optimisation of the kinetic conditions was necessary. Using the 
initial kinetic tests as a starting point the first stage of optimisation used an extended time 
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course and increased enzyme concentration compared to wild-type SeDS kinetic conditions 
(Figure 4-23).  
 
Figure 4-23 – V187F kinetic optimisation. V187F was tested at 40 µM FPP over the 
course of 6 hours with 2.5 µM enzyme. The time range tested is an extended time range 
compared to wild-type kinetics and shows linear activity between 1 and 5 hours.  
 
Following initial kinetic condition tests (Figure 4-23) a 2-hour time range was selected with a 
range of concentrations between 5 and 80 µM FPP, which is similar to the wild-type 5 and 
160 µM FPP. These optimised conditions provided the opportunity to calculate kinetic 
parameters (Figure 4-24). In addition, Y152F’s kinetic conditions were optimised to calculate 
kinetic parameters by altering the substrate concentration range and the assay length.    























Figure 4-24 V187F kinetic characterisation. (a) V187F at 2.5 µM was tested at 6 farnesyl 
pyrophosphate concentration between 5 µM and 80 µM. For each concentration the initial 
rate of reaction was calculated using GraphPad linear regression. (b) Michealis Menten 
curve using the farnesyl pyrophosphate concentration against the initial rate of reaction in 




Figure 4-25 Y152F kinetic characterisation. (a) Y152F at 0.5 µM was tested at 6 farnesyl 
pyrophosphate concentration between 3.75 µM and 120 µM. For each concentration the 
initial rate of reaction was calculated using GraphPad linear regression. (b) Michealis 
Menten curve using the farnesyl pyrophosphate concentration against the initial rate of 
reaction in pyrophosphate produced per minute with the kinetic parameters displayed in the 
table.  
 
The kinetic parameters of the V187F variant show a significant increase in Km, from 
approximately 15 µM to 70 µM a factor of 4. (Figure 4-24). An increase in Km suggests a 
reduction in affinity for the substrate which could explain the switch in specificity and relate 
to the stabilisation of the cation. In comparison Y152F has a Km of approximately 2-fold 
higher than wild-type while also slightly increasing the Vmax (Figure 4-25). A less significant 
increase in Km could explain the change in product profile while not seeing the full switch in 




Both Y152 and V187 were detected in both ligand protein interacting softwares as residues 
interacting with SeDS’s substrate mimic (Figure 4-2 and 4-15). Both of these residues are 
found within the hydrophobic cleft of the enzyme’s active site and predicted to be where the 
cation is moved to be quenched and form the final products. Y152 is in the middle of the 
hydrophobic cleft opposite residue F79, however the residue is deeper into the active site 
with the ring angled in the same direction (Figure 4-26). Mutagenesis of F79 has previously 
shown product profile changes that resemble Y152 but there is a significant effect on 
activity, suggesting these residues have a direct effect on the formation of the final products. 
V187F is a distance away from the magnesium ions, deep within the active site cleft and 
sticks into the hydrophobic cleft (Figure 4-26).  
 
Figure 4-26 Active site image of selina-4(15),7(11)-diene synthase (4OKZ) with 
residues Y152 and V187 highlighted. Surface representation of the active site of SeDS 
with the magnesium ions depicted as red spheres and substrate mimic dihydrofarnesyl 
pyrophosphate in yellow sticks. The key residues mutated in this engineering attempt are 
depicted as blue sticks with residue Y152 coloured pink and V187 coloured orange (A) 
Image shows the position and orientation of Y152 in the active site and its position in relation 
to F79. (B) Image shows the position and orientation of V187 in the active site and the effect 
a large change in size would have on the active site surface.    
 
Y152F is a small change in polarity with the removal of a hydroxyl group but maintains the 
volume with a benzene ring. This smaller change within the active site could explain why 
there is only a change in product distribution and not a significant change in activity. When 
residue F79 was mutated to benzene-containing amino acids there was a shift in product 
profile with the increased production of side product of germacrene B. However, when 
residue F79 mutagenesis removes the benzene ring, for example F79A and F79E, the 
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enzyme activity is lost or significantly impacted but, there is still the product shift. Therefore, 
the loss of this hydroxyl group shifts the product ratio to an approximate 50:50 ratio 
suggesting the hydroxyl group could push the cation into favouring selina-4(15),7(11)-diene 
production following the formation of germacrene B (Figure 3-5). 
 
V187F is a significant change in size and volume with the addition of a benzene ring 
changing the contour of the hydrophobic cleft. This significant change deep within the 
hydrophobic cleft could potentially explain why there is a full specificity switch to germacrene 
B. The addition of a ring deep within the hydrophobic cleft affects the proton abstraction from 
germacrene B and the formation of two distinct rings in the selina-4(15),7(11)-diene pathway 
(Figure 3-5 and 4-26). Following the identification of these two positions further mutagenesis 
was suggested at these two sites including other benzene ring-containing amino acids and 
additional chemical groups.   
 
4.3.4 Mutagenesis analysis  
Other selinadiene synthases have been characterised from biosynthetic gene cluster 
analysis but there are no other crystal structures for structural comparison. However, the 
product profile of these enzymes has been characterised with one selinadiene synthase, %-
selinadiene synthase from Abies alba, which produces; % -selinadiene, germacrene B, 
guaia-6,9-diene, germacrene A and %-cadinene (Christopher L. Steele et al., 1998). 
Germacrene products and intermediates in other selinadiene synthase supports the 
mechanism, however due to the low primary sequence homology between terpene 
synthase, no structural comparison can be made.  
 
Other terpene synthases’ also produce germacrene products that have been structurally 
characterised. As a result, these structures and enzyme mechanisms could be compared to 
SeDS and potentially explain engineering effort and specificity switch. One significant 
example is 5-epi-aritolochene synthase which has been crystallised with both FPP and PPi, 
with germacrene A, in addition to an apo structure (Figure 4-27). A structural alignment of all 
selina-4(15),7(11)-diene synthases and a selection of the many 5-epi-aritsolchene synthase 
structures (variety of ligands and apo forms) (Figure 4-28) was performed to find a structural 




Figure 4-27 Active site image of tobacco 5-epi-aristolochene synthase (PDB 5IK6) and 
selina-4(15),7(11)-diene synthase (40KZ). (a) Active site image of tobacoo-5-epi-
aristolochene synthase showing the residues interacting with germacrene A as analysed by 
Leview. Germacrene A is displayed as yellow sticks with the three magnesium ions 
displayed as red dots. Resides Y527, Y367, Y520 and I294 are labelled and displayed as 
sticks due to their location in relation to similar residues in the SeDS active site as shown by 
alignment (Figure 4-28). (b) Active site image of selina-4(15),7(11)-diene synthase showing 












Figure 4-28 Structural alignment of selina-4(15),7(11)-diene synthase with tobacco 5-
epi-aristolochene synthase (PDB 4OKZ, 4OKM, 5EAS, 5IK0, 5IK6 and 5IKA). Structural 
alignment using the SALIGN web tool gave a score of 81.8 %. 4OKZ is coloured 
aquamarine, 4OKM is coloured blue, 5EAS is coloured pink, 5IK0 is coloured in pale pink, 
5IK6 is coloured purple and 5IKA is coloured orange. (A) Structural alignment of all 
structures using only chain A of both 4OKM and 4OKZ. From the image the active site of all 
enzymes aligns well with a score of 81.8%. 5-epi-aristlochene is a significantly larger 
enzyme than one chain of SeDS. (B) Enlargement of the active site. Subtle differences 
between the two active sites specifically at the top of the enzyme active site can be seen.  
 
The SeDS active site (Figure 4-27 and 4-28) has three ring containing residues in the top 
half of the active site, F55, F79 and Y152. Engineering at both F79 and Y152 have led to 
changes in product profile and in activity levels of the enzyme and have been postulated to 
push the cation to favour the major product. Residues in similar positions are seen in 5-epi-
aristolochene with three tyrosines at positions 367, 520 and 527. Potentially these bulky 
residues direct the cation into a germacrene like shape and the remaining residues lead to 
the differences in product profile in between the two enzymes. In addition, the enzyme has 
an isoleucine at position 294 which is similar to the valine at position 187 in SeDS. This 
residue allows more space in the active site and could be a key residue in allowing the 
formation of the two rings of epi-aritsolochene, as with the two rings of selina-4(15),7(11)-
diene.  
 
Figure 4-28 shows the structural alignment of chain A of SeDS and 5-epi-aristolochene 
showing that the active sites are similar with a SALIGN alignment score of 81.8% (Braberg 
et al., 2012). Chain A is significantly smaller that 5-epi-aristolochene potentially explaining 
the product differences between the two enzymes and their two ringed products, as can be 
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seen at the bottom of Figure 4-28a. Figure 4-28b shows an enlargement of the active site 
region and shows the subtle differences between the two enzymes, specifically at what is 
described as the G-helix in SeDS (Figure 3-3). The subtle differences between the active 
sites could explain the product profile differences but show how the proposed reaction 
mechanism goes through the same initial stage with the formation of a germacrene ion.  
 
4.4 Summary 
The aim of this project was to engineer a sesquiterpene synthase to produce novel products, 
while gaining insight into the mechanism of action. Initial engineering used the technique of 
alanine scanning to identify a set of residues to target for further engineering. From the 
alanine scanning results the most interesting residue was F79A with the most significant loss 
in activity but also the most significant change in product profile. Despite the product profile 
change, a 50:50 ratio of wild-type products with additional peaks, the activity is too low to be 
useful. In addition to the further study of F79A, both F55A and L78A were kinetically 
characterised due to their initial activity test results (Figure 4-6). F55A shows an increase in 
Km whereas L78A shows no significant difference. Increasing the Km shows a reduction in 
affinity for the substrate (Figure 4-7 and 4-8). Therefore, F55A reduces the affinity for the 
substrate whereas L78A affects the reaction rate.  Increasing the Km and therefore 
decreasing affinity for the substrate would be useful method to potentially relax product 
specificity as terpene synthase products are determined by the active site contour shaping 
the cation. With reduced substrate affinity the cation may take up new conformations 
consequently diversifying the product profile. However, this must be balanced with the 
substrate having sufficient binding affinity for a productive conformation.  
 
Along with testing positions to target in further mutagenesis, but also tested screening 
methods for reliable and efficient results, both GC/MS in culture and malachite green assay 
were tested and compared. Overall, GC/MS screening was selected as the first initial screen 
as it was the most reliable, the easiest and of the two methods had the highest throughput.   
Following screening, a further two variants (Y152F and V187F) had the most significant 
change in product profile. No novel products were detected, however a selection of variants 
showed changes in the product distribution of the wild-type products (Figure 4-16 to 4-18). 
These mutations, along with other mutations with the most common result of screening, 
were taken forward for basic characterisation. The variants were purified and tested with the 
malachite green assay and with GC/MS screening (Figure 4-20 and 4-21). GC/MS product 
analysis from purified proteins confirmed the results of the ‘overlay screen’ (Figure 4-21 and 
4-22). Y15F and V187F were taken forward for kinetic characterisation to provide further 
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information on how the mutation affects the reaction (Figure 4-23 and 4-24). V187F shows 
an increase of 4-fold in Km showing a reduction in affinity for the substrate similar to F55A. 
V187F is a significant change in the active site shape reducing the available space in the 
enzyme active site pushing the product profile in favour of germacrene B.  No novel products 
have been characterised from our engineering efforts, however a change in specificity has 
been characterised with the mutation V187F. In addition, Y152F has shown a change in 
product profile ratio with 50:50 ratio of the two products. Y152F shows a 2-fold increase in 
Km a smaller reduction in affinity than V187F and a less significant change in active site 
contour and product profile.  
 
This engineering has shown key residues in determining the product profile and also key 
residues for activity levels. When comparing SeDS to other enzymes that also have a 
mechanism that progress through a germacrene cation, or which produce germacrenes, we 
find that these have similar size residues in the same position in the active site. This 
suggests that they could be important in steps leading to the formation of the germacrene 
cation. These residues include three containing ring structures at the top of the active site 
and a smaller non-polar residue at the bottom of the hydrophobic cleft. In conclusion the 
engineering of SeDS was successful in changing the product profile and giving mechanistic 




Chapter 5 – Conclusion  
 
This thesis has described the kinetic characterisation of engineering efforts of selina-
4(15),7(11)-diene synthase with the aim of producing novel products.  
 
Chapter 1 introduces natural product terpenes, which are a broad range of chemical 
products from simple C5 skeletons and the enzymes that produce this chemical diversity 
(Harms, Kirschning and Dickschat, 2020) (Zhou and Peters, 2011) (Ajikumar et al., 2008). 
Due to the broad range of uses for terpenes the recent focus has switched to engineering 
terpene synthase with the goal of increasing or decreasing specificity or expanding the 
range of characterised terpenes (Steiner and Schwab, 2012). The engineering  of terpene 
synthase can be rational, semi-rational engineering and directed evolution (Rynkiewicz, 
Cane and Christianson, 2002) (Li et al., 2014) (Lauchli et al., 2014) (Salmon et al., 2015). In 
addition to engineering for novel terpenes, terpene production pathways are engineering to 
increase the production of terpenes particularly in heterologous hosts (Chen, Zhang and 
Lindley, 2019) (Chang and Keasling, 2006). SeDS has previously been engineered with the 
intention of gaining mechanistic insight into its tight specificty, however it has never been 
engineered with the aim of producing novel products. As a result, further mutagenesis and 
further residue were targeted with the specific goal of producing novel terpenes form a highly 
specific terpene synthase.   
 
The first results chapter describes the selection of a sesquiterpene synthase to study and 
take forward. The criteria were the sesquiterpene synthase must be expressed 
heterologously expressed in E. coli, have a crystal structure available and limited previous 
engineering. From this criteria four sesquiterpene synthase were narrowed down to four 
sesquiterpene synthase which were further narrowed down to Abies grandis bisabolene 
synthase and Streptomyces pristinaespiralis selina-4(15),7(11)-diene synthase. Following 
initial expression trials, selina-4(15),7(11)-diene synthase was selected as the target enzyme 
due to its higher expression levels. Subsequently SeDS was used to optimise the malachite 
green enzyme assay to kinetically characterise the enzyme and calculate the kinetic 
parameters. The Vmax ranged from 0.9 to 0.4 µMmin-1, the Km ranges from 10.9 to 14.6 µM 
and the kcat 1 to 1.8 min-1. In addition, the product profile of SeDS was analysed using gas 
chromatography mass spectrometry on purified protein and “in culture” using and organic 




The second results chapter describes the engineering efforts of SeDS through site directed 
mutagenesis. Initial mutagenesis used alanine scanning at positions identified using ligand 
protein analysis software Ligplot+. These alanine mutants were screened using two methods 
to evaluate the screening throughput; malachite green assay and in culture GC/MS. 
Following the evaluation of the screening methods in-culture GC/MS screening was selected 
as the initial screening method for further mutagenesis, due to the accuracy between purified 
protein and expression culture samples therefore removing the need to purify samples and 
increasing the throughput. In addition, the alanine mutagenesis screening highlighted three 
positions which were further explored; F55A, L78A, F79A. All three variants were further 
tested in the malachite green assay to calculate kinetic parameters and GC/MS analysis. 
F55A’s and L78A’s product profile is similar to the wild-type product profile but with lower 
activity. Both variants’ kinetic parameters were calculated with F55A having a significant (6-
fold) increase in Km whereas the Km for L78A is within the wild-type range as with the 
variant’s other kinetic parameters. However, F79A was inactive in both screening method 
conditions. As a result, no kinetic parameters were calculated for F79A and an accurate 
product profile could not be determined. These results show F79 has a key role within the 
enzyme active site and due to its position near the mouth of active site potentially directing 
the cation down into the depth of the hydrophobic cleft and provided a starting point for 
further mutagenesis. 
 
Subsequently further mutagenesis was completed using the positions in alanine scanning 
and additional positions identified by the protein ligand interaction software Leview. A series 
of variants were produced for each position by site directed mutagenesis, based on a set of 
defined rules, and the variants were screened using “in culture” GC/MS. The majority of 
variants showed low activity or expression with a product profile resembling the wild-type 
profile. Two variants had interesting product profiles with V187F showing a switch specificity 
and Y152F’s profile changing to a 50:50 product ratio of selina-4(15),7(110-diene and 
germacrene B. Along with additional related variants, V187F and Y152F were tested with the 
malachite green enzyme assay and GC/MS with purified protein. In addition, the kinetic 
parameters were calculated. Both variants showed an increased Km and a reduced affinity 
for the substrate. V187F Km increased by a factor of 4 while Y152F Km increased by a factor 
of 2. This could explain the difference in the product profile changes with Y152F having 
higher binding affinity for farnesyl pyrophosphate reducing the potential orientations 
therefore there is only a partial switch in specificity. The differences might also be show that 




The immediate future research area would be to confirm the structures of the products by 
NMR spectroscopy as GC/MS analysis can only give a mass and all sesquiterpene products 
have the same mass. As a result, although a switch in specificity in the product distribution is 
observed, the identity of the products had not been elucidated. Initial work had begun on 
finding the concentration limit for farnesyl pyrophosphate with the spectrometer. To complete 
this concentration test, a sesquiterpene bisabolene standard was used and the optimal 
conditions, with the minimum farnesyl pyrophosphate concentration while maintaining a low 
background, was 100 #M with 1024 scans. Following the concentration optimisation, the 
sample preparation method was optimised as the product is separated from an incubated 
reaction in an aqueous solutions. The optimisation was to separate the products using snap 
freezing with an organic solvent based on methods of purification for GC-MS samples along 
with filtration with sodium sulfate. However, this work was unable to be completed using a 
reaction with purified SeDS. This confirmation would be undisputable proof the two peaks 
are selina-4(15),7(11)-diene and germacrene B.  
 
In addition, further investigation of positions Y152 and V187 would benefit the engineering 
effort. This further engineering could improve the selectivity of the altered product 
distribution or alternatively lead to the further changes in activity and product profiles. This 
further investigation would involve rational engineering, varying additional properties, at both 
positions including the addition of a sulfide in methionine to alter the active site environment. 
These changes can change the hydrophobicity within the active site altering the orientations 
of the cation. Also, a number of small hydrophobic amino acids were selected to see the 
how the loss of bulk affects the product ratio.  This work could have given further insight into 
the effect or importance of these positions in the control of the reaction mechanism.  
 
In conclusion, this research has provided insights into the active site cleft of SeDS and 
potential key residues involved in the determination of the products. Variants of F79, Y152 
and V187 have shown changes in the product profile or in activity. These positions vary 
within the active site, with F79A near the active site mouth while Y152 and V187 are deeper 
within the active site.  This work can be a grounding point for further engineering in SeDS 
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